<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
	<head>
		<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
		<meta http-equiv="Content-Style-Type" content="text/css" />
		<meta name="generator" content="MediaWiki 1.15alpha" />
		<meta name="keywords" content="Sertraline,Brand,British Journal of Psychiatry,CNN.com,David Healy (psychiatrist),Digital object identifier,Medicines and Healthcare products Regulatory Agency,News release,PLoS Medicine,Science (journal),Sic" />
		<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Sertraline&amp;action=edit" />
		<link rel="edit" title="Edit this page" href="/w/index.php?title=Sertraline&amp;action=edit" />
		<link rel="apple-touch-icon" href="http://en.wikipedia.org/apple-touch-icon.png" />
		<link rel="shortcut icon" href="/favicon.ico" />
		<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)" />
		<link rel="copyright" href="http://www.gnu.org/copyleft/fdl.html" />
		<link rel="alternate" type="application/rss+xml" title="Wikipedia RSS Feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=rss" />
		<link rel="alternate" type="application/atom+xml" title="Wikipedia Atom Feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=atom" />
		<title>Sertraline - Wikipedia, the free encyclopedia</title>
		<link rel="stylesheet" href="/skins-1.5/common/shared.css?207xx" type="text/css" media="screen" />
		<link rel="stylesheet" href="/skins-1.5/common/commonPrint.css?207xx" type="text/css" media="print" />
		<link rel="stylesheet" href="/skins-1.5/monobook/main.css?207xx" type="text/css" media="screen" />
		<link rel="stylesheet" href="/skins-1.5/chick/main.css?207xx" type="text/css" media="handheld" />
		<!--[if lt IE 5.5000]><link rel="stylesheet" href="/skins-1.5/monobook/IE50Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<!--[if IE 5.5000]><link rel="stylesheet" href="/skins-1.5/monobook/IE55Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<!--[if IE 6]><link rel="stylesheet" href="/skins-1.5/monobook/IE60Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<!--[if IE 7]><link rel="stylesheet" href="/skins-1.5/monobook/IE70Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Common.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" />
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Print.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" media="print" />
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Handheld.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" media="handheld" />
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Monobook.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" />
		<link rel="stylesheet" href="/w/index.php?title=-&amp;action=raw&amp;maxage=2678400&amp;gen=css" type="text/css" />
		<!--[if lt IE 7]><script type="text/javascript" src="/skins-1.5/common/IEFixes.js?207xx"></script>
		<meta http-equiv="imagetoolbar" content="no" /><![endif]-->

		<script type= "text/javascript">/*<![CDATA[*/
		var skin = "monobook";
		var stylepath = "/skins-1.5";
		var wgArticlePath = "/wiki/$1";
		var wgScriptPath = "/w";
		var wgScript = "/w/index.php";
		var wgVariantArticlePath = false;
		var wgActionPaths = {};
		var wgServer = "http://en.wikipedia.org";
		var wgCanonicalNamespace = "";
		var wgCanonicalSpecialPageName = false;
		var wgNamespaceNumber = 0;
		var wgPageName = "Sertraline";
		var wgTitle = "Sertraline";
		var wgAction = "view";
		var wgArticleId = "149612";
		var wgIsArticle = true;
		var wgUserName = null;
		var wgUserGroups = null;
		var wgUserLanguage = "en";
		var wgContentLanguage = "en";
		var wgBreakFrames = false;
		var wgCurRevisionId = 280831519;
		var wgVersion = "1.15alpha";
		var wgEnableAPI = true;
		var wgEnableWriteAPI = true;
		var wgSeparatorTransformTable = ["", ""];
		var wgDigitTransformTable = ["", ""];
		var wgMWSuggestTemplate = "http://en.wikipedia.org/w/api.php?action=opensearch\x26search={searchTerms}\x26namespace={namespaces}\x26suggest";
		var wgDBname = "enwiki";
		var wgSearchNamespaces = [0];
		var wgMWSuggestMessages = ["with suggestions", "no suggestions"];
		var wgRestrictionEdit = [];
		var wgRestrictionMove = [];
		/*]]>*/</script>

		<script type="text/javascript" src="/skins-1.5/common/wikibits.js?207xx"><!-- wikibits js --></script>
		<!-- Head Scripts -->
		<script type="text/javascript" src="/skins-1.5/common/ajax.js?207xx"></script>
		<script type="text/javascript" src="/skins-1.5/common/mwsuggest.js?207xx"></script>
<script type="text/javascript">/*<![CDATA[*/
var wgNotice='';var wgNoticeLocal='';
/*]]>*/</script>		<script type="text/javascript" src="http://upload.wikimedia.org/centralnotice/wikipedia/en/centralnotice.js?207xx"></script>
		<script type="text/javascript" src="/w/index.php?title=-&amp;action=raw&amp;gen=js&amp;useskin=monobook"><!-- site js --></script>
	</head>
<body class="mediawiki ltr ns-0 ns-subject page-Sertraline skin-monobook">
	<div id="globalWrapper">
		<div id="column-content">
	<div id="content">
		<a name="top" id="top"></a>
		<div id="siteNotice"><script type='text/javascript'>if (wgNotice != '') document.writeln(wgNotice);</script></div>		<h1 id="firstHeading" class="firstHeading">Sertraline</h1>
		<div id="bodyContent">
			<h3 id="siteSub">From Wikipedia, the free encyclopedia</h3>
			<div id="contentSub"></div>
									<div id="jump-to-nav">Jump to: <a href="#column-one">navigation</a>, <a href="#searchInput">search</a></div>			<!-- start content -->
			<div class="dablink">"Lustral" redirects here. For the electronic music band, see <a href="/wiki/Lustral_(band)" title="Lustral (band)">Lustral (band)</a>.</div>
<table id="drugInfoBox" style="float: right; clear: right; margin: 0 0 0.5em 1em; background: #ffffff;" class="toccolours" border="0" cellpadding="1" align="right" width="280">
<tr>
<td align="center" colspan="2"><a href="/wiki/File:Sertraline_structure.svg" class="image" title="Sertraline structure.svg"><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/thumb/9/9f/Sertraline_structure.svg/200px-Sertraline_structure.svg.png" width="200" height="126" border="0" /></a></td>
</tr>
<tr>
<td align="center" colspan="2"><a href="/wiki/File:Sertraline-A-3D-balls.png" class="image" title="Sertraline-A-3D-balls.png"><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/thumb/6/61/Sertraline-A-3D-balls.png/200px-Sertraline-A-3D-balls.png" width="200" height="124" border="0" /></a></td>
</tr>
<tr>
<td align="center" colspan="2">
<div style="font-size:medium; line-height:167%;">Sertraline</div>
</td>
</tr>
<tr>
<td align="center" colspan="2" bgcolor="#DDDDDD"><b>Systematic (<a href="/wiki/International_Union_of_Pure_and_Applied_Chemistry_nomenclature" title="International Union of Pure and Applied Chemistry nomenclature" class="mw-redirect">IUPAC</a>) name</b></td>
</tr>
<tr>
<td bgcolor="#EEEEEE" style="text-align: center; vertical-align: top;" colspan="2"><span style="font-size:11px">(1<i>S</i>,4<i>S</i>)-4-(3,4-dichlorophenyl)-<i>N</i>-methyl-1,2,3,4-tetrahydronaphthalen-1-amine</span></td>
</tr>
<tr>
<td colspan="2" bgcolor="#DDDDDD"><b>Identifiers</b></td>
</tr>
<tr>
<td bgcolor="#DDEEFF" width="90"><a href="/wiki/CAS_registry_number" title="CAS registry number">CAS number</a></td>
<td bgcolor="#EEEEEE"><span class="reflink plainlinksneverexpand"><a href="http://www.nlm.nih.gov/cgi/mesh/2009/MB_cgi?term=79617-96-2&amp;rn=1" class="external text" title="http://www.nlm.nih.gov/cgi/mesh/2009/MB_cgi?term=79617-96-2&amp;rn=1" rel="nofollow">79617-96-2</a></span></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="/wiki/Anatomical_Therapeutic_Chemical_Classification_System" title="Anatomical Therapeutic Chemical Classification System">ATC code</a></td>
<td bgcolor="#EEEEEE"><a href="/wiki/ATC_code_N06" title="ATC code N06">N06</a><span class="reflink plainlinksneverexpand"><a href="http://www.whocc.no/atcddd/indexdatabase/index.php?query=N06AB06" class="external text" title="http://www.whocc.no/atcddd/indexdatabase/index.php?query=N06AB06" rel="nofollow">AB06</a></span></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="/wiki/PubChem" title="PubChem">PubChem</a></td>
<td bgcolor="#EEEEEE"><span class="reflink plainlinksneverexpand"><a href="http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=68617" class="external text" title="http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=68617" rel="nofollow">68617</a></span></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="/wiki/DrugBank" title="DrugBank">DrugBank</a></td>
<td bgcolor="#EEEEEE"><span class="reflink plainlinksneverexpand"><a href="http://www.drugbank.ca/cgi-bin/show_drug.cgi?CARD=APRD00175" class="external text" title="http://www.drugbank.ca/cgi-bin/show_drug.cgi?CARD=APRD00175" rel="nofollow">APRD00175</a></span></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="/wiki/ChemSpider" title="ChemSpider">ChemSpider</a></td>
<td bgcolor="#EEEEEE"><span class="reflink plainlinksneverexpand"><a href="http://www.chemspider.com/Chemical-Structure.61881" class="external text" title="http://www.chemspider.com/Chemical-Structure.61881" rel="nofollow">61881</a></span></td>
</tr>
<tr>
<td colspan="2" bgcolor="#DDDDDD"><b>Chemical data</b></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="/wiki/Chemical_formula" title="Chemical formula">Formula</a></td>
<td bgcolor="#EEEEEE"><a href="/wiki/Carbon" title="Carbon"><span style="color: rgb(000,000,000); font-weight: bold;">C</span></a><sub>17</sub><a href="/wiki/Hydrogen" title="Hydrogen"><span style="color: rgb(77,77,77); font-weight: bold;">H</span></a><sub>17</sub><a href="/wiki/Chlorine" title="Chlorine"><span style="color: rgb(15,95,15); font-weight: bold;">Cl</span></a><sub>2</sub><a href="/wiki/Nitrogen" title="Nitrogen"><span style="color: rgb(0,0,128); font-weight: bold;">N</span></a><sup>&#160;</sup></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="/wiki/Molecular_mass" title="Molecular mass">Mol. mass</a></td>
<td bgcolor="#EEEEEE">306.229 g/mol</td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="/wiki/Simplified_molecular_input_line_entry_specification" title="Simplified molecular input line entry specification">SMILES</a></td>
<td bgcolor="#EEEEEE"><span class="reflink plainlinksneverexpand"><a href="http://www.emolecules.com/cgi-bin/search?t=ex&amp;q=CN%5BC%40H%5D1CC%5BC%40%40H%5D%28c2ccc%28Cl%29c%28Cl%29c2%29c2ccccc12" class="external text" title="http://www.emolecules.com/cgi-bin/search?t=ex&amp;q=CN%5BC%40H%5D1CC%5BC%40%40H%5D%28c2ccc%28Cl%29c%28Cl%29c2%29c2ccccc12" rel="nofollow">eMolecules</a></span> &amp; <span class="reflink plainlinksneverexpand"><a href="http://pubchem.ncbi.nlm.nih.gov/search/?smarts=CN%5BC%40H%5D1CC%5BC%40%40H%5D%28c2ccc%28Cl%29c%28Cl%29c2%29c2ccccc12" class="external text" title="http://pubchem.ncbi.nlm.nih.gov/search/?smarts=CN%5BC%40H%5D1CC%5BC%40%40H%5D%28c2ccc%28Cl%29c%28Cl%29c2%29c2ccccc12" rel="nofollow">PubChem</a></span></td>
</tr>
<tr>
<td colspan="2" bgcolor="#DDDDDD"><b>Pharmacokinetic data</b></td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="/wiki/Bioavailability" title="Bioavailability">Bioavailability</a></td>
<td bgcolor="#EEEEEE">44%</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="/wiki/Drug_metabolism" title="Drug metabolism">Metabolism</a></td>
<td bgcolor="#EEEEEE">N-<a href="/wiki/Demethylation" title="Demethylation">demethylation</a> (<a href="/wiki/Liver" title="Liver">liver</a>)</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="/wiki/Biological_half-life" title="Biological half-life">Half life</a></td>
<td bgcolor="#EEEEEE">Approximately 26 hours</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="/wiki/Excretion" title="Excretion">Excretion</a></td>
<td bgcolor="#EEEEEE">Renal</td>
</tr>
<tr>
<td colspan="2" bgcolor="#DDDDDD"><b>Therapeutic considerations</b></td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="/wiki/Pregnancy_category" title="Pregnancy category">Pregnancy cat.</a></td>
<td bgcolor="#EEEEEE">
<p>C</p>
</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="/wiki/Regulation_of_therapeutic_goods" title="Regulation of therapeutic goods">Legal status</a></td>
<td bgcolor="#EEEEEE">
<p><span class="Unicode">℞</span> P<small>rescription only</small></p>
</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="/wiki/Route_of_administration" title="Route of administration">Routes</a></td>
<td bgcolor="#EEEEEE">Oral</td>
</tr>
</table>
<p><b>Sertraline hydrochloride</b> (trade names <b>Zoloft</b>, <b>Lustral</b>) is an <a href="/wiki/Antidepressant" title="Antidepressant">antidepressant</a> of the <a href="/wiki/Selective_serotonin_reuptake_inhibitor" title="Selective serotonin reuptake inhibitor">selective serotonin reuptake inhibitor</a> (SSRI) class. It was introduced to the market by <a href="/wiki/Pfizer" title="Pfizer">Pfizer</a> in 1991. Sertraline is primarily used to treat <a href="/wiki/Major_depressive_disorder" title="Major depressive disorder">major depression</a> in adult <a href="/wiki/Patient#Outpatient_vs_inpatient" title="Patient">outpatients</a> as well as <a href="/wiki/Obsessive-compulsive_disorder" title="Obsessive-compulsive disorder">obsessive–compulsive</a>, <a href="/wiki/Panic_disorder" title="Panic disorder">panic</a>, and <a href="/wiki/Social_phobia" title="Social phobia">social anxiety</a> disorders in both adults and children. In 2007, it was the most prescribed antidepressant on the U.S. retail market, with 29,652,000 prescriptions.<sup id="cite_ref-0" class="reference"><a href="#cite_note-0" title=""><span>[</span>1<span>]</span></a></sup></p>
<p>The efficacy of sertraline for depression is similar to that of older <a href="/wiki/Tricyclic_antidepressant" title="Tricyclic antidepressant">tricyclic antidepressants</a>, but its <a href="/wiki/Adverse_drug_reaction" title="Adverse drug reaction">side effects</a> are much less pronounced. Differences with newer antidepressants are subtler and also mostly confined to side effects. Evidence suggests that sertraline may work better than <a href="/wiki/Fluoxetine" title="Fluoxetine">fluoxetine</a> (Prozac) for some subtypes of depression.<sup id="cite_ref-pmid10529069_1-0" class="reference"><a href="#cite_note-pmid10529069-1" title=""><span>[</span>2<span>]</span></a></sup> Sertraline is highly effective for the treatment of panic disorder, but <a href="/wiki/Cognitive_behavioral_therapy" title="Cognitive behavioral therapy">cognitive behavioral therapy</a> is a better treatment for obsessive-compulsive disorder, whether by itself or in combination with sertraline. Although approved for <a href="/wiki/Social_phobia" title="Social phobia">social phobia</a> and <a href="/wiki/Posttraumatic_stress_disorder" title="Posttraumatic stress disorder">posttraumatic stress disorder</a>, sertraline leads to only modest improvement in these conditions.<sup id="cite_ref-pmid14709946_2-0" class="reference"><a href="#cite_note-pmid14709946-2" title=""><span>[</span>3<span>]</span></a></sup><sup id="cite_ref-pmid11343529_3-0" class="reference"><a href="#cite_note-pmid11343529-3" title=""><span>[</span>4<span>]</span></a></sup> Sertraline also alleviates the symptoms of <a href="/wiki/Premenstrual_dysphoric_disorder" title="Premenstrual dysphoric disorder">premenstrual dysphoric disorder</a> and can be used in sub-therapeutic doses or intermittently for its treatment.</p>
<p>Sertraline shares the common side effects and <a href="/wiki/Contraindication" title="Contraindication">contraindications</a> of other SSRIs, with high rates of nausea, diarrhea, insomnia, and sexual side effects; however, it does not cause <a href="/wiki/Weight_gain" title="Weight gain">weight gain</a>, and its effects on cognition are mild. In <a href="/wiki/Pregnancy" title="Pregnancy">pregnant women</a> taking sertraline, the drug was present in significant concentrations in <a href="/wiki/Fetal_hemoglobin" title="Fetal hemoglobin">fetal blood</a>, and was also associated with a higher rate of various <a href="/wiki/Congenital_disorder#Congenital_malformations_.28birth_defects.29" title="Congenital disorder">birth defects</a>. Similarly to other antidepressants, the use of sertraline for depression may be associated with a higher rate of suicidality. Due to the rarity of this side effect, <a href="/wiki/Statistical_significance" title="Statistical significance">statistically significant</a> data is difficult to obtain, and suicidality continues to be a subject of controversy.</p>
<table id="toc" class="toc" summary="Contents">
<tr>
<td>
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1"><a href="#History"><span class="tocnumber">1</span> <span class="toctext">History</span></a></li>
<li class="toclevel-1"><a href="#Indications"><span class="tocnumber">2</span> <span class="toctext">Indications</span></a>
<ul>
<li class="toclevel-2"><a href="#Depression"><span class="tocnumber">2.1</span> <span class="toctext">Depression</span></a>
<ul>
<li class="toclevel-3"><a href="#Comparison_with_tricyclic_antidepressants"><span class="tocnumber">2.1.1</span> <span class="toctext">Comparison with tricyclic antidepressants</span></a></li>
<li class="toclevel-3"><a href="#Comparison_with_other_antidepressants"><span class="tocnumber">2.1.2</span> <span class="toctext">Comparison with other antidepressants</span></a></li>
<li class="toclevel-3"><a href="#Depression_in_the_elderly"><span class="tocnumber">2.1.3</span> <span class="toctext">Depression in the elderly</span></a></li>
</ul>
</li>
<li class="toclevel-2"><a href="#Obsessive-compulsive_disorder"><span class="tocnumber">2.2</span> <span class="toctext">Obsessive-compulsive disorder</span></a></li>
<li class="toclevel-2"><a href="#Panic_disorder"><span class="tocnumber">2.3</span> <span class="toctext">Panic disorder</span></a></li>
<li class="toclevel-2"><a href="#Social_phobia"><span class="tocnumber">2.4</span> <span class="toctext">Social phobia</span></a></li>
<li class="toclevel-2"><a href="#Premenstrual_dysphoric_disorder"><span class="tocnumber">2.5</span> <span class="toctext">Premenstrual dysphoric disorder</span></a></li>
<li class="toclevel-2"><a href="#Posttraumatic_stress_disorder"><span class="tocnumber">2.6</span> <span class="toctext">Posttraumatic stress disorder</span></a></li>
<li class="toclevel-2"><a href="#Other_indications"><span class="tocnumber">2.7</span> <span class="toctext">Other indications</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Adverse_effects"><span class="tocnumber">3</span> <span class="toctext">Adverse effects</span></a>
<ul>
<li class="toclevel-2"><a href="#Birth_defects_and_effects_on_breast-fed_infants"><span class="tocnumber">3.1</span> <span class="toctext">Birth defects and effects on breast-fed infants</span></a></li>
<li class="toclevel-2"><a href="#Sexual_side_effects"><span class="tocnumber">3.2</span> <span class="toctext">Sexual side effects</span></a></li>
<li class="toclevel-2"><a href="#Suicidality"><span class="tocnumber">3.3</span> <span class="toctext">Suicidality</span></a></li>
<li class="toclevel-2"><a href="#Discontinuation_syndrome"><span class="tocnumber">3.4</span> <span class="toctext">Discontinuation syndrome</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Mechanism_of_action"><span class="tocnumber">4</span> <span class="toctext">Mechanism of action</span></a></li>
<li class="toclevel-1"><a href="#Pharmacokinetics"><span class="tocnumber">5</span> <span class="toctext">Pharmacokinetics</span></a></li>
<li class="toclevel-1"><a href="#Interactions"><span class="tocnumber">6</span> <span class="toctext">Interactions</span></a></li>
<li class="toclevel-1"><a href="#Controversy"><span class="tocnumber">7</span> <span class="toctext">Controversy</span></a></li>
<li class="toclevel-1"><a href="#Notes"><span class="tocnumber">8</span> <span class="toctext">Notes</span></a></li>
<li class="toclevel-1"><a href="#References"><span class="tocnumber">9</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1"><a href="#External_links"><span class="tocnumber">10</span> <span class="toctext">External links</span></a></li>
</ul>
</td>
</tr>
</table>
<script type="text/javascript">
//<![CDATA[
 if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } 
//]]>
</script>
<p><a name="History" id="History"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Sertraline&amp;action=edit&amp;section=1" title="Edit section: History">edit</a>]</span> <span class="mw-headline">History</span></h2>
<div class="thumb tright">
<div class="thumbinner" style="width:182px;"><a href="/wiki/File:Chlorprotixene_and_tametraline.png" class="image" title="Skeletal formulae of chlorprothixene and tametraline, from which sertraline was derived"><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/thumb/7/73/Chlorprotixene_and_tametraline.png/180px-Chlorprotixene_and_tametraline.png" width="180" height="289" border="0" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Chlorprotixene_and_tametraline.png" class="internal" title="Enlarge"><img src="/skins-1.5/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
<a href="/wiki/Skeletal_formula" title="Skeletal formula">Skeletal formulae</a> of chlorprothixene and tametraline, from which sertraline was derived</div>
</div>
</div>
<p>The history of sertraline dates back to the early 1970s, when <a href="/wiki/Pfizer" title="Pfizer">Pfizer</a> chemist Reinhard Sarges invented a novel series of psychoactive compounds based on the structures of neuroleptics <a href="/wiki/Chlorprothixene" title="Chlorprothixene">chlorprothixene</a> and <a href="/wiki/Thiothixene" title="Thiothixene">thiothixene</a>.<sup id="cite_ref-Welch_4-0" class="reference"><a href="#cite_note-Welch-4" title=""><span>[</span>5<span>]</span></a></sup><sup id="cite_ref-5" class="reference"><a href="#cite_note-5" title=""><span>[</span>6<span>]</span></a></sup> Further work on these compounds led to tametraline, a <a href="/wiki/Norepinephrine_reuptake_inhibitor" title="Norepinephrine reuptake inhibitor">norepinephrine</a> and weaker <a href="/wiki/Dopamine_reuptake_inhibitor" title="Dopamine reuptake inhibitor">dopamine reuptake inhibitor</a>. Development of tametraline was soon stopped because of undesired <a href="/wiki/Stimulant" title="Stimulant">stimulant</a> effects observed in animals. A few years later, in 1977, pharmacologist Kenneth Koe, after comparing the structural features of a variety of reuptake inhibitors, became interested in the tametraline series. He asked another Pfizer chemist, Willard Welch, to synthesize some previously unexplored tametraline derivatives. Welch generated a number of potent norepinephrine and <a href="/wiki/Serotonin-noradrenaline-dopamine_reuptake_inhibitor" title="Serotonin-noradrenaline-dopamine reuptake inhibitor">triple reuptake</a> inhibitors, but to the surprise of the scientists, one representative of the generally inactive <a href="/wiki/Cis-trans_isomerism" title="Cis-trans isomerism">cis-analogs</a> was a serotonin reuptake inhibitor. Welch then prepared <a href="/wiki/Stereoisomerism" title="Stereoisomerism">stereoisomers</a> of this compound, which were tested <i><a href="/wiki/In_vivo" title="In vivo">in vivo</a></i> by animal <a href="/wiki/Behavioural_sciences" title="Behavioural sciences">behavioral scientist</a> Albert Weissman. The most potent and selective (+)-isomer was taken into further development and eventually named sertraline. Weissman and Koe recalled that the group did not set up to produce an antidepressant of the SSRI type—in that sense their inquiry was not "very goal driven", and the discovery of the sertraline molecule was <a href="/wiki/Serendipity#Pharmacology" title="Serendipity">serendipitous</a>. According to Welch, they worked outside the mainstream at Pfizer, and even "did not have a formal project team". The group had to overcome initial bureaucratic reluctance to pursue sertraline development, as Pfizer was considering licensing an antidepressant candidate from another company.<sup id="cite_ref-Welch_4-1" class="reference"><a href="#cite_note-Welch-4" title=""><span>[</span>5<span>]</span></a></sup><sup id="cite_ref-6" class="reference"><a href="#cite_note-6" title=""><span>[</span>7<span>]</span></a></sup><sup id="cite_ref-7" class="reference"><a href="#cite_note-7" title=""><span>[</span>8<span>]</span></a></sup></p>
<p>Sertraline was approved by the U.S. <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration" class="mw-redirect">Food and Drug Administration</a> (FDA) in 1991 based on the recommendation of the Psychopharmacological Drugs Advisory Committee; it had already become available in <a href="/wiki/United_Kingdom" title="United Kingdom">the United Kingdom</a> the previous year.<sup id="cite_ref-He168_8-0" class="reference"><a href="#cite_note-He168-8" title=""><span>[</span>9<span>]</span></a></sup> The FDA committee achieved a consensus that sertraline was safe and effective for the treatment of <a href="/wiki/Major_depressive_disorder" title="Major depressive disorder">major depression</a>. During the discussion, Paul Leber, Director of the FDA Division of Neuropharmacological Drug Products, noted that granting approval was a "tough decision", since the treatment effect on <a href="/wiki/Patient#Outpatient_vs_inpatient" title="Patient">outpatients</a> with depression had been "modest to minimal". Other experts emphasized that the drug's effect on inpatients had not differed from <a href="/wiki/Placebo" title="Placebo">placebo</a> and criticized poor design of the trials by Pfizer.<sup id="cite_ref-pdac_9-0" class="reference"><a href="#cite_note-pdac-9" title=""><span>[</span>10<span>]</span></a></sup> For example, 40% of participants dropped out of the trials, significantly decreasing their <a href="/wiki/Validity" title="Validity">validity</a>.<sup id="cite_ref-pmid8573661_10-0" class="reference"><a href="#cite_note-pmid8573661-10" title=""><span>[</span>11<span>]</span></a></sup></p>
<p>Sertraline entered the <a href="/wiki/Australia" title="Australia">Australian</a> market in 1994 and became the most often prescribed antidepressant in 1996 (2004 data).<sup id="cite_ref-pmid15462638_11-0" class="reference"><a href="#cite_note-pmid15462638-11" title=""><span>[</span>12<span>]</span></a></sup> It was measured as among the top ten drugs ranked by cost to the Australian government in 1998 and 2000–01, having cost $45 million and $87 million in subsidies respectively.<sup id="cite_ref-12" class="reference"><a href="#cite_note-12" title=""><span>[</span>13<span>]</span></a></sup><sup id="cite_ref-13" class="reference"><a href="#cite_note-13" title=""><span>[</span>14<span>]</span></a></sup> Sertraline is less popular in the UK (2003 data) and Canada (2006 data)—in both countries it was fifth, based on the number of prescriptions.<sup id="cite_ref-url_14-0" class="reference"><a href="#cite_note-url-14" title=""><span>[</span>15<span>]</span></a></sup><sup id="cite_ref-15" class="reference"><a href="#cite_note-15" title=""><span>[</span>16<span>]</span></a></sup></p>
<p>Until 2002, sertraline was only approved for use in adults ages 18 and over; that year, it was approved by the FDA for use in treating children aged 6 or older with severe <a href="/wiki/Obsessive-compulsive_disorder" title="Obsessive-compulsive disorder">obsessive-compulsive disorder</a> (OCD). In 2003, the UK <a href="/wiki/Medicines_and_Healthcare_products_Regulatory_Agency" title="Medicines and Healthcare products Regulatory Agency">Medicines and Healthcare products Regulatory Agency</a> issued a guidance that, apart from <a href="/wiki/Fluoxetine" title="Fluoxetine">fluoxetine</a> (trade name<span class="reference"><sup id="ref_TradeNameA"><a href="#endnote_TradeNameA" title="">[A]</a></sup></span> Prozac), <a href="/wiki/Selective_serotonin_reuptake_inhibitor" title="Selective serotonin reuptake inhibitor">SSRIs</a> are not suitable for the treatment of depression in patients under 18.<sup id="cite_ref-16" class="reference"><a href="#cite_note-16" title=""><span>[</span>17<span>]</span></a></sup><sup id="cite_ref-17" class="reference"><a href="#cite_note-17" title=""><span>[</span>18<span>]</span></a></sup> However, sertraline can still be used in the UK for the treatment of OCD in children and adolescents.<sup id="cite_ref-18" class="reference"><a href="#cite_note-18" title=""><span>[</span>19<span>]</span></a></sup> In 2005, the FDA added a <a href="/wiki/Black_box_warning" title="Black box warning">black box warning</a> concerning pediatric suicidality to all <a href="/wiki/Antidepressant" title="Antidepressant">antidepressants</a>, including sertraline. In 2007, labeling was again changed to add a warning regarding suicidality in young adults ages 18 to 24.<sup id="cite_ref-19" class="reference"><a href="#cite_note-19" title=""><span>[</span>20<span>]</span></a></sup></p>
<p>The <a href="/wiki/United_States_patent_law" title="United States patent law">U.S. patent</a> for Zoloft expired in 2006,<sup id="cite_ref-20" class="reference"><a href="#cite_note-20" title=""><span>[</span>21<span>]</span></a></sup> and sertraline is now available in <a href="/wiki/Generic_drug" title="Generic drug">generic</a> form.</p>
<p><a name="Indications" id="Indications"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Sertraline&amp;action=edit&amp;section=2" title="Edit section: Indications">edit</a>]</span> <span class="mw-headline">Indications</span></h2>
<p>Sertraline has been approved for the following indications: <a href="/wiki/Major_depressive_disorder" title="Major depressive disorder">major depression</a>, <a href="/wiki/Obsessive-compulsive_disorder" title="Obsessive-compulsive disorder">obsessive-compulsive disorder</a> (OCD), <a href="/wiki/Posttraumatic_stress_disorder" title="Posttraumatic stress disorder">posttraumatic stress disorder</a> (PTSD), <a href="/wiki/Premenstrual_dysphoric_disorder" title="Premenstrual dysphoric disorder">premenstrual dysphoric disorder</a> (PMDD), <a href="/wiki/Panic_disorder" title="Panic disorder">panic disorder</a> and <a href="/wiki/Social_phobia" title="Social phobia">social phobia</a> (social <a href="/wiki/Anxiety_disorder" title="Anxiety disorder">anxiety disorder</a>).</p>
<p><a name="Depression" id="Depression"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Sertraline&amp;action=edit&amp;section=3" title="Edit section: Depression">edit</a>]</span> <span class="mw-headline">Depression</span></h3>
<p>The original pre-marketing clinical trials demonstrated only weak-to-moderate efficacy of sertraline for depression.<sup id="cite_ref-pmid18199864_21-0" class="reference"><a href="#cite_note-pmid18199864-21" title=""><span>[</span>22<span>]</span></a></sup> Nevertheless, a considerable body of later research established it as one of the drugs of choice for the treatment of depression in <a href="/wiki/Patient#Outpatient_vs_inpatient" title="Patient">outpatients</a>. Despite the negative results of early trials, sertraline is often used to treat depressed inpatients as well.<sup id="cite_ref-pmid17475736_22-0" class="reference"><a href="#cite_note-pmid17475736-22" title=""><span>[</span>23<span>]</span></a></sup> Sertraline is effective for both severe depression<sup id="cite_ref-pmid10993128_23-0" class="reference"><a href="#cite_note-pmid10993128-23" title=""><span>[</span>24<span>]</span></a></sup> and <a href="/wiki/Dysthymia" title="Dysthymia">dysthymia</a>, a milder and more chronic variety of depression. In several <a href="/wiki/Blind_experiment#Double-blind_trials" title="Blind experiment">double-blind</a> studies, sertraline was consistently more effective than <a href="/wiki/Placebo" title="Placebo">placebo</a> for dysthymia<sup id="cite_ref-pmid11105734_24-0" class="reference"><a href="#cite_note-pmid11105734-24" title=""><span>[</span>25<span>]</span></a></sup><sup id="cite_ref-pmid8792754_25-0" class="reference"><a href="#cite_note-pmid8792754-25" title=""><span>[</span>26<span>]</span></a></sup><sup id="cite_ref-pmid10518174_26-0" class="reference"><a href="#cite_note-pmid10518174-26" title=""><span>[</span>27<span>]</span></a></sup><sup id="cite_ref-pmid16263177_27-0" class="reference"><a href="#cite_note-pmid16263177-27" title=""><span>[</span>28<span>]</span></a></sup> and comparable to <a href="/wiki/Imipramine" title="Imipramine">imipramine</a> (Tofranil) in that respect.<sup id="cite_ref-pmid8792754_25-1" class="reference"><a href="#cite_note-pmid8792754-25" title=""><span>[</span>26<span>]</span></a></sup> Sertraline also improved the depression of dysthymic patients to a greater degree than group <a href="/wiki/Cognitive_behavioral_therapy" title="Cognitive behavioral therapy">cognitive behavioral therapy</a> or <a href="/wiki/Interpersonal_psychotherapy" title="Interpersonal psychotherapy">interpersonal psychotherapy</a>, and adding psychotherapy to sertraline did not seem to enhance the outcome.<sup id="cite_ref-pmid10518174_26-1" class="reference"><a href="#cite_note-pmid10518174-26" title=""><span>[</span>27<span>]</span></a></sup><sup id="cite_ref-pmid16263177_27-1" class="reference"><a href="#cite_note-pmid16263177-27" title=""><span>[</span>28<span>]</span></a></sup> These results also held up in a two-year follow-up of sertraline-treated and interpersonal-therapy-treated groups.<sup id="cite_ref-pmid12063159_28-0" class="reference"><a href="#cite_note-pmid12063159-28" title=""><span>[</span>29<span>]</span></a></sup> In the treatment of depression accompanied by <a href="/wiki/Obsessive-compulsive_disorder" title="Obsessive-compulsive disorder">OCD</a>, sertraline performed <a href="/wiki/Statistical_significance" title="Statistical significance">significantly</a> better than <a href="/wiki/Desipramine" title="Desipramine">desipramine</a> (Norpramine) on the measures of both OCD and depression.<sup id="cite_ref-pmid10632236_29-0" class="reference"><a href="#cite_note-pmid10632236-29" title=""><span>[</span>30<span>]</span></a></sup> Sertraline was equivalent to imipramine for the treatment of depression with co-morbid <a href="/wiki/Panic_disorder" title="Panic disorder">panic disorder</a>, but it was better tolerated.<sup id="cite_ref-pmid12823079_30-0" class="reference"><a href="#cite_note-pmid12823079-30" title=""><span>[</span>31<span>]</span></a></sup> Sertraline treatment of depressed patients with co-morbid <a href="/wiki/Personality_disorder" title="Personality disorder">personality disorders</a> improved their personality traits, and this improvement was almost independent from the improvement of their depression.<sup id="cite_ref-pmid9817625_31-0" class="reference"><a href="#cite_note-pmid9817625-31" title=""><span>[</span>32<span>]</span></a></sup></p>
<p><a name="Comparison_with_tricyclic_antidepressants" id="Comparison_with_tricyclic_antidepressants"></a></p>
<h4><span class="editsection">[<a href="/w/index.php?title=Sertraline&amp;action=edit&amp;section=4" title="Edit section: Comparison with tricyclic antidepressants">edit</a>]</span> <span class="mw-headline">Comparison with tricyclic antidepressants</span></h4>
<p>The effect of sertraline on the core symptoms of depression is similar to that of <a href="/wiki/Tricyclic_antidepressant" title="Tricyclic antidepressant">tricyclic antidepressants</a> (TCAs); however, it is better tolerated and results in a better <a href="/wiki/Quality_of_life" title="Quality of life">quality of life</a>. Similar improvement of depression scores was seen in studies comparing sertraline with <a href="/wiki/Clomipramine" title="Clomipramine">clomipramine</a> (Anafranil)<sup id="cite_ref-pmid10993128_23-1" class="reference"><a href="#cite_note-pmid10993128-23" title=""><span>[</span>24<span>]</span></a></sup> and <a href="/wiki/Amitriptyline" title="Amitriptyline">amitriptyline</a> (Elavil).<sup id="cite_ref-pmid2258378_32-0" class="reference"><a href="#cite_note-pmid2258378-32" title=""><span>[</span>33<span>]</span></a></sup><sup id="cite_ref-pmid9413414_33-0" class="reference"><a href="#cite_note-pmid9413414-33" title=""><span>[</span>34<span>]</span></a></sup> At the same time, sertraline resulted in a much lower rate of side effects than amitriptyline (49%, vs. 72% for amitriptyline and 32% for <a href="/wiki/Placebo" title="Placebo">placebo</a>), particularly dry mouth, somnolence, constipation and <a href="/wiki/Polyphagia" title="Polyphagia">increased appetite</a>.<sup id="cite_ref-pmid9413414_33-1" class="reference"><a href="#cite_note-pmid9413414-33" title=""><span>[</span>34<span>]</span></a></sup> However, there were more cases of nausea and <a href="/wiki/Sexual_dysfunction" title="Sexual dysfunction">sexual dysfunction</a> in the sertraline group.<sup id="cite_ref-pmid2258378_32-1" class="reference"><a href="#cite_note-pmid2258378-32" title=""><span>[</span>33<span>]</span></a></sup><sup id="cite_ref-pmid9413414_33-2" class="reference"><a href="#cite_note-pmid9413414-33" title=""><span>[</span>34<span>]</span></a></sup> Participants taking sertraline showed a greater improvement of the subjective quality of life on such measures as work satisfaction, subjective feeling, perceptions of health and cognitive function.<sup id="cite_ref-pmid9413414_33-3" class="reference"><a href="#cite_note-pmid9413414-33" title=""><span>[</span>34<span>]</span></a></sup></p>
<p>A large and thorough <a href="/wiki/Blind_experiment#Double-blind_trials" title="Blind experiment">double-blind</a> study compared sertraline—prescribed for chronic (longer than two years) depression or depression with <a href="/wiki/Dysthymia" title="Dysthymia">dysthymia</a>—to the "gold standard" of depression treatment, the TCA <a href="/wiki/Imipramine" title="Imipramine">imipramine</a> (Tofranil). Sertraline was equivalent to imipramine for both of these indications during the first 12&#160;weeks of the study<sup id="cite_ref-pmid9862605_34-0" class="reference"><a href="#cite_note-pmid9862605-34" title=""><span>[</span>35<span>]</span></a></sup><sup id="cite_ref-pmid9862606_35-0" class="reference"><a href="#cite_note-pmid9862606-35" title=""><span>[</span>36<span>]</span></a></sup><sup id="cite_ref-pmid9862607_36-0" class="reference"><a href="#cite_note-pmid9862607-36" title=""><span>[</span>37<span>]</span></a></sup> and the 16-week continuation phase.<sup id="cite_ref-pmid11426506_37-0" class="reference"><a href="#cite_note-pmid11426506-37" title=""><span>[</span>38<span>]</span></a></sup> Only 11% of patients on sertraline suffered from severe side effects vs. 24% on imipramine. Constipation, dizziness, tremor, dry mouth, <a href="/wiki/Micturition" title="Micturition" class="mw-redirect">micturition</a> disorder and sweating were observed more often with imipramine, and diarrhea and insomnia with sertraline.<sup id="cite_ref-pmid9862606_35-1" class="reference"><a href="#cite_note-pmid9862606-35" title=""><span>[</span>36<span>]</span></a></sup> Patients on sertraline also reported significantly better social and physical functioning. The 30% of the patients treated with sertraline or imipramine who achieved a remission during the trial did not differ from the healthy population on the measures of marital, parental, physical and work functioning and were close to normal on <a href="/wiki/Social_interaction" title="Social interaction">social adjustment</a> and other measures of <a href="/wiki/Interpersonal_relationship" title="Interpersonal relationship">interpersonal functioning</a>.<sup id="cite_ref-pmid9862607_36-1" class="reference"><a href="#cite_note-pmid9862607-36" title=""><span>[</span>37<span>]</span></a></sup></p>
<p>TCAs as a group are considered to work better than <a href="/wiki/Selective_serotonin_reuptake_inhibitor" title="Selective serotonin reuptake inhibitor">selective serotonin reuptake inhibitors</a> for <a href="/wiki/Melancholic_depression" title="Melancholic depression">melancholic depression</a><sup id="cite_ref-pmid11247097_38-0" class="reference"><a href="#cite_note-pmid11247097-38" title=""><span>[</span>39<span>]</span></a></sup> and in inpatients,<sup id="cite_ref-pmid9597346_39-0" class="reference"><a href="#cite_note-pmid9597346-39" title=""><span>[</span>40<span>]</span></a></sup> but not necessarily for simply more severe depression.<sup id="cite_ref-pmid10362442_40-0" class="reference"><a href="#cite_note-pmid10362442-40" title=""><span>[</span>41<span>]</span></a></sup> In line with this generalization, sertraline was no better than placebo in inpatients (see <a href="/wiki/Sertraline#History" title="Sertraline">History</a>) and as effective as the TCA clomipramine for severe depression.<sup id="cite_ref-pmid10993128_23-2" class="reference"><a href="#cite_note-pmid10993128-23" title=""><span>[</span>24<span>]</span></a></sup> The comparative efficacy of sertraline and TCAs for melancholic depression has not been studied. A 1998 review suggested that, due to its pharmacology, sertraline may be more efficacious than other SSRIs and equal to TCAs for the treatment of melancholic depression.<sup id="cite_ref-pmid9808081_41-0" class="reference"><a href="#cite_note-pmid9808081-41" title=""><span>[</span>42<span>]</span></a></sup> A later <a href="/wiki/Open-label_trial" title="Open-label trial">open-label</a> study of general practice patients, funded by <a href="/wiki/Pfizer" title="Pfizer">Pfizer</a>, found that sertraline had equal efficacy in melancholic vs. non-melancholic patients, as well as in previous TCA non-responders vs. all other patients.<sup id="cite_ref-pmid15014677_42-0" class="reference"><a href="#cite_note-pmid15014677-42" title=""><span>[</span>43<span>]</span></a></sup></p>
<p><a name="Comparison_with_other_antidepressants" id="Comparison_with_other_antidepressants"></a></p>
<h4><span class="editsection">[<a href="/w/index.php?title=Sertraline&amp;action=edit&amp;section=5" title="Edit section: Comparison with other antidepressants">edit</a>]</span> <span class="mw-headline">Comparison with other antidepressants</span></h4>
<p>According to a meta-analysis of 12 new-generation antidepressants, sertraline and escitalopram are the best in terms of efficacy and acceptability in the acute-phase treatment of adults with unipolar major depression. Reboxetine was significantly worse.<sup id="cite_ref-43" class="reference"><a href="#cite_note-43" title=""><span>[</span>44<span>]</span></a></sup><sup id="cite_ref-44" class="reference"><a href="#cite_note-44" title=""><span>[</span>45<span>]</span></a></sup></p>
<p>Comparative clinical trials demonstrated that sertraline's efficacy in depression is similar to that of <a href="/wiki/Moclobemide" title="Moclobemide">moclobemide</a> (Aurorix),<sup id="cite_ref-pmid17168253_45-0" class="reference"><a href="#cite_note-pmid17168253-45" title=""><span>[</span>46<span>]</span></a></sup> <a href="/wiki/Nefazodone" title="Nefazodone">nefazodone</a> (Serzone),<sup id="cite_ref-pmid8626364_46-0" class="reference"><a href="#cite_note-pmid8626364-46" title=""><span>[</span>47<span>]</span></a></sup> <a href="/wiki/Escitalopram" title="Escitalopram">escitalopram</a> (Lexapro),<sup id="cite_ref-pmid17288677_47-0" class="reference"><a href="#cite_note-pmid17288677-47" title=""><span>[</span>48<span>]</span></a></sup> <a href="/wiki/Bupropion" title="Bupropion">bupropion</a> (Wellbutrin),<sup id="cite_ref-pmid9448656_48-0" class="reference"><a href="#cite_note-pmid9448656-48" title=""><span>[</span>49<span>]</span></a></sup> <a href="/wiki/Citalopram" title="Citalopram">citalopram</a> (Celexa), <a href="/wiki/Fluvoxamine" title="Fluvoxamine">fluvoxamine</a> (Luvox), <a href="/wiki/Paroxetine" title="Paroxetine">paroxetine</a> (Paxil) and <a href="/wiki/Mirtazapine" title="Mirtazapine">mirtazapine</a> (Remeron).<sup id="cite_ref-pmid16172440_49-0" class="reference"><a href="#cite_note-pmid16172440-49" title=""><span>[</span>50<span>]</span></a></sup> Compared to patients on bupropion, those taking sertraline had much higher rates of sexual dysfunction (61% vs. 10% for men and 41% vs. 7% for women), nausea, diarrhea, somnolence and sweating, as well as a higher rate of discontinuation due to side effects (13% vs. 3%).<sup id="cite_ref-pmid9448656_48-1" class="reference"><a href="#cite_note-pmid9448656-48" title=""><span>[</span>49<span>]</span></a></sup> <a href="/wiki/Meta-analysis" title="Meta-analysis">Meta-analysis</a> by the independent <a href="/wiki/Cochrane_Collaboration" title="Cochrane Collaboration">Cochrane Collaboration</a> indicated that sertraline is more effective for the treatment of depression than <a href="/wiki/Fluoxetine" title="Fluoxetine">fluoxetine</a> (Prozac), with a 1.4&#160;times higher probability of response, and is possibly better tolerated.<sup id="cite_ref-pmid16235353_50-0" class="reference"><a href="#cite_note-pmid16235353-50" title=""><span>[</span>51<span>]</span></a></sup> The greatest advantage of sertraline over fluoxetine was seen among severely depressed and <a href="/wiki/Melancholic_depression" title="Melancholic depression">melancholic</a> patients with low anxiety.<sup id="cite_ref-pmid10529069_1-1" class="reference"><a href="#cite_note-pmid10529069-1" title=""><span>[</span>2<span>]</span></a></sup> <a href="/wiki/Comparison" title="Comparison">Comparative studies</a> of sertraline and <a href="/wiki/Venlafaxine" title="Venlafaxine">venlafaxine</a> (Effexor) found marginal differences in favor of venlafaxine<sup id="cite_ref-pmid10732656_51-0" class="reference"><a href="#cite_note-pmid10732656-51" title=""><span>[</span>52<span>]</span></a></sup><sup id="cite_ref-pmid17196045_52-0" class="reference"><a href="#cite_note-pmid17196045-52" title=""><span>[</span>53<span>]</span></a></sup><sup id="cite_ref-pmid11105744_53-0" class="reference"><a href="#cite_note-pmid11105744-53" title=""><span>[</span>54<span>]</span></a></sup> or no differences.<sup id="cite_ref-pmid16259546_54-0" class="reference"><a href="#cite_note-pmid16259546-54" title=""><span>[</span>55<span>]</span></a></sup></p>
<p><a name="Depression_in_the_elderly" id="Depression_in_the_elderly"></a></p>
<h4><span class="editsection">[<a href="/w/index.php?title=Sertraline&amp;action=edit&amp;section=6" title="Edit section: Depression in the elderly">edit</a>]</span> <span class="mw-headline">Depression in the elderly</span></h4>
<p>Sertraline used for the treatment of depression in elderly (older than 60) patients was superior to <a href="/wiki/Placebo" title="Placebo">placebo</a> and comparable to another SSRI fluoxetine, and TCAs amitriptyline, <a href="/wiki/Nortriptyline" title="Nortriptyline">nortriptyline</a> (Pamelor) and imipramine. Sertraline had much lower rates of adverse effects than these TCAs, with the exception of nausea, which occurred more frequently with sertraline. In addition, sertraline appeared to be more effective than fluoxetine or nortriptyline in the older-than-70 subgroup.<sup id="cite_ref-pmid12093324_55-0" class="reference"><a href="#cite_note-pmid12093324-55" title=""><span>[</span>56<span>]</span></a></sup> A 2003 trial of sertraline vs. placebo in elderly patients showed a <a href="/wiki/Statistical_significance" title="Statistical significance">statistically significant</a> (that is, unlikely to occur by chance), but clinically very modest improvement in depression and no improvement in <a href="/wiki/Quality_of_life" title="Quality of life">quality of life</a>.<sup id="cite_ref-pmid12832242_56-0" class="reference"><a href="#cite_note-pmid12832242-56" title=""><span>[</span>57<span>]</span></a></sup> The authors were sharply criticized by Bernard Carroll, a one-time chairman of the FDA Psychopharmacological Drugs Advisory Committee,<sup id="cite_ref-57" class="reference"><a href="#cite_note-57" title=""><span>[</span>58<span>]</span></a></sup> for presenting these results as positive: "The study has all the hallmarks of an 'experimercial,' a cost-is-no-object exercise driven by a corporate sponsor to create positive publicity for its product in a market niche. ... Thus does the corporate mandate to put lipstick on the pig prevail over the academic duty to communicate independent analyses of the data."<sup id="cite_ref-pmid15056533_58-0" class="reference"><a href="#cite_note-pmid15056533-58" title=""><span>[</span>59<span>]</span></a></sup></p>
<p><a name="Obsessive-compulsive_disorder" id="Obsessive-compulsive_disorder"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Sertraline&amp;action=edit&amp;section=7" title="Edit section: Obsessive-compulsive disorder">edit</a>]</span> <span class="mw-headline">Obsessive-compulsive disorder</span></h3>
<p><a href="/wiki/Placebo#Use_in_clinical_trials" title="Placebo">Placebo-controlled</a> studies have demonstrated sertraline to be efficacious for the treatment of OCD in adults and children.<sup id="cite_ref-59" class="reference"><a href="#cite_note-59" title=""><span>[</span>60<span>]</span></a></sup><sup id="cite_ref-pmid2274626_60-0" class="reference"><a href="#cite_note-pmid2274626-60" title=""><span>[</span>61<span>]</span></a></sup><sup id="cite_ref-pmid7702445_61-0" class="reference"><a href="#cite_note-pmid7702445-61" title=""><span>[</span>62<span>]</span></a></sup><sup id="cite_ref-pmid14594734_62-0" class="reference"><a href="#cite_note-pmid14594734-62" title=""><span>[</span>63<span>]</span></a></sup> It was better tolerated and, based on <a href="/wiki/Intention_to_treat_analysis" title="Intention to treat analysis">intention to treat analysis</a>, performed better than the gold standard of OCD treatment <a href="/wiki/Clomipramine" title="Clomipramine">clomipramine</a>.<sup id="cite_ref-pmid9393392_63-0" class="reference"><a href="#cite_note-pmid9393392-63" title=""><span>[</span>64<span>]</span></a></sup> Sertraline was also marginally more efficacious than <a href="/wiki/Fluoxetine" title="Fluoxetine">fluoxetine</a> (Prozac).<sup id="cite_ref-pmid11910259_64-0" class="reference"><a href="#cite_note-pmid11910259-64" title=""><span>[</span>65<span>]</span></a></sup> If the patient did not respond to sertraline, increasing the dose to 250–400&#160;mg, higher than the maximum recommended, did not bring any additional benefits.<sup id="cite_ref-pmid16426083_65-0" class="reference"><a href="#cite_note-pmid16426083-65" title=""><span>[</span>66<span>]</span></a></sup> The patients who responded to sertraline during a short-term trial sustained their improvement when the treatment continued for a year<sup id="cite_ref-pmid7673657_66-0" class="reference"><a href="#cite_note-pmid7673657-66" title=""><span>[</span>67<span>]</span></a></sup> and longer.<sup id="cite_ref-pmid9547132_67-0" class="reference"><a href="#cite_note-pmid9547132-67" title=""><span>[</span>68<span>]</span></a></sup> At the same time, the prolonged treatment may not be necessary for everyone. In a <a href="/wiki/Randomized_controlled_trial#Types_of_trial" title="Randomized controlled trial">double-blind study</a>, half of the subjects who had been successfully treated for a year were discontinued from sertraline. More of the subjects who stopped taking sertraline, than of those who continued, subsequently dropped out of the study, mostly, due to worsening of the OCD symptoms and side effects, possibly <a href="/wiki/Sertraline#Discontinuation_syndrome" title="Sertraline">withdrawal syndrome</a>. Only 48% of the patients in the discontinuation group were able to complete the study; however, these completers fared as well as the subjects who continued taking sertraline.<sup id="cite_ref-pmid11772695_68-0" class="reference"><a href="#cite_note-pmid11772695-68" title=""><span>[</span>69<span>]</span></a></sup> <a href="/wiki/Cognitive_behavioral_therapy" title="Cognitive behavioral therapy">CBT</a> alone was superior to sertraline in both adults and children; however, the best results were achieved using a combination of these treatments.<sup id="cite_ref-pmid15507582_69-0" class="reference"><a href="#cite_note-pmid15507582-69" title=""><span>[</span>70<span>]</span></a></sup><sup id="cite_ref-pmid16889458_70-0" class="reference"><a href="#cite_note-pmid16889458-70" title=""><span>[</span>71<span>]</span></a></sup> A review mentions that sertraline can be used for the treatment of OCD co-morbid with <a href="/wiki/Tourette_syndrome" title="Tourette syndrome">Tourette syndrome</a>;<sup id="cite_ref-pmid11772131_71-0" class="reference"><a href="#cite_note-pmid11772131-71" title=""><span>[</span>72<span>]</span></a></sup> however, sertraline may cause exacerbation of tics in Tourette syndrome.<sup id="cite_ref-pmid8552129_72-0" class="reference"><a href="#cite_note-pmid8552129-72" title=""><span>[</span>73<span>]</span></a></sup></p>
<p><a name="Panic_disorder" id="Panic_disorder"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Sertraline&amp;action=edit&amp;section=8" title="Edit section: Panic disorder">edit</a>]</span> <span class="mw-headline">Panic disorder</span></h3>
<p>In four large <a href="/wiki/Randomized_controlled_trial#Types_of_trial" title="Randomized controlled trial">double-blind</a> studies sertraline was shown to be superior to <a href="/wiki/Placebo" title="Placebo">placebo</a> for the treatment of panic disorder. The <a href="/wiki/Response_rate" title="Response rate">response rate</a> was independent of the dose (50–200&#160;mg). In addition to decreasing the frequency of panic attacks by about 80% (vs. 45% for placebo) and decreasing general anxiety, sertraline resulted in improvement of quality of life on most parameters. The patients rated as "improved" on sertraline reported better quality of life than the ones who "improved" on placebo. The authors of the study argued that the improvement achieved with sertraline is different and of a better quality than the improvement achieved with placebo.<sup id="cite_ref-pmid10945134_73-0" class="reference"><a href="#cite_note-pmid10945134-73" title=""><span>[</span>74<span>]</span></a></sup><sup id="cite_ref-pmid16292466_74-0" class="reference"><a href="#cite_note-pmid16292466-74" title=""><span>[</span>75<span>]</span></a></sup> Sertraline was equally effective for men and women<sup id="cite_ref-pmid16292466_74-1" class="reference"><a href="#cite_note-pmid16292466-74" title=""><span>[</span>75<span>]</span></a></sup> and for patients with or without <a href="/wiki/Agoraphobia" title="Agoraphobia">agoraphobia</a>.<sup id="cite_ref-pmid11206597_75-0" class="reference"><a href="#cite_note-pmid11206597-75" title=""><span>[</span>76<span>]</span></a></sup> Previous unsuccessful treatment with <a href="/wiki/Benzodiazepine" title="Benzodiazepine">benzodiazepines</a> did not diminish its efficacy.<sup id="cite_ref-pmid11199932_76-0" class="reference"><a href="#cite_note-pmid11199932-76" title=""><span>[</span>77<span>]</span></a></sup> However, the response rate was lower for the patients with more severe panic.<sup id="cite_ref-pmid11206597_75-1" class="reference"><a href="#cite_note-pmid11206597-75" title=""><span>[</span>76<span>]</span></a></sup> Double-blind comparative studies found sertraline to have the same effect on panic disorder as <a href="/wiki/Paroxetine" title="Paroxetine">paroxetine</a> (Paxil)<sup id="cite_ref-pmid15096081_77-0" class="reference"><a href="#cite_note-pmid15096081-77" title=""><span>[</span>78<span>]</span></a></sup> or the gold standard of panic disorder treatment <a href="/wiki/Alprazolam" title="Alprazolam">alprazolam</a> (Xanax).<sup id="cite_ref-pmid16053461_78-0" class="reference"><a href="#cite_note-pmid16053461-78" title=""><span>[</span>79<span>]</span></a></sup> While imprecise, comparison of the results of trials of sertraline with separate trials of other anti-panic agents (<a href="/wiki/Clomipramine" title="Clomipramine">clomipramine</a> (Anafranil), <a href="/wiki/Imipramine" title="Imipramine">imipramine</a> (Tofranil), <a href="/wiki/Clonazepam" title="Clonazepam">clonazepam</a> (Klonopin), alprazolam, <a href="/wiki/Fluvoxamine" title="Fluvoxamine">fluvoxamine</a> (Luvox) and paroxetine) indicates approximate equivalence of these medications.<sup id="cite_ref-pmid10945134_73-1" class="reference"><a href="#cite_note-pmid10945134-73" title=""><span>[</span>74<span>]</span></a></sup> Although panic disorder is considered to be a chronic condition, continuous treatment may not be necessary for everyone. In a double-blind discontinuation trial, abruptly stopping sertraline after one year of successful treatment resulted in relapse of the disorder in 33% of the patients vs. 13% of those who continued taking sertraline over the following 28&#160;weeks. The patients experienced distinct <a href="/wiki/Sertraline#Discontinuation_syndrome" title="Sertraline">withdrawal syndrome</a>, expressed primarily as insomnia and dizziness, and the authors noted that a significant part of the relapse rate among the discontinued patients could possibly be accounted for by the withdrawal syndrome.<sup id="cite_ref-pmid11722304_79-0" class="reference"><a href="#cite_note-pmid11722304-79" title=""><span>[</span>80<span>]</span></a></sup> Confirming these hypotheses, in another study, gradual discontinuation of sertraline after 12&#160;weeks of treatment did not lead to the return of panic symptoms. In the same study, discontinuation of paroxetine caused exacerbation of panic in about a fifth of the previously responding patients. The authors attributed this difference to the more severe withdrawal syndrome with paroxetine, which even discontinuation over three weeks could not remedy.<sup id="cite_ref-pmid15096081_77-1" class="reference"><a href="#cite_note-pmid15096081-77" title=""><span>[</span>78<span>]</span></a></sup></p>
<p><a name="Social_phobia" id="Social_phobia"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Sertraline&amp;action=edit&amp;section=9" title="Edit section: Social phobia">edit</a>]</span> <span class="mw-headline">Social phobia</span></h3>
<p>Sertraline has been successfully used for the treatment of <a href="/wiki/Social_phobia" title="Social phobia">social phobia</a> (social anxiety disorder).<sup id="cite_ref-pmid17092192_80-0" class="reference"><a href="#cite_note-pmid17092192-80" title=""><span>[</span>81<span>]</span></a></sup> In a flexible dosing study, it appeared that a higher dose range was needed for adequate response. Furthermore, improvement was achieved slowly, separating from the placebo response only by week six, and continuing to increase until week&#160;12.<sup id="cite_ref-pmid12934979_81-0" class="reference"><a href="#cite_note-pmid12934979-81" title=""><span>[</span>82<span>]</span></a></sup> The response was higher among the patients with later onset, especially adult onset, of the disorder.<sup id="cite_ref-pmid14709946_2-1" class="reference"><a href="#cite_note-pmid14709946-2" title=""><span>[</span>3<span>]</span></a></sup> Among the different rating scales, the clinician-rated global improvement demonstrated the highest difference vs. placebo, while the patient self-rated quality of life differed from placebo only modestly. The greatest improvement of quality of life was observed among the most impaired patients.<sup id="cite_ref-pmid12934979_81-1" class="reference"><a href="#cite_note-pmid12934979-81" title=""><span>[</span>82<span>]</span></a></sup> In addition to psychological components of social phobia, such as fear and avoidance, sertraline also ameliorated some physiological components, such as blushing and palpitations but not sweating and trembling.<sup id="cite_ref-pmid16216019_82-0" class="reference"><a href="#cite_note-pmid16216019-82" title=""><span>[</span>83<span>]</span></a></sup> In a four-way placebo-controlled comparison trial of sertraline and exposure therapy, sertraline performed significantly better than placebo, while the exposure therapy resulted in only marginal improvement. The combination of sertraline and exposure therapy was not significantly better than sertraline alone; however, it appeared that the response was achieved faster with the combined treatment.<sup id="cite_ref-pmid11435264_83-0" class="reference"><a href="#cite_note-pmid11435264-83" title=""><span>[</span>84<span>]</span></a></sup></p>
<p><a name="Premenstrual_dysphoric_disorder" id="Premenstrual_dysphoric_disorder"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Sertraline&amp;action=edit&amp;section=10" title="Edit section: Premenstrual dysphoric disorder">edit</a>]</span> <span class="mw-headline">Premenstrual dysphoric disorder</span></h3>
<p>According to several double-blind studies, sertraline is effective in alleviating the symptoms of <a href="/wiki/Premenstrual_dysphoric_disorder" title="Premenstrual dysphoric disorder">PMDD</a>, a severe form of <a href="/wiki/Premenstrual_syndrome" title="Premenstrual syndrome">premenstrual syndrome</a>. Significant improvement was observed in 50–60% of cases treated with sertraline vs. 20–30% of cases on placebo. The improvement began during the first week of treatment, and in addition to mood, irritability, and anxiety, improvement was reflected in better family functioning, social activity and general quality of life. Work functioning and physical symptoms, such as swelling, bloating and breast tenderness, were less responsive to sertraline.<sup id="cite_ref-84" class="reference"><a href="#cite_note-84" title=""><span>[</span>85<span>]</span></a></sup><sup id="cite_ref-pmid12215058_85-0" class="reference"><a href="#cite_note-pmid12215058-85" title=""><span>[</span>86<span>]</span></a></sup><sup id="cite_ref-pmid11972726_86-0" class="reference"><a href="#cite_note-pmid11972726-86" title=""><span>[</span>87<span>]</span></a></sup> Despite the well-known sexual side effects of sertraline, significantly higher improvement of <a href="/wiki/Sexual_function" title="Sexual function">sexual functioning</a> was achieved by the sertraline group as compared to the placebo group.<sup id="cite_ref-pmid14754784_87-0" class="reference"><a href="#cite_note-pmid14754784-87" title=""><span>[</span>88<span>]</span></a></sup> A three-way comparison of sertraline, <a href="/wiki/Norepinephrine_reuptake_inhibitor" title="Norepinephrine reuptake inhibitor">norepinephrine reuptake inhibitor</a> <a href="/wiki/Tricyclic_antidepressant" title="Tricyclic antidepressant">tricyclic antidepressant</a> <a href="/wiki/Desipramine" title="Desipramine">desipramine</a>, and placebo demonstrated the superiority of sertraline, while desipramine fared no better than placebo.<sup id="cite_ref-pmid10530636_88-0" class="reference"><a href="#cite_note-pmid10530636-88" title=""><span>[</span>89<span>]</span></a></sup> Taking sertraline only during the <a href="/wiki/Luteal_phase" title="Luteal phase">luteal phase</a>, that is, the 12–14&#160;days before menses, was shown to work as well as continuous treatment.<sup id="cite_ref-pmid10418540_89-0" class="reference"><a href="#cite_note-pmid10418540-89" title=""><span>[</span>90<span>]</span></a></sup><sup id="cite_ref-pmid12468166_90-0" class="reference"><a href="#cite_note-pmid12468166-90" title=""><span>[</span>91<span>]</span></a></sup><sup id="cite_ref-pmid14754784_87-1" class="reference"><a href="#cite_note-pmid14754784-87" title=""><span>[</span>88<span>]</span></a></sup> Although the luteal-phase treatment may be more acceptable to patients, there have been indications that by the end of a three-month period it is less well-tolerated than the continuous treatment. The study authors suggested that the continuous treatment may allow the tolerance to side effects of sertraline to develop faster.<sup id="cite_ref-pmid14754784_87-2" class="reference"><a href="#cite_note-pmid14754784-87" title=""><span>[</span>88<span>]</span></a></sup> The most recent (2006) trial findings indicate that continuous treatment with sub-therapeutic doses of sertraline (25&#160;mg vs. usual 50–100&#160;mg) may both afford the highest effectiveness and minimize the side effects.<sup id="cite_ref-pmid17107257_91-0" class="reference"><a href="#cite_note-pmid17107257-91" title=""><span>[</span>92<span>]</span></a></sup></p>
<p><a name="Posttraumatic_stress_disorder" id="Posttraumatic_stress_disorder"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Sertraline&amp;action=edit&amp;section=11" title="Edit section: Posttraumatic stress disorder">edit</a>]</span> <span class="mw-headline">Posttraumatic stress disorder</span></h3>
<p>Two double-blind placebo-controlled studies confirmed the efficacy of sertraline for severe chronic PTSD in civilians, with the mean duration of the illness more than ten years. Physical or <a href="/wiki/Sexual_assault" title="Sexual assault">sexual assault</a> was the traumatic event for more than 60% of the subjects, and 75% of them were women. Over the 12-week period, 53–60% of the patients treated with sertraline were much or very much improved vs. 32–38% for placebo.<sup id="cite_ref-pmid10770145_92-0" class="reference"><a href="#cite_note-pmid10770145-92" title=""><span>[</span>93<span>]</span></a></sup><sup id="cite_ref-pmid11343529_3-1" class="reference"><a href="#cite_note-pmid11343529-3" title=""><span>[</span>4<span>]</span></a></sup> The treatment was continued for another year with some participants from both trials. The condition of the responders further improved; some of the patients who did not respond to the initial 12-week trial slowly improved as well, so that about half of them were classified as responders by the end of the following 24&#160;weeks. The authors noted that the medication worked more slowly for those with more severe symptoms.<sup id="cite_ref-pmid11411812_93-0" class="reference"><a href="#cite_note-pmid11411812-93" title=""><span>[</span>94<span>]</span></a></sup><sup id="cite_ref-pmid16734498_94-0" class="reference"><a href="#cite_note-pmid16734498-94" title=""><span>[</span>95<span>]</span></a></sup> Discontinuation of the successful treatment after six months resulted in the return of the PTSD symptoms in 52% of the patients vs. 16% in those who continued taking sertraline.<sup id="cite_ref-pmid11729012_95-0" class="reference"><a href="#cite_note-pmid11729012-95" title=""><span>[</span>96<span>]</span></a></sup> Longer-term treatment has been advocated in such cases.<sup id="cite_ref-pmid16734498_94-1" class="reference"><a href="#cite_note-pmid16734498-94" title=""><span>[</span>95<span>]</span></a></sup></p>
<p>Three-way (placebo–sertraline–third antidepressant) comparison trials of sertraline for PTSD found it to be better than placebo and equivalent to <a href="/wiki/Venlafaxine" title="Venlafaxine">venlafaxine</a> (Effexor)<sup id="cite_ref-pmid16702890_96-0" class="reference"><a href="#cite_note-pmid16702890-96" title=""><span>[</span>97<span>]</span></a></sup> or <a href="/wiki/Citalopram" title="Citalopram">citalopram</a> (Celexa),<sup id="cite_ref-pmid14608246_97-0" class="reference"><a href="#cite_note-pmid14608246-97" title=""><span>[</span>98<span>]</span></a></sup> and in a two-way comparison it had the same efficacy as <a href="/wiki/Nefazodone" title="Nefazodone">nefazodone</a> (Serzone).<sup id="cite_ref-pmid15129422_98-0" class="reference"><a href="#cite_note-pmid15129422-98" title=""><span>[</span>99<span>]</span></a></sup> Sertraline was not effective for veterans with combat-related PTSD.<sup id="cite_ref-pmid11910265_99-0" class="reference"><a href="#cite_note-pmid11910265-99" title=""><span>[</span>100<span>]</span></a></sup><sup id="cite_ref-pmid17503980_100-0" class="reference"><a href="#cite_note-pmid17503980-100" title=""><span>[</span>101<span>]</span></a></sup></p>
<p><a name="Other_indications" id="Other_indications"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Sertraline&amp;action=edit&amp;section=12" title="Edit section: Other indications">edit</a>]</span> <span class="mw-headline">Other indications</span></h3>
<p>Two large placebo-controlled clinical trials of sertraline for <a href="/wiki/Generalized_anxiety_disorder" title="Generalized anxiety disorder">generalized anxiety disorder</a> have been conducted. While one trial demonstrated highly significant improvements on all measures used, including anxiety, depression and quality of life,<sup id="cite_ref-101" class="reference"><a href="#cite_note-101" title=""><span>[</span>102<span>]</span></a></sup> the other showed only marginal improvement of anxiety, and insignificant improvement of quality of life.<sup id="cite_ref-pmid16848646_102-0" class="reference"><a href="#cite_note-pmid16848646-102" title=""><span>[</span>103<span>]</span></a></sup> Small double-blind studies of sertraline for <a href="/wiki/Eating_disorder" title="Eating disorder">eating disorders</a>, such as <a href="/wiki/Binge_eating_disorder" title="Binge eating disorder">binge eating disorder</a>,<sup id="cite_ref-103" class="reference"><a href="#cite_note-103" title=""><span>[</span>104<span>]</span></a></sup><sup id="cite_ref-pmid18598735_104-0" class="reference"><a href="#cite_note-pmid18598735-104" title=""><span>[</span>105<span>]</span></a></sup> <a href="/wiki/Night_eating_syndrome" title="Night eating syndrome">night eating syndrome</a><sup id="cite_ref-pmid16648332_105-0" class="reference"><a href="#cite_note-pmid16648332-105" title=""><span>[</span>106<span>]</span></a></sup> and <a href="/wiki/Bulimia_nervosa" title="Bulimia nervosa">bulimia nervosa</a><sup id="cite_ref-pmid15605617_106-0" class="reference"><a href="#cite_note-pmid15605617-106" title=""><span>[</span>107<span>]</span></a></sup> indicated its effectiveness.</p>
<p>Although sertraline can be used for the treatment of <a href="/wiki/Premature_ejaculation" title="Premature ejaculation">premature ejaculation</a><sup id="cite_ref-107" class="reference"><a href="#cite_note-107" title=""><span>[</span>108<span>]</span></a></sup> a comparative study found it to be inferior to another SSRI, <a href="/wiki/Paroxetine" title="Paroxetine">paroxetine</a>.<sup id="cite_ref-pmid9690692_108-0" class="reference"><a href="#cite_note-pmid9690692-108" title=""><span>[</span>109<span>]</span></a></sup> A general disadvantage of SSRIs is that they require continuous daily treatment to delay ejaculation significantly.<sup id="cite_ref-pmid17983899_109-0" class="reference"><a href="#cite_note-pmid17983899-109" title=""><span>[</span>110<span>]</span></a></sup> For the occasional "on-demand", a few hours before coitus, treatment, <a href="/wiki/Clomipramine" title="Clomipramine">clomipramine</a> gave better results than <a href="/wiki/Paroxetine" title="Paroxetine">paroxetine</a> in one study,<sup id="cite_ref-pmid15363569_110-0" class="reference"><a href="#cite_note-pmid15363569-110" title=""><span>[</span>111<span>]</span></a></sup> while in another study both sertraline and clomipramine were indistinguishable from the pause–squeeze technique and inferior to paroxetine.<sup id="cite_ref-pmid11313839_111-0" class="reference"><a href="#cite_note-pmid11313839-111" title=""><span>[</span>112<span>]</span></a></sup> The most recent research, conducted in 2007, suggests that on-demand treatment with <a href="/wiki/Sildenafil" title="Sildenafil">sildenafil</a> (Viagra) offers a dramatic improvement in ejaculation delay and sexual satisfaction as compared with daily paroxetine,<sup id="cite_ref-pmid17470165_112-0" class="reference"><a href="#cite_note-pmid17470165-112" title=""><span>[</span>113<span>]</span></a></sup> with on-demand sertraline, paroxetine or clomipramine,<sup id="cite_ref-pmid11313839_111-1" class="reference"><a href="#cite_note-pmid11313839-111" title=""><span>[</span>112<span>]</span></a></sup> and with the pause–squeeze technique.<sup id="cite_ref-pmid11313839_111-2" class="reference"><a href="#cite_note-pmid11313839-111" title=""><span>[</span>112<span>]</span></a></sup><sup id="cite_ref-pmid17470165_112-1" class="reference"><a href="#cite_note-pmid17470165-112" title=""><span>[</span>113<span>]</span></a></sup></p>
<p>A small study suggested that sertraline may help some children and adolescents with refractory <a href="/wiki/Vasovagal_syncope" title="Vasovagal syncope" class="mw-redirect">syncope</a>.<sup id="cite_ref-113" class="reference"><a href="#cite_note-113" title=""><span>[</span>114<span>]</span></a></sup> Subsequent case reports indicated that sertraline may itself cause syncope in adolescents<sup id="cite_ref-pmid9433163_114-0" class="reference"><a href="#cite_note-pmid9433163-114" title=""><span>[</span>115<span>]</span></a></sup> and that sertraline treatment of syncope may make it more frequent.<sup id="cite_ref-pmid9365060_115-0" class="reference"><a href="#cite_note-pmid9365060-115" title=""><span>[</span>116<span>]</span></a></sup><sup id="cite_ref-pmid9113018_116-0" class="reference"><a href="#cite_note-pmid9113018-116" title=""><span>[</span>117<span>]</span></a></sup></p>
<p><a name="Adverse_effects" id="Adverse_effects"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Sertraline&amp;action=edit&amp;section=13" title="Edit section: Adverse effects">edit</a>]</span> <span class="mw-headline">Adverse effects</span></h2>
<div class="thumb tright">
<div class="thumbinner" style="width:182px;"><a href="/wiki/File:Zoloft_bottles.jpg" class="image" title="Bottles of Zoloft as sold in the United States, with blue (50&#160;mg) and green (25&#160;mg) tablets"><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/thumb/4/48/Zoloft_bottles.jpg/180px-Zoloft_bottles.jpg" width="180" height="160" border="0" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Zoloft_bottles.jpg" class="internal" title="Enlarge"><img src="/skins-1.5/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
Bottles of Zoloft as sold in the United States, with blue (50&#160;mg) and green (25&#160;mg) tablets</div>
</div>
</div>
<p>According to Pfizer, sertraline is <a href="/wiki/Contraindicated" title="Contraindicated" class="mw-redirect">contraindicated</a> in individuals taking <a href="/wiki/Monoamine_oxidase_inhibitor" title="Monoamine oxidase inhibitor">monoamine oxidase inhibitors</a> or the <a href="/wiki/Antipsychotic" title="Antipsychotic">antipsychotic</a> <a href="/wiki/Pimozide" title="Pimozide">pimozide</a> (Orap). Sertraline concentrate contains alcohol, and is therefore contraindicated with <a href="/wiki/Disulfiram" title="Disulfiram">disulfiram</a> (Antabuse). The prescribing information recommends that treatment of the elderly and patients with liver impairment "must be approached with caution". Due to the slower elimination of sertraline in these groups, their exposure to sertraline may be as high as three times the average exposure for the same dose.<sup id="cite_ref-zoloftpi_117-0" class="reference"><a href="#cite_note-zoloftpi-117" title=""><span>[</span>118<span>]</span></a></sup></p>
<p>Among the common <a href="/wiki/Adverse_drug_reaction" title="Adverse drug reaction">adverse effects</a> associated with sertraline and listed in the prescribing information, those with the greatest difference from <a href="/wiki/Placebo" title="Placebo">placebo</a> are <a href="/wiki/Nausea" title="Nausea">nausea</a> (25% vs. 11% for placebo), <a href="/wiki/Ejaculation" title="Ejaculation">ejaculation</a> failure (14% vs. 1% for placebo), <a href="/wiki/Insomnia" title="Insomnia">insomnia</a> (21% vs. 11% for placebo), <a href="/wiki/Diarrhea" title="Diarrhea">diarrhea</a> (20% vs. 10% for placebo), <a href="/wiki/Dry_mouth" title="Dry mouth" class="mw-redirect">dry mouth</a> (14% vs. 8% for placebo), <a href="/wiki/Somnolence" title="Somnolence">somnolence</a> (13% vs. 7% for placebo), <a href="/wiki/Dizziness" title="Dizziness">dizziness</a> (12% vs. 7% for placebo), <a href="/wiki/Tremor" title="Tremor">tremor</a> (8% vs. 2% for placebo) and decreased <a href="/wiki/Libido" title="Libido">libido</a> (6% vs. 1% for placebo).<sup id="cite_ref-zoloftpi_117-1" class="reference"><a href="#cite_note-zoloftpi-117" title=""><span>[</span>118<span>]</span></a></sup> Those that most often resulted in interruption of the treatment were nausea (3%), diarrhea (2%) and insomnia (2%).<sup id="cite_ref-zoloftpi_117-2" class="reference"><a href="#cite_note-zoloftpi-117" title=""><span>[</span>118<span>]</span></a></sup> Sertraline appears to be associated with <a href="/wiki/Microscopic_colitis" title="Microscopic colitis">microscopic colitis</a>, a rare condition of unknown <a href="/wiki/Etiology" title="Etiology">etiology</a>.<sup id="cite_ref-pmid17100977_118-0" class="reference"><a href="#cite_note-pmid17100977-118" title=""><span>[</span>119<span>]</span></a></sup></p>
<p><a href="/wiki/Akathisia" title="Akathisia">Akathisia</a>—that is, "inner tension, restlessness, and the inability to stay still"—caused by sertraline was observed in 16% of patients in a <a href="/wiki/Case_series" title="Case series">case series</a>.<sup id="cite_ref-pmid9018398_119-0" class="reference"><a href="#cite_note-pmid9018398-119" title=""><span>[</span>120<span>]</span></a></sup> This and other reports<sup id="cite_ref-pmid8909330_120-0" class="reference"><a href="#cite_note-pmid8909330-120" title=""><span>[</span>121<span>]</span></a></sup><sup id="cite_ref-pmid9378692_121-0" class="reference"><a href="#cite_note-pmid9378692-121" title=""><span>[</span>122<span>]</span></a></sup><sup id="cite_ref-pmid12407283_122-0" class="reference"><a href="#cite_note-pmid12407283-122" title=""><span>[</span>123<span>]</span></a></sup> note that akathisia begins soon after the initiation of treatment or a dose increase; often, several hours after taking the medication. Akathisia usually disappears within several days after sertraline is stopped or its dose is decreased. In some cases, clinicians confused akathisia with <a href="/wiki/Anxiety" title="Anxiety">anxiety</a> and increased the dose of sertraline, causing further worsening of the patients' symptoms.<sup id="cite_ref-pmid12407283_122-1" class="reference"><a href="#cite_note-pmid12407283-122" title=""><span>[</span>123<span>]</span></a></sup> Experts note that because of the possible link of akathisia with suicide and the distress it causes to the patient, "it is of vital importance to increase awareness amongst staff and patients of the symptoms of this relatively common condition".<sup id="cite_ref-pmid12404546_123-0" class="reference"><a href="#cite_note-pmid12404546-123" title=""><span>[</span>124<span>]</span></a></sup><sup id="cite_ref-pmid16449715_124-0" class="reference"><a href="#cite_note-pmid16449715-124" title=""><span>[</span>125<span>]</span></a></sup></p>
<p>Over more than six months of sertraline therapy for depression, patients showed an insignificant weight increase of 0.1%.<sup id="cite_ref-pmid11105740_125-0" class="reference"><a href="#cite_note-pmid11105740-125" title=""><span>[</span>126<span>]</span></a></sup> Similarly, a 30-month-long treatment with sertraline for <a href="/wiki/Obsessive_compulsive_disorder" title="Obsessive compulsive disorder" class="mw-redirect">OCD</a> resulted in a mean weight gain of 1.5% (1&#160;kg).<sup id="cite_ref-pmid15491240_126-0" class="reference"><a href="#cite_note-pmid15491240-126" title=""><span>[</span>127<span>]</span></a></sup> Although the difference did not reach <a href="/wiki/Statistical_significance" title="Statistical significance">statistical significance</a>, the weight gain was lower for <a href="/wiki/Fluoxetine" title="Fluoxetine">fluoxetine</a> (Prozac) (1%) but higher for <a href="/wiki/Citalopram" title="Citalopram">citalopram</a> (Celexa), <a href="/wiki/Fluvoxamine" title="Fluvoxamine">fluvoxamine</a> (Luvox) and <a href="/wiki/Paroxetine" title="Paroxetine">paroxetine</a> (Paxil) (2.5%). Only 4.5% of the sertraline group gained a large amount of weight (defined as more than 7% gain). This result compares favorably with placebo, where, according to the literature, 3–6% of patients gained more than 7% of their initial weight. The large weight gain was observed only among female members of the sertraline group; the significance of this finding is unclear because of the small size of the group.<sup id="cite_ref-pmid15491240_126-1" class="reference"><a href="#cite_note-pmid15491240-126" title=""><span>[</span>127<span>]</span></a></sup></p>
<p>Over a two-week treatment of healthy volunteers, sertraline slightly improved verbal <a href="/wiki/Fluency" title="Fluency">fluency</a> but did not affect word learning, <a href="/wiki/Short-term_memory" title="Short-term memory">short-term memory</a>, <a href="/wiki/Alertness" title="Alertness">vigilance</a>, <a href="/wiki/Flicker_fusion_threshold" title="Flicker fusion threshold">flicker fusion time</a>, choice <a href="/wiki/Reaction_time" title="Reaction time">reaction time</a>, <a href="/wiki/Memory_span" title="Memory span">memory span</a>, or <a href="/wiki/Motor_coordination" title="Motor coordination">psychomotor coordination</a>.<sup id="cite_ref-pmid11565624_127-0" class="reference"><a href="#cite_note-pmid11565624-127" title=""><span>[</span>128<span>]</span></a></sup><sup id="cite_ref-pmid12692706_128-0" class="reference"><a href="#cite_note-pmid12692706-128" title=""><span>[</span>129<span>]</span></a></sup> In spite of lower subjective rating, that is, feeling that they performed worse, no clinically relevant differences were observed in the objective cognitive performance in a group of people treated for depression with sertraline for 1.5&#160;year as compared to healthy controls.<sup id="cite_ref-pmid16485140_129-0" class="reference"><a href="#cite_note-pmid16485140-129" title=""><span>[</span>130<span>]</span></a></sup> In children and adolescents taking sertraline for six weeks for anxiety disorders, 18 out of 20&#160;measures of memory, attention and alertness stayed unchanged. <a href="/wiki/Attention#Clinical_model_of_attention" title="Attention">Divided attention</a> was improved and verbal memory under <a href="/wiki/Interference_theory#Proactive_interference" title="Interference theory">interference conditions</a> decreased marginally. Because of the large number of measures taken, it is possible that these changes were still due to chance.<sup id="cite_ref-pmid16190792_130-0" class="reference"><a href="#cite_note-pmid16190792-130" title=""><span>[</span>131<span>]</span></a></sup></p>
<p><a name="Birth_defects_and_effects_on_breast-fed_infants" id="Birth_defects_and_effects_on_breast-fed_infants"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Sertraline&amp;action=edit&amp;section=14" title="Edit section: Birth defects and effects on breast-fed infants">edit</a>]</span> <span class="mw-headline">Birth defects and effects on breast-fed infants</span></h3>
<p>The studies comparing the levels of sertraline and its principal <a href="/wiki/Metabolite" title="Metabolite">metabolite</a>, desmethylsertraline, in mother's blood to their concentration in <a href="/wiki/Umbilical_cord" title="Umbilical cord">umbilical cord</a> blood at the time of delivery indicated that fetal exposure to sertraline and its metabolite is approximately a third of the maternal exposure.<sup id="cite_ref-pmid11082480_131-0" class="reference"><a href="#cite_note-pmid11082480-131" title=""><span>[</span>132<span>]</span></a></sup><sup id="cite_ref-pmid12727706_132-0" class="reference"><a href="#cite_note-pmid12727706-132" title=""><span>[</span>133<span>]</span></a></sup> The use of sertraline during the <a href="/wiki/Trimester" title="Trimester">first trimester</a> of pregnancy was associated with increased odds of the following <a href="/wiki/Congenital_disorder" title="Congenital disorder">birth defects</a>: <a href="/wiki/Omphalocele" title="Omphalocele">omphalocele</a> (six-fold), <a href="/wiki/Anal_atresia" title="Anal atresia" class="mw-redirect">anal atresia</a> and limb reduction defects (four-fold), and <a href="/wiki/Septal_defect" title="Septal defect" class="mw-redirect">septal defects</a> (two-fold).<sup id="cite_ref-pmid17596601_133-0" class="reference"><a href="#cite_note-pmid17596601-133" title=""><span>[</span>134<span>]</span></a></sup> Concentration of sertraline and desmethylsertraline in <a href="/wiki/Breast_milk" title="Breast milk">breast milk</a> is highly variable and, on average, is of the same <a href="/wiki/Order_of_magnitude" title="Order of magnitude">order of magnitude</a> as their concentration in the <a href="/wiki/Blood_plasma" title="Blood plasma">blood plasma</a> of the mother. As a result, more than half of breast-fed babies receive less than 2&#160;mg/day of sertraline and desmethylsertraline combined, and in most cases these substances are undetectable in their blood.<sup id="cite_ref-pmid12590627_134-0" class="reference"><a href="#cite_note-pmid12590627-134" title=""><span>[</span>135<span>]</span></a></sup> No changes in <a href="/wiki/Serotonin" title="Serotonin">serotonin</a> uptake by the <a href="/wiki/Platelets" title="Platelets" class="mw-redirect">platelets</a> of breast-fed infants were found, as measured by their blood serotonin levels before and after their mothers began sertraline treatment.<sup id="cite_ref-pmid11578995_135-0" class="reference"><a href="#cite_note-pmid11578995-135" title=""><span>[</span>136<span>]</span></a></sup></p>
<p><a name="Sexual_side_effects" id="Sexual_side_effects"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Sertraline&amp;action=edit&amp;section=15" title="Edit section: Sexual side effects">edit</a>]</span> <span class="mw-headline">Sexual side effects</span></h3>
<p>Like other SSRIs, sertraline is associated with sexual side effects, including arousal disorder and difficulty achieving orgasm. The observed frequency of sexual side effects depends greatly on whether they are reported by patients spontaneously, as in the manufacturer's trials, or actively solicited by the physicians. There have been several <a href="/wiki/Blind_experiment" title="Blind experiment">double-blind studies</a> of sexual side effects comparing sertraline with placebo or other antidepressants.<sup id="cite_ref-pmid11229450_136-0" class="reference"><a href="#cite_note-pmid11229450-136" title=""><span>[</span>137<span>]</span></a></sup> While <a href="/wiki/Nefazodone" title="Nefazodone">nefazodone</a> (Serzone) and <a href="/wiki/Bupropion" title="Bupropion">bupropion</a> did not have negative effects on sexual functioning, 67% of men on sertraline experienced ejaculation difficulties vs. 18% before the treatment<sup id="cite_ref-pmid11229450_136-1" class="reference"><a href="#cite_note-pmid11229450-136" title=""><span>[</span>137<span>]</span></a></sup> (or 61% vs. 0% according to another paper<sup id="cite_ref-pmid9448656_48-2" class="reference"><a href="#cite_note-pmid9448656-48" title=""><span>[</span>49<span>]</span></a></sup>). Similarly, in a group of women who initially did not have difficulties achieving orgasm, 41% acquired this problem during treatment with sertraline.<sup id="cite_ref-pmid9448656_48-3" class="reference"><a href="#cite_note-pmid9448656-48" title=""><span>[</span>49<span>]</span></a></sup> A 40% rate of <a href="/wiki/Anorgasmia" title="Anorgasmia">orgasm dysfunction</a> (vs. 9% for placebo) on sertraline was observed in a mixed group in another study.<sup id="cite_ref-pmid10363731_137-0" class="reference"><a href="#cite_note-pmid10363731-137" title=""><span>[</span>138<span>]</span></a></sup> <a href="/wiki/Sexual_arousal" title="Sexual arousal">Sexual arousal</a> disorder, defined as "inadequate lubrication and swelling for women and erectile difficulties for men," occurred in 12% of patients on sertraline as compared with 1% of patients on placebo. The mood improvement resulting from the treatment with sertraline counteracted these side effects, so that <a href="/wiki/Sexual_desire" title="Sexual desire" class="mw-redirect">sexual desire</a> and overall satisfaction with sex stayed the same as before the sertraline treatment. However, under the action of placebo the desire and satisfaction slightly improved.<sup id="cite_ref-pmid10363731_137-1" class="reference"><a href="#cite_note-pmid10363731-137" title=""><span>[</span>138<span>]</span></a></sup></p>
<p><a name="Suicidality" id="Suicidality"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Sertraline&amp;action=edit&amp;section=16" title="Edit section: Suicidality">edit</a>]</span> <span class="mw-headline">Suicidality</span></h3>
<p>The FDA requires all antidepressants, including sertraline, to carry a <a href="/wiki/Black_box_warning" title="Black box warning">black box warning</a> stating that antidepressants may increase the risk of suicide in persons younger than 25. This warning is based on statistical analyses conducted by two independent groups of FDA experts that found a 2-fold increase of suicidal ideation and behavior in children and adolescents, and a 1.5-fold increase of suicidality in the 18–24 age group.<sup id="cite_ref-FDA_138-0" class="reference"><a href="#cite_note-FDA-138" title=""><span>[</span>139<span>]</span></a></sup><sup id="cite_ref-FDA2_139-0" class="reference"><a href="#cite_note-FDA2-139" title=""><span>[</span>140<span>]</span></a></sup><sup id="cite_ref-FDA3_140-0" class="reference"><a href="#cite_note-FDA3-140" title=""><span>[</span>141<span>]</span></a></sup></p>
<p><a href="/wiki/Suicidal_ideation" title="Suicidal ideation">Suicidal ideation</a> and behavior in clinical trials are rare. For the above analysis, the FDA combined the results of 295&#160;trials of 11&#160;antidepressants for psychiatric indications in order to obtain <a href="/wiki/Statistically_significant" title="Statistically significant" class="mw-redirect">statistically significant</a> results. Considered separately, sertraline use in adults decreased the odds of suicidality with a marginal statistical significance by 37%<sup id="cite_ref-FDA3_140-1" class="reference"><a href="#cite_note-FDA3-140" title=""><span>[</span>141<span>]</span></a></sup> or 50%<sup id="cite_ref-FDA2_139-1" class="reference"><a href="#cite_note-FDA2-139" title=""><span>[</span>140<span>]</span></a></sup> depending on the statistical technique used. The authors of the FDA analysis note that "given the large number of comparisons made in this review, chance is a very plausible explanation for this difference".<sup id="cite_ref-FDA2_139-2" class="reference"><a href="#cite_note-FDA2-139" title=""><span>[</span>140<span>]</span></a></sup> The more complete data submitted later by the sertraline manufacturer Pfizer indicated increased suicidality.<sup id="cite_ref-141" class="reference"><a href="#cite_note-141" title=""><span>[</span>142<span>]</span></a></sup> Similarly, the analysis conducted by the UK <a href="/wiki/Medicines_and_Healthcare_products_Regulatory_Agency" title="Medicines and Healthcare products Regulatory Agency">MHRA</a> found a 50% increase of odds of suicide-related events, not reaching statistical significance, in the patients on sertraline as compared to the ones on placebo.<sup id="cite_ref-142" class="reference"><a href="#cite_note-142" title=""><span>[</span>143<span>]</span></a></sup><sup id="cite_ref-pmid15718537_143-0" class="reference"><a href="#cite_note-pmid15718537-143" title=""><span>[</span>144<span>]</span></a></sup></p>
<p><a name="Discontinuation_syndrome" id="Discontinuation_syndrome"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Sertraline&amp;action=edit&amp;section=17" title="Edit section: Discontinuation syndrome">edit</a>]</span> <span class="mw-headline">Discontinuation syndrome</span></h3>
<div class="rellink noprint relarticle mainarticle">Main article: <a href="/wiki/SSRI_discontinuation_syndrome" title="SSRI discontinuation syndrome">SSRI discontinuation syndrome</a></div>
<p>Abrupt interruption of sertraline treatment may result in <a href="/wiki/Withdrawal" title="Withdrawal">withdrawal</a> or discontinuation syndrome. This syndrome occurred in 60% of the remitted depressed patients taking sertraline in a blind discontinuation study, as compared to 14% of patients on fluoxetine and 66% of patients on paroxetine.<sup id="cite_ref-pmid9646889_144-0" class="reference"><a href="#cite_note-pmid9646889-144" title=""><span>[</span>145<span>]</span></a></sup> During the 5–8-day period when sertraline was temporarily replaced by placebo, the most frequent symptoms (reported by more than a quarter of patients) were irritability, agitation, dizziness, headache, nervousness, crying, <a href="/wiki/Labile_affect" title="Labile affect">emotional lability</a>, <a href="/wiki/Bad_Dreams" title="Bad Dreams">bad dreams</a> and anger. Around a third experienced mood worsening to the level generally associated with a major depressive episode.<sup id="cite_ref-pmid9646889_144-1" class="reference"><a href="#cite_note-pmid9646889-144" title=""><span>[</span>145<span>]</span></a></sup> In a double-blind study of remitted panic disorder patients, abrupt discontinuation of sertraline treatment resulted in insomnia and dizziness (both 16–17% vs. 4% for continuing treatment), although headache, depression and malaise did not increase significantly.<sup id="cite_ref-pmid11722304_79-1" class="reference"><a href="#cite_note-pmid11722304-79" title=""><span>[</span>80<span>]</span></a></sup> In another double-blind study of recovered panic disorder patients, the withdrawal syndrome was completely avoided when sertraline was gradually discontinued over three weeks, while patients stopping paroxetine treatment still suffered from it.<sup id="cite_ref-pmid15096081_77-2" class="reference"><a href="#cite_note-pmid15096081-77" title=""><span>[</span>78<span>]</span></a></sup></p>
<p><a name="Mechanism_of_action" id="Mechanism_of_action"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Sertraline&amp;action=edit&amp;section=18" title="Edit section: Mechanism of action">edit</a>]</span> <span class="mw-headline">Mechanism of action</span></h2>
<p>Sertraline is primarily a <a href="/wiki/Serotonin_reuptake_inhibitor" title="Serotonin reuptake inhibitor" class="mw-redirect">serotonin reuptake inhibitor</a> (SRI). Therapeutic doses of sertraline (50–200&#160;mg/day) taken by patients for four weeks resulted in 80–90% inhibition of <a href="/wiki/Serotonin_transporter" title="Serotonin transporter">serotonin transporter</a> (SERT) in <a href="/wiki/Striatum" title="Striatum">striatum</a> as measured by <a href="/wiki/Positron_emission_tomography" title="Positron emission tomography">positron emission tomography</a>. A daily 9&#160;mg dose was sufficient to inhibit 50% of SERT.<sup id="cite_ref-pmid15121647_145-0" class="reference"><a href="#cite_note-pmid15121647-145" title=""><span>[</span>146<span>]</span></a></sup> Sertraline is also a <a href="/wiki/Dopamine_reuptake_inhibitor" title="Dopamine reuptake inhibitor">dopamine reuptake inhibitor</a>, with 1% of its SRI potency,<sup id="cite_ref-pmid11543737_146-0" class="reference"><a href="#cite_note-pmid11543737-146" title=""><span>[</span>147<span>]</span></a></sup> and a <a href="/wiki/Sigma-1_receptor" title="Sigma-1 receptor">sigma-1 receptor</a> agonist with 5% of its SRI potency.<sup id="cite_ref-pmid8831113_147-0" class="reference"><a href="#cite_note-pmid8831113-147" title=""><span>[</span>148<span>]</span></a></sup> Sertraline weakly blocks <a href="/wiki/Alpha_blocker" title="Alpha blocker">α1-adrenoreceptors</a> with 1–10% of its SRI potency.<sup id="cite_ref-pmid11543737_146-1" class="reference"><a href="#cite_note-pmid11543737-146" title=""><span>[</span>147<span>]</span></a></sup><sup id="cite_ref-pmid9400006_148-0" class="reference"><a href="#cite_note-pmid9400006-148" title=""><span>[</span>149<span>]</span></a></sup></p>
<p><a name="Pharmacokinetics" id="Pharmacokinetics"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Sertraline&amp;action=edit&amp;section=19" title="Edit section: Pharmacokinetics">edit</a>]</span> <span class="mw-headline">Pharmacokinetics</span></h2>
<p>Sertraline is absorbed slowly when taken by mouth, achieving its maximal concentration in the plasma 4–6&#160;hours after ingestion. In the blood, it is 98.5% <a href="/wiki/Plasma_protein_binding" title="Plasma protein binding">bound to plasma proteins</a>. Its half-life in the body is 13–45&#160;hours and, on average, is about 1.5&#160;times longer in women (32&#160;hours) than in men (22&#160;hours), leading to a 1.5-times-higher exposure in women.<sup id="cite_ref-pmid12452737_149-0" class="reference"><a href="#cite_note-pmid12452737-149" title=""><span>[</span>150<span>]</span></a></sup> According to <i><a href="/wiki/In_vitro" title="In vitro">in vitro</a></i> studies, sertraline is metabolized by multiple <a href="/wiki/Cytochrome_450" title="Cytochrome 450" class="mw-redirect">cytochrome 450</a> <a href="/wiki/Isoenzyme" title="Isoenzyme" class="mw-redirect">isoforms</a>: <a href="/wiki/CYP2D6" title="CYP2D6">CYP2D6</a>, <a href="/wiki/CYP2C9" title="CYP2C9">CYP2C9</a>, <a href="/wiki/CYP2B6" title="CYP2B6">CYP2B6</a>, <a href="/wiki/CYP2C19" title="CYP2C19">CYP2C19</a> and <a href="/wiki/CYP3A4" title="CYP3A4">CYP3A4</a>. It appeared unlikely that inhibition of any single isoform could cause clinically significant changes in sertraline pharmacokinetics.<sup id="cite_ref-pmid10383917_150-0" class="reference"><a href="#cite_note-pmid10383917-150" title=""><span>[</span>151<span>]</span></a></sup><sup id="cite_ref-pmid15547048_151-0" class="reference"><a href="#cite_note-pmid15547048-151" title=""><span>[</span>152<span>]</span></a></sup> No differences in sertraline pharmacokinetics were observed between people with high and low activity of CYP2D6;<sup id="cite_ref-pmid8941024_152-0" class="reference"><a href="#cite_note-pmid8941024-152" title=""><span>[</span>153<span>]</span></a></sup> however, <a href="/wiki/Poor_metabolizer" title="Poor metabolizer" class="mw-redirect">poor CYP2C19 metabolizers</a> had a 1.5-times-higher level of sertraline than normal metabolizers.<sup id="cite_ref-pmid11452243_153-0" class="reference"><a href="#cite_note-pmid11452243-153" title=""><span>[</span>154<span>]</span></a></sup> <i>In vitro</i> data also indicate that the inhibition of CYP2B6 should have even greater effect than the inhibition of CYP2C19, while the contribution of CYP2C9 and CYP3A4 to the <a href="/wiki/Metabolism" title="Metabolism">metabolism</a> of sertraline would be minor. These conclusions have not been verified in human studies.<sup id="cite_ref-pmid15547048_151-1" class="reference"><a href="#cite_note-pmid15547048-151" title=""><span>[</span>152<span>]</span></a></sup> Sertraline can be <a href="/wiki/Deamination" title="Deamination">deaminated</a> <i>in vitro</i> by <a href="/wiki/Monoamine_oxidase" title="Monoamine oxidase">monoamine oxidases</a>; however, this <a href="/wiki/Metabolic_pathway" title="Metabolic pathway">metabolic pathway</a> has never been studied <i>in vivo</i>.<sup id="cite_ref-pmid15547048_151-2" class="reference"><a href="#cite_note-pmid15547048-151" title=""><span>[</span>152<span>]</span></a></sup> The major metabolite of sertraline, desmethylsertraline, is about 50 times weaker as a serotonin transporter inhibitor than sertraline and its clinical effect is negligible.<sup id="cite_ref-pmid9400006_148-1" class="reference"><a href="#cite_note-pmid9400006-148" title=""><span>[</span>149<span>]</span></a></sup></p>
<p><a name="Interactions" id="Interactions"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Sertraline&amp;action=edit&amp;section=20" title="Edit section: Interactions">edit</a>]</span> <span class="mw-headline">Interactions</span></h2>
<p>Sertraline is a moderate <a href="/wiki/Enzyme_inhibitor" title="Enzyme inhibitor">inhibitor</a> of <a href="/wiki/CYP2D6" title="CYP2D6">CYP2D6</a> and <a href="/wiki/CYP2B6" title="CYP2B6">CYP2B6</a> <i>in vitro</i>.<sup id="cite_ref-pmid16192315_154-0" class="reference"><a href="#cite_note-pmid16192315-154" title=""><span>[</span>155<span>]</span></a></sup> Accordingly, in human trials it caused increased blood levels of CYP2D6 <a href="/wiki/Substrate_(biochemistry)" title="Substrate (biochemistry)" class="mw-redirect">substrates</a> such as <a href="/wiki/Metoprolol" title="Metoprolol">metoprolol</a> (Lopressor, Toprol XL), <a href="/wiki/Dextromethorphan" title="Dextromethorphan">dextromethorphan</a> (Robitussin <a href="/wiki/Cough_medicine" title="Cough medicine">cough suppressant</a>), <a href="/wiki/Desipramine" title="Desipramine">desipramine</a> (Norpramin), <a href="/wiki/Imipramine" title="Imipramine">imipramine</a> (Tofranil) and <a href="/wiki/Nortriptyline" title="Nortriptyline">nortriptyline</a> (Pamelor), as well as the <a href="/wiki/CYP3A4" title="CYP3A4">CYP3A4</a>/<a href="/wiki/CYP2D6" title="CYP2D6">CYP2D6</a> substrate <a href="/wiki/Haloperidol" title="Haloperidol">haloperidol</a> (Haldol).<sup id="cite_ref-pmid9472843_155-0" class="reference"><a href="#cite_note-pmid9472843-155" title=""><span>[</span>156<span>]</span></a></sup><sup id="cite_ref-pmid10211917_156-0" class="reference"><a href="#cite_note-pmid10211917-156" title=""><span>[</span>157<span>]</span></a></sup><sup id="cite_ref-pmid10631623_157-0" class="reference"><a href="#cite_note-pmid10631623-157" title=""><span>[</span>158<span>]</span></a></sup> This effect is dose-dependent; for example, co-administration with 50&#160;mg of sertraline resulted in 20% greater exposure to desipramine, while 150&#160;mg of sertraline led to a 70% increase.<sup id="cite_ref-pmid12452737_149-1" class="reference"><a href="#cite_note-pmid12452737-149" title=""><span>[</span>150<span>]</span></a></sup><sup id="cite_ref-pmid17224709_158-0" class="reference"><a href="#cite_note-pmid17224709-158" title=""><span>[</span>159<span>]</span></a></sup> In a placebo-controlled study, the concomitant administration of sertraline and <a href="/wiki/Methadone" title="Methadone">methadone</a> caused a 40% increase in blood levels of the latter, which is primarily metabolized by CYP2B6.<sup id="cite_ref-pmid10914294_159-0" class="reference"><a href="#cite_note-pmid10914294-159" title=""><span>[</span>160<span>]</span></a></sup> Sertraline had a slight inhibitory effect on the metabolism of <a href="/wiki/Diazepam" title="Diazepam">diazepam</a> (Valium), <a href="/wiki/Tolbutamide" title="Tolbutamide">tolbutamide</a> (Orinase) and <a href="/wiki/Warfarin" title="Warfarin">warfarin</a> (Coumadin), which are <a href="/wiki/CYP2C9" title="CYP2C9">CYP2C9</a> or <a href="/wiki/CYP2C19" title="CYP2C19">CYP2C19</a> substrates; this effect was not considered to be clinically relevant.<sup id="cite_ref-pmid12452737_149-2" class="reference"><a href="#cite_note-pmid12452737-149" title=""><span>[</span>150<span>]</span></a></sup> As expected from <i>in vitro</i> data, sertraline did not alter the human metabolism of the <a href="/wiki/CYP3A4" title="CYP3A4">CYP3A4</a> substrates <a href="/wiki/Erythromycin" title="Erythromycin">erythromycin</a>, <a href="/wiki/Alprazolam" title="Alprazolam">alprazolam</a> (Xanax), <a href="/wiki/Carbamazepine" title="Carbamazepine">carbamazepine</a> (Tegretol), <a href="/wiki/Clonazepam" title="Clonazepam">clonazepam</a> (Klonopin), and <a href="/wiki/Terfenadine" title="Terfenadine">terfenadine</a> (Seldane); neither did it affect metabolism of the <a href="/wiki/CYP1A2" title="CYP1A2">CYP1A2</a> substrate <a href="/wiki/Clozapine" title="Clozapine">clozapine</a> (Clozaril). Sertraline had no effect on the actions of <a href="/wiki/Digoxin" title="Digoxin">digoxin</a> (Lanoxin) and <a href="/wiki/Atenolol" title="Atenolol">atenolol</a> (Tenormin), which are not metabolized in the liver.<sup id="cite_ref-pmid12452737_149-3" class="reference"><a href="#cite_note-pmid12452737-149" title=""><span>[</span>150<span>]</span></a></sup><sup id="cite_ref-pmid16192315_154-1" class="reference"><a href="#cite_note-pmid16192315-154" title=""><span>[</span>155<span>]</span></a></sup><sup id="cite_ref-zoloftpi_117-3" class="reference"><a href="#cite_note-zoloftpi-117" title=""><span>[</span>118<span>]</span></a></sup><sup id="cite_ref-pmid14709940_160-0" class="reference"><a href="#cite_note-pmid14709940-160" title=""><span>[</span>161<span>]</span></a></sup> <a href="/wiki/Case_report" title="Case report">Case reports</a> suggest that taking sertraline with <a href="/wiki/Phenytoin" title="Phenytoin">phenytoin</a> (Dilantin) or <a href="/wiki/Zolpidem" title="Zolpidem">zolpidem</a> (Ambien) may induce sertraline metabolism and decrease its efficacy, and taking sertraline with <a href="/wiki/Lamotrigine" title="Lamotrigine">lamotrigine</a> (Lamictal) may increase the blood level of lamotrigine via an unknown mechanism. Clinical reports indicate that interaction between sertraline and the <a href="/wiki/Monoamine_oxidase_inhibitor" title="Monoamine oxidase inhibitor">MAOIs</a> <a href="/wiki/Isocarboxazid" title="Isocarboxazid">isocarboxazid</a> (Marplan) and <a href="/wiki/Tranylcypromine" title="Tranylcypromine">tranylcypromine</a> (Parnate) may cause <a href="/wiki/Serotonin_syndrome" title="Serotonin syndrome">serotonin syndrome</a>. In a placebo-controlled study in which sertraline was co-administered with <a href="/wiki/Lithium_pharmacology" title="Lithium pharmacology">lithium</a>, 35% of the subjects experienced <a href="/wiki/Tremor" title="Tremor">tremors</a>, while none of those taking placebo did.<sup id="cite_ref-pmid12452737_149-4" class="reference"><a href="#cite_note-pmid12452737-149" title=""><span>[</span>150<span>]</span></a></sup></p>
<p><a name="Controversy" id="Controversy"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Sertraline&amp;action=edit&amp;section=21" title="Edit section: Controversy">edit</a>]</span> <span class="mw-headline">Controversy</span></h2>
<p>The brand-name form of sertraline, Zoloft, was <a href="/wiki/Direct-to-consumer_advertising" title="Direct-to-consumer advertising">advertised to consumers</a> by Pfizer using the following wording: "While the cause is unknown, depression may be related to an imbalance of natural chemicals between nerve cells in the brain. Prescription Zoloft works to correct this imbalance. You just shouldn't have to feel this way anymore." An essay published in the journal <i><a href="/wiki/PLoS_Medicine" title="PLoS Medicine">PLoS Medicine</a></i> noted that there is no scientific support for the "serotonin imbalance" theory of depression, and criticized Pfizer and manufacturers of other SSRIs for using it. When asked to comment on this apparent breach of federal regulations, the FDA answered that such "reductionist statements" are acceptable to explain the neurochemistry of depression "to the fraction of the public that functions at no higher than a 6th-grade reading level."<sup id="cite_ref-PLoS_161-0" class="reference"><a href="#cite_note-PLoS-161" title=""><span>[</span>162<span>]</span></a></sup> However, the FDA reacted promptly with a warning letter when a Zoloft advertisement omitted information about the risk of suicidality.<sup id="cite_ref-162" class="reference"><a href="#cite_note-162" title=""><span>[</span>163<span>]</span></a></sup></p>
<p>In the case of <i>Regina v Hawkins,</i> an Australian criminal case from the state of <a href="/wiki/New_South_Wales" title="New South Wales">New South Wales</a>, Zoloft was described as an important factor in David Hawkins's killing in 1999 (through strangling) of his wife. Hawkins had been depressed, was prescribed 50&#160;mg of Zoloft a day and on his first day of treatment took 250&#160;mg. He claimed that on the night of the murder he could not sleep and was agitated, and that he had hallucinations during the attack on his wife. Several experts agreed that "Zoloft can cause agitation and a certain amount of disinhibition so that some individuals engage in aggressive or dangerous behaviours without due regard for the consequences and in a manner that is out of character for them" and that the prisoner's behavior was consistent with <a href="/wiki/Mixed_state_(psychiatry)" title="Mixed state (psychiatry)">agitated depression</a> further exacerbated by akathisia and toxic delirium that developed as a result of Zoloft overdose. The court concluded that "it can be seen that the medical evidence strongly supports a conclusion that, but for the effects of the 250&#160;milligrams of Zoloft he had taken, it is wholly unlikely that the prisoner would have committed the crime to which he has pleaded guilty. Furthermore, it is common ground that his having done such an act is quite foreign to his former life history, his personality and psychological makeup. It was also wholly inconsistent with his love for his marriage partner of nearly 50 years."<sup id="cite_ref-163" class="reference"><a href="#cite_note-163" title=""><span>[</span>164<span>]</span></a></sup></p>
<p>In 2004, a <a href="/wiki/Los_Angeles,_California" title="Los Angeles, California" class="mw-redirect">Los Angeles</a> nurse sued Pfizer as a <a href="/wiki/Private_attorney_general" title="Private attorney general">private attorney general</a> "on behalf of all California residents who have been misled about Zoloft," claiming the company covered up side effects.<sup id="cite_ref-164" class="reference"><a href="#cite_note-164" title=""><span>[</span>165<span>]</span></a></sup> In 2005, the Los Angeles Superior Court dismissed the case and ordered the plaintiff to pay Pfizer's cost of the suit.<sup id="cite_ref-lasc_165-0" class="reference"><a href="#cite_note-lasc-165" title=""><span>[</span>166<span>]</span></a></sup></p>
<p><a name="Notes" id="Notes"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Sertraline&amp;action=edit&amp;section=22" title="Edit section: Notes">edit</a>]</span> <span class="mw-headline">Notes</span></h2>
<div class="references-small">
<dl>
<dd><cite id="endnote_TradeNameA"><a href="#ref_TradeNameA" title=""><b><sup>A</sup></b></a></cite>&#160; Medication trade names may differ between countries. In general, this article uses North American trade names.</dd>
</dl>
</div>
<p><a name="References" id="References"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Sertraline&amp;action=edit&amp;section=23" title="Edit section: References">edit</a>]</span> <span class="mw-headline">References</span></h2>
<div class="references-small references-column-count references-column-count-2" style="-moz-column-count:2; column-count:2;">
<ol class="references">
<li id="cite_note-0"><b><a href="#cite_ref-0" title="">^</a></b> The sertraline prescriptions were calculated as a total of prescriptions for Zoloft and generic Sertraline using data from the charts for generic and <a href="/wiki/Brand" title="Brand">brand name</a> drugs, see: <cite style="font-style:normal" class="web" id="CITEREFVerispan2008">Verispan (2008-02-18). <a href="http://www.drugtopics.com/drugtopics/article/articleDetail.jsp?id=491181" class="external text" title="http://www.drugtopics.com/drugtopics/article/articleDetail.jsp?id=491181" rel="nofollow">"Top 200 Generic Drugs by Units in 2007"</a> (PDF). Drug Topics<span class="printonly">. <a href="http://www.drugtopics.com/drugtopics/article/articleDetail.jsp?id=491181" class="external free" title="http://www.drugtopics.com/drugtopics/article/articleDetail.jsp?id=491181" rel="nofollow">http://www.drugtopics.com/drugtopics/article/articleDetail.jsp?id=491181</a></span><span class="reference-accessdate">. Retrieved on 2008-03-30</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Top+200+Generic+Drugs+by+Units+in+2007&amp;rft.atitle=&amp;rft.aulast=Verispan&amp;rft.au=Verispan&amp;rft.date=2008-02-18&amp;rft.pub=Drug+Topics&amp;rft_id=http%3A%2F%2Fwww.drugtopics.com%2Fdrugtopics%2Farticle%2FarticleDetail.jsp%3Fid%3D491181&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span> and <cite style="font-style:normal" class="web" id="CITEREFVerispan2008">Verispan (2008-02-18). <a href="http://www.drugtopics.com/drugtopics/article/articleDetail.jsp?id=491207" class="external text" title="http://www.drugtopics.com/drugtopics/article/articleDetail.jsp?id=491207" rel="nofollow">"Top 200 Brand Drugs by Units in 2007"</a> (PDF). Drug Topics<span class="printonly">. <a href="http://www.drugtopics.com/drugtopics/article/articleDetail.jsp?id=491207" class="external free" title="http://www.drugtopics.com/drugtopics/article/articleDetail.jsp?id=491207" rel="nofollow">http://www.drugtopics.com/drugtopics/article/articleDetail.jsp?id=491207</a></span><span class="reference-accessdate">. Retrieved on 2008-03-30</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Top+200+Brand+Drugs+by+Units+in+2007&amp;rft.atitle=&amp;rft.aulast=Verispan&amp;rft.au=Verispan&amp;rft.date=2008-02-18&amp;rft.pub=Drug+Topics&amp;rft_id=http%3A%2F%2Fwww.drugtopics.com%2Fdrugtopics%2Farticle%2FarticleDetail.jsp%3Fid%3D491207&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid10529069-1">^ <a href="#cite_ref-pmid10529069_1-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid10529069_1-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFFlament_MF.2C_Lane_RM.2C_Zhu_R.2C_Ying_Z1999">Flament MF, Lane RM, Zhu R, Ying Z (1999). "Predictors of an acute antidepressant response to fluoxetine and sertraline". <i>Int Clin Psychopharmacol</i> <b>14</b> (5): 259–75. <a href="http://www.ncbi.nlm.nih.gov/pubmed/10529069" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/10529069">PMID 10529069</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Predictors+of+an+acute+antidepressant+response+to+fluoxetine+and+sertraline&amp;rft.jtitle=Int+Clin+Psychopharmacol&amp;rft.aulast=Flament+MF%2C+Lane+RM%2C+Zhu+R%2C+Ying+Z&amp;rft.au=Flament+MF%2C+Lane+RM%2C+Zhu+R%2C+Ying+Z&amp;rft.date=1999&amp;rft.volume=14&amp;rft.issue=5&amp;rft.pages=259%E2%80%9375&amp;rft_id=info:pmid/10529069&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid14709946-2">^ <a href="#cite_ref-pmid14709946_2-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid14709946_2-1" title=""><sup><i><b>b</b></i></sup></a> The BSPS15 criterion identified 28 (21%) of sertraline-treated patients and 4 (6%) of placebo-treated patients as responders. The 50% reduction in BSPS criterion identified 47 (35%) of sertraline-treated patients and 9 (13%) of placebo-treated patients as responders. Finally, the 50% reduction in MFQ-SP criterion identified 53 (39%) of sertraline-treated patients and 9 (13%) of placebo-treated patients as responders. <cite style="font-style:normal" class="" id="CITEREFVan_Ameringen_M.2C_Oakman_J.2C_Mancini_C.2C_Pipe_B.2C_Chung_H2004">Van Ameringen M, Oakman J, Mancini C, Pipe B, Chung H (February 2004). "Predictors of response in generalized social phobia: effect of age of onset". <i>J Clin Psychopharmacol</i> <b>24</b> (1): 42–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1097%2F01.jcp.0000104909.75206.6f" class="external text" title="http://dx.doi.org/10.1097%2F01.jcp.0000104909.75206.6f" rel="nofollow">10.1097/01.jcp.0000104909.75206.6f</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/14709946" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/14709946">PMID 14709946</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Predictors+of+response+in+generalized+social+phobia%3A+effect+of+age+of+onset&amp;rft.jtitle=J+Clin+Psychopharmacol&amp;rft.aulast=Van+Ameringen+M%2C+Oakman+J%2C+Mancini+C%2C+Pipe+B%2C+Chung+H&amp;rft.au=Van+Ameringen+M%2C+Oakman+J%2C+Mancini+C%2C+Pipe+B%2C+Chung+H&amp;rft.date=February+2004&amp;rft.volume=24&amp;rft.issue=1&amp;rft.pages=42%E2%80%938&amp;rft_id=info:doi/10.1097%2F01.jcp.0000104909.75206.6f&amp;rft_id=info:pmid/14709946&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid11343529-3">^ <a href="#cite_ref-pmid11343529_3-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid11343529_3-1" title=""><sup><i><b>b</b></i></sup></a> CGI-Improvement, mean ± SD: Sertraline = 2.3 ± 0.1 Placebo = 2.8 ± 0.1. CGI-Severity, mean ± SD: Change Sertraline = −1.3 ± 0.1; placebo = −1.0 ± 0.1 <cite style="font-style:normal" class="" id="CITEREFDavidson_JR.2C_Rothbaum_BO.2C_van_der_Kolk_BA.2C_Sikes_CR.2C_Farfel_GM2001">Davidson JR, Rothbaum BO, van der Kolk BA, Sikes CR, Farfel GM (2001). "Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder". <i>Arch. Gen. Psychiatry</i> <b>58</b> (5): 485–92. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1001%2Farchpsyc.58.5.485" class="external text" title="http://dx.doi.org/10.1001%2Farchpsyc.58.5.485" rel="nofollow">10.1001/archpsyc.58.5.485</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11343529" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11343529">PMID 11343529</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Multicenter%2C+double-blind+comparison+of+sertraline+and+placebo+in+the+treatment+of+posttraumatic+stress+disorder&amp;rft.jtitle=Arch.+Gen.+Psychiatry&amp;rft.aulast=Davidson+JR%2C+Rothbaum+BO%2C+van+der+Kolk+BA%2C+Sikes+CR%2C+Farfel+GM&amp;rft.au=Davidson+JR%2C+Rothbaum+BO%2C+van+der+Kolk+BA%2C+Sikes+CR%2C+Farfel+GM&amp;rft.date=2001&amp;rft.volume=58&amp;rft.issue=5&amp;rft.pages=485%E2%80%9392&amp;rft_id=info:doi/10.1001%2Farchpsyc.58.5.485&amp;rft_id=info:pmid/11343529&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Welch-4">^ <a href="#cite_ref-Welch_4-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Welch_4-1" title=""><sup><i><b>b</b></i></sup></a> The most complete account of sertraline discovery, targeted at chemists, see: <cite style="font-style:normal" class="" id="CITEREFWelch_WM1995">Welch WM (1995). "Discovery and Development of Sertraline". <i>Advances in Medicinal Chemistry</i> <b>3</b>: 113–148. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2FS1067-5698%2806%2980005-2" class="external text" title="http://dx.doi.org/10.1016%2FS1067-5698%2806%2980005-2" rel="nofollow">10.1016/S1067-5698(06)80005-2</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Discovery+and+Development+of+Sertraline&amp;rft.jtitle=Advances+in+Medicinal+Chemistry&amp;rft.aulast=Welch+WM&amp;rft.au=Welch+WM&amp;rft.date=1995&amp;rft.volume=3&amp;rft.pages=113%E2%80%93148&amp;rft_id=info:doi/10.1016%2FS1067-5698%2806%2980005-2&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-5"><b><a href="#cite_ref-5" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFSarges_R.2C_Tretter_JR.2C_Tenen_SS.2C_Weissman_A1973">Sarges R, Tretter JR, Tenen SS, Weissman A (1973). "5,8-Disubstituted 1-Aminotetralins. A Class of Compounds with a Novel Profile of Central Nervous System Activity". <i>Journal of Medicinal Chemistry</i> <b>16</b> (9): 1003–1011. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1021%2Fjm00267a010" class="external text" title="http://dx.doi.org/10.1021%2Fjm00267a010" rel="nofollow">10.1021/jm00267a010</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=5%2C8-Disubstituted+1-Aminotetralins.+A+Class+of+Compounds+with+a+Novel+Profile+of+Central+Nervous+System+Activity&amp;rft.jtitle=Journal+of+Medicinal+Chemistry&amp;rft.aulast=Sarges+R%2C+Tretter+JR%2C+Tenen+SS%2C+Weissman+A&amp;rft.au=Sarges+R%2C+Tretter+JR%2C+Tenen+SS%2C+Weissman+A&amp;rft.date=1973&amp;rft.volume=16&amp;rft.issue=9&amp;rft.pages=1003%E2%80%931011&amp;rft_id=info:doi/10.1021%2Fjm00267a010&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-6"><b><a href="#cite_ref-6" title="">^</a></b> See also: <cite style="font-style:normal" class="" id="CITEREFMullin_R2006">Mullin R (2006). "ACS Award for Team Innovation". <i>Chemical &amp; Engineering News</i> <b>84</b> (5): 45–52.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=ACS+Award+for+Team+Innovation&amp;rft.jtitle=Chemical+%26+Engineering+News&amp;rft.aulast=Mullin+R&amp;rft.au=Mullin+R&amp;rft.date=2006&amp;rft.volume=84&amp;rft.issue=5&amp;rft.pages=45%E2%80%9352&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-7"><b><a href="#cite_ref-7" title="">^</a></b> A short blurb on the history of sertraline, see: <cite style="font-style:normal" class="" id="CITEREFCouzin_J2005">Couzin J (2005). "The brains behind blockbusters". <i><a href="/wiki/Science_(journal)" title="Science (journal)">Science</a></i> <b>309</b> (5735): 728. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1126%2Fscience.309.5735.728" class="external text" title="http://dx.doi.org/10.1126%2Fscience.309.5735.728" rel="nofollow">10.1126/science.309.5735.728</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16051786" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16051786">PMID 16051786</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+brains+behind+blockbusters&amp;rft.jtitle=%5B%5BScience+%28journal%29%7CScience%5D%5D&amp;rft.aulast=Couzin+J&amp;rft.au=Couzin+J&amp;rft.date=2005&amp;rft.volume=309&amp;rft.issue=5735&amp;rft.pages=728&amp;rft_id=info:doi/10.1126%2Fscience.309.5735.728&amp;rft_id=info:pmid/16051786&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-He168-8"><b><a href="#cite_ref-He168_8-0" title="">^</a></b> <cite style="font-style:normal" class="book" id="CITEREFHealy1999"><a href="/wiki/David_Healy_(psychiatrist)" title="David Healy (psychiatrist)">Healy, David</a> (1999). <i>The Antidepressant Era</i>. Cambridge, Massachusetts: Harvard University Press. pp.&#160;168. <a href="/wiki/Special:BookSources/0674039580" class="internal">ISBN 0-674-03958-0</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=The+Antidepressant+Era&amp;rft.aulast=Healy&amp;rft.aufirst=David&amp;rft.au=Healy%2C+David&amp;rft.date=1999&amp;rft.pages=pp.%26nbsp%3B168&amp;rft.place=Cambridge%2C+Massachusetts&amp;rft.pub=Harvard+University+Press&amp;rft.isbn=0-674-03958-0&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pdac-9"><b><a href="#cite_ref-pdac_9-0" title="">^</a></b> <cite style="font-style:normal" class="web"><a href="http://www.healyprozac.com/PDAC/PDAC-Zoloft%20Nov%2090.pdf" class="external text" title="http://www.healyprozac.com/PDAC/PDAC-Zoloft%20Nov%2090.pdf" rel="nofollow">"Minutes of the 33rd Meeting of Psychopharmacological Drugs Advisory Committee on November 19, 1990"</a> (PDF). FDA. 1990<span class="printonly">. <a href="http://www.healyprozac.com/PDAC/PDAC-Zoloft%20Nov%2090.pdf" class="external free" title="http://www.healyprozac.com/PDAC/PDAC-Zoloft%20Nov%2090.pdf" rel="nofollow">http://www.healyprozac.com/PDAC/PDAC-Zoloft%20Nov%2090.pdf</a></span><span class="reference-accessdate">. Retrieved on 2008-07-11</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Minutes+of+the+33rd+Meeting+of+Psychopharmacological+Drugs+Advisory+Committee+on+November+19%2C+1990&amp;rft.atitle=&amp;rft.date=1990&amp;rft.pub=FDA&amp;rft_id=http%3A%2F%2Fwww.healyprozac.com%2FPDAC%2FPDAC-Zoloft%2520Nov%252090.pdf&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid8573661-10"><b><a href="#cite_ref-pmid8573661_10-0" title="">^</a></b> See also:<cite style="font-style:normal" class="" id="CITEREFFabre_LF.2C_Abuzzahab_FS.2C_Amin_M.2C_Claghorn_JL.2C_Mendels_J.2C_Petrie_WM.2C_Dub.C3.A9_S.2C_Small_JG1995">Fabre LF, Abuzzahab FS, Amin M, Claghorn JL, Mendels J, Petrie WM, Dubé S, Small JG (1995). "Sertraline safety and efficacy in major depression: a double-blind fixed-dose comparison with placebo". <i>Biol. Psychiatry</i> <b>38</b> (9): 592–602. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2F0006-3223%2895%2900178-8" class="external text" title="http://dx.doi.org/10.1016%2F0006-3223%2895%2900178-8" rel="nofollow">10.1016/0006-3223(95)00178-8</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/8573661" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/8573661">PMID 8573661</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Sertraline+safety+and+efficacy+in+major+depression%3A+a+double-blind+fixed-dose+comparison+with+placebo&amp;rft.jtitle=Biol.+Psychiatry&amp;rft.aulast=Fabre+LF%2C+Abuzzahab+FS%2C+Amin+M%2C+Claghorn+JL%2C+Mendels+J%2C+Petrie+WM%2C+Dub%C3%A9+S%2C+Small+JG&amp;rft.au=Fabre+LF%2C+Abuzzahab+FS%2C+Amin+M%2C+Claghorn+JL%2C+Mendels+J%2C+Petrie+WM%2C+Dub%C3%A9+S%2C+Small+JG&amp;rft.date=1995&amp;rft.volume=38&amp;rft.issue=9&amp;rft.pages=592%E2%80%93602&amp;rft_id=info:doi/10.1016%2F0006-3223%2895%2900178-8&amp;rft_id=info:pmid/8573661&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid15462638-11"><b><a href="#cite_ref-pmid15462638_11-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFMant_A.2C_Rendle_VA.2C_Hall_WD.2C_.27.27et_al.27.272004">Mant A, Rendle VA, Hall WD, <i>et al</i> (October 2004). "<a href="http://www.mja.com.au/public/issues/181_07%20Suppl_041004/man10822_fm.html" class="external text" title="http://www.mja.com.au/public/issues/181_07%20Suppl_041004/man10822_fm.html" rel="nofollow">Making new choices about antidepressants in Australia: the long view 1975-2002</a>". <i>Med. J. Aust.</i> <b>181</b> (7 Suppl): S21–4. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15462638" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15462638">PMID 15462638</a><span class="printonly">. <a href="http://www.mja.com.au/public/issues/181_07%20Suppl_041004/man10822_fm.html" class="external free" title="http://www.mja.com.au/public/issues/181_07%20Suppl_041004/man10822_fm.html" rel="nofollow">http://www.mja.com.au/public/issues/181_07%20Suppl_041004/man10822_fm.html</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Making+new+choices+about+antidepressants+in+Australia%3A+the+long+view+1975-2002&amp;rft.jtitle=Med.+J.+Aust.&amp;rft.aulast=Mant+A%2C+Rendle+VA%2C+Hall+WD%2C+%27%27et+al%27%27&amp;rft.au=Mant+A%2C+Rendle+VA%2C+Hall+WD%2C+%27%27et+al%27%27&amp;rft.date=October+2004&amp;rft.volume=181&amp;rft.issue=7+Suppl&amp;rft.pages=S21%E2%80%934&amp;rft_id=info:pmid/15462638&amp;rft_id=http%3A%2F%2Fwww.mja.com.au%2Fpublic%2Fissues%2F181_07%2520Suppl_041004%2Fman10822_fm.html&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-12"><b><a href="#cite_ref-12" title="">^</a></b> <cite style="font-style:normal" class="">"<a href="http://www.australianprescriber.com/magazine/22/5/artid/328/" class="external text" title="http://www.australianprescriber.com/magazine/22/5/artid/328/" rel="nofollow">Top 10 drugs - 1998</a>". <i>Australian Prescriber</i> <b>22</b>: 119. 1999<span class="printonly">. <a href="http://www.australianprescriber.com/magazine/22/5/artid/328/" class="external free" title="http://www.australianprescriber.com/magazine/22/5/artid/328/" rel="nofollow">http://www.australianprescriber.com/magazine/22/5/artid/328/</a></span><span class="reference-accessdate">. Retrieved on 2008-04-30</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Top+10+drugs+-+1998&amp;rft.jtitle=Australian+Prescriber&amp;rft.date=1999&amp;rft.volume=22&amp;rft.pages=119&amp;rft_id=http%3A%2F%2Fwww.australianprescriber.com%2Fmagazine%2F22%2F5%2Fartid%2F328%2F&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-13"><b><a href="#cite_ref-13" title="">^</a></b> <cite style="font-style:normal" class="">"<a href="http://www.australianprescriber.com/magazine/24/6/artid/549/" class="external text" title="http://www.australianprescriber.com/magazine/24/6/artid/549/" rel="nofollow">Top 10 drugs - 2000-01</a>". <i>Australian Prescriber</i> <b>24</b>: 136. 2001<span class="printonly">. <a href="http://www.australianprescriber.com/magazine/24/6/artid/549/" class="external free" title="http://www.australianprescriber.com/magazine/24/6/artid/549/" rel="nofollow">http://www.australianprescriber.com/magazine/24/6/artid/549/</a></span><span class="reference-accessdate">. Retrieved on 2008-04-30</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Top+10+drugs+-+2000-01&amp;rft.jtitle=Australian+Prescriber&amp;rft.date=2001&amp;rft.volume=24&amp;rft.pages=136&amp;rft_id=http%3A%2F%2Fwww.australianprescriber.com%2Fmagazine%2F24%2F6%2Fartid%2F549%2F&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-url-14"><b><a href="#cite_ref-url_14-0" title="">^</a></b> <cite style="font-style:normal" class="web"><a href="http://www.mhra.gov.uk/home/groups/pl-p/documents/websiteresources/con019473.pdf" class="external text" title="http://www.mhra.gov.uk/home/groups/pl-p/documents/websiteresources/con019473.pdf" rel="nofollow">"Prescribing trends for SSRIs and related antidepressants"</a> (PDF). UK MHRA. 2004<span class="printonly">. <a href="http://www.mhra.gov.uk/home/groups/pl-p/documents/websiteresources/con019473.pdf" class="external free" title="http://www.mhra.gov.uk/home/groups/pl-p/documents/websiteresources/con019473.pdf" rel="nofollow">http://www.mhra.gov.uk/home/groups/pl-p/documents/websiteresources/con019473.pdf</a></span><span class="reference-accessdate">. Retrieved on 2008-04-30</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Prescribing+trends+for+SSRIs+and+related+antidepressants&amp;rft.atitle=&amp;rft.date=2004&amp;rft.pub=UK+MHRA&amp;rft_id=http%3A%2F%2Fwww.mhra.gov.uk%2Fhome%2Fgroups%2Fpl-p%2Fdocuments%2Fwebsiteresources%2Fcon019473.pdf&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-15"><b><a href="#cite_ref-15" title="">^</a></b> <cite style="font-style:normal" class="web" id="CITEREFSkinner_BJ.2C_Rovere_M2007">Skinner BJ, Rovere M (2007-07-31). <a href="http://www.fraserinstitute.org/COMMERCE.WEB/publication_details.aspx?pubID=4542" class="external text" title="http://www.fraserinstitute.org/COMMERCE.WEB/publication_details.aspx?pubID=4542" rel="nofollow">"Canada's Drug Price Paradox 2007"</a> (PDF). The Fraser Institute. 21-29<span class="printonly">. <a href="http://www.fraserinstitute.org/COMMERCE.WEB/publication_details.aspx?pubID=4542" class="external free" title="http://www.fraserinstitute.org/COMMERCE.WEB/publication_details.aspx?pubID=4542" rel="nofollow">http://www.fraserinstitute.org/COMMERCE.WEB/publication_details.aspx?pubID=4542</a></span><span class="reference-accessdate">. Retrieved on 2008-07-11</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Canada%27s+Drug+Price+Paradox+2007&amp;rft.atitle=&amp;rft.aulast=Skinner+BJ%2C+Rovere+M&amp;rft.au=Skinner+BJ%2C+Rovere+M&amp;rft.date=2007-07-31&amp;rft.pages=21-29&amp;rft.pub=The+Fraser+Institute&amp;rft_id=http%3A%2F%2Fwww.fraserinstitute.org%2FCOMMERCE.WEB%2Fpublication_details.aspx%3FpubID%3D4542&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-16"><b><a href="#cite_ref-16" title="">^</a></b> <cite style="font-style:normal" class="web"><a href="http://www.mhra.gov.uk/NewsCentre/Pressreleases/CON002045" class="external text" title="http://www.mhra.gov.uk/NewsCentre/Pressreleases/CON002045" rel="nofollow">"Safety review of antidepressants used by children completed"</a>. <a href="/wiki/Medicines_and_Healthcare_products_Regulatory_Agency" title="Medicines and Healthcare products Regulatory Agency">MHRA</a>. 2003-12-10<span class="printonly">. <a href="http://www.mhra.gov.uk/NewsCentre/Pressreleases/CON002045" class="external free" title="http://www.mhra.gov.uk/NewsCentre/Pressreleases/CON002045" rel="nofollow">http://www.mhra.gov.uk/NewsCentre/Pressreleases/CON002045</a></span><span class="reference-accessdate">. Retrieved on 2008-07-11</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Safety+review+of+antidepressants+used+by+children+completed&amp;rft.atitle=&amp;rft.date=2003-12-10&amp;rft.pub=%5B%5BMedicines+and+Healthcare+products+Regulatory+Agency%7CMHRA%5D%5D&amp;rft_id=http%3A%2F%2Fwww.mhra.gov.uk%2FNewsCentre%2FPressreleases%2FCON002045&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-17"><b><a href="#cite_ref-17" title="">^</a></b> <cite style="font-style:normal" class="news" id="CITEREFBoseley2003">Boseley, Sarah (2003-12-10). "<a href="http://www.guardian.co.uk/uk_news/story/0,3604,1103563,00.html" class="external text" title="http://www.guardian.co.uk/uk_news/story/0,3604,1103563,00.html" rel="nofollow">Drugs for depressed children banned</a>". <i><a href="/wiki/The_Guardian" title="The Guardian">The Guardian</a></i><span class="printonly">. <a href="http://www.guardian.co.uk/uk_news/story/0,3604,1103563,00.html" class="external free" title="http://www.guardian.co.uk/uk_news/story/0,3604,1103563,00.html" rel="nofollow">http://www.guardian.co.uk/uk_news/story/0,3604,1103563,00.html</a></span><span class="reference-accessdate">. Retrieved on 2007-04-19</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Drugs+for+depressed+children+banned&amp;rft.jtitle=%5B%5BThe+Guardian%5D%5D&amp;rft.aulast=Boseley&amp;rft.aufirst=Sarah&amp;rft.au=Boseley%2C+Sarah&amp;rft.date=2003-12-10&amp;rft_id=http%3A%2F%2Fwww.guardian.co.uk%2Fuk_news%2Fstory%2F0%2C3604%2C1103563%2C00.html&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-18"><b><a href="#cite_ref-18" title="">^</a></b> <cite style="font-style:normal" class="web"><a href="http://www.mhra.gov.uk/Safetyinformation/Safetywarningsalertsandrecalls/Safetywarningsandmessagesformedicines/CON019494" class="external text" title="http://www.mhra.gov.uk/Safetyinformation/Safetywarningsalertsandrecalls/Safetywarningsandmessagesformedicines/CON019494" rel="nofollow">"Overview of regulatory status and CSM advice relating to major depressive disorder (MDD) in children and adolescents"</a>. MHRA<span class="printonly">. <a href="http://www.mhra.gov.uk/Safetyinformation/Safetywarningsalertsandrecalls/Safetywarningsandmessagesformedicines/CON019494" class="external free" title="http://www.mhra.gov.uk/Safetyinformation/Safetywarningsalertsandrecalls/Safetywarningsandmessagesformedicines/CON019494" rel="nofollow">http://www.mhra.gov.uk/Safetyinformation/Safetywarningsalertsandrecalls/Safetywarningsandmessagesformedicines/CON019494</a></span><span class="reference-accessdate">. Retrieved on 2008-04-17</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Overview+of+regulatory+status+and+CSM+advice+relating+to+major+depressive+disorder+%28MDD%29+in+children+and+adolescents&amp;rft.atitle=&amp;rft.pub=MHRA&amp;rft_id=http%3A%2F%2Fwww.mhra.gov.uk%2FSafetyinformation%2FSafetywarningsalertsandrecalls%2FSafetywarningsandmessagesformedicines%2FCON019494&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-19"><b><a href="#cite_ref-19" title="">^</a></b> <cite style="font-style:normal" class="web" id="CITEREFFood_and_Drug_Administration2007">Food and Drug Administration (2007-05-02). <a href="http://www.fda.gov/bbs/topics/NEWS/2007/NEW01624.html" class="external text" title="http://www.fda.gov/bbs/topics/NEWS/2007/NEW01624.html" rel="nofollow">"FDA Proposes New Warnings About Suicidal Thinking, Behavior in Young Adults Who Take Antidepressant Medications"</a><span class="printonly">. <a href="http://www.fda.gov/bbs/topics/NEWS/2007/NEW01624.html" class="external free" title="http://www.fda.gov/bbs/topics/NEWS/2007/NEW01624.html" rel="nofollow">http://www.fda.gov/bbs/topics/NEWS/2007/NEW01624.html</a></span><span class="reference-accessdate">. Retrieved on 2008-07-11</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=FDA+Proposes+New+Warnings+About+Suicidal+Thinking%2C+Behavior+in+Young+Adults+Who+Take+Antidepressant+Medications&amp;rft.atitle=&amp;rft.aulast=Food+and+Drug+Administration&amp;rft.au=Food+and+Drug+Administration&amp;rft.date=2007-05-02&amp;rft_id=http%3A%2F%2Fwww.fda.gov%2Fbbs%2Ftopics%2FNEWS%2F2007%2FNEW01624.html&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-20"><b><a href="#cite_ref-20" title="">^</a></b> <cite style="font-style:normal" class="web" id="CITEREFSmith2006">Smith, Aaron (2006-07-17). <a href="http://money.cnn.com/2006/07/17/news/companies/pfizer/index.htm" class="external text" title="http://money.cnn.com/2006/07/17/news/companies/pfizer/index.htm" rel="nofollow">"Pfizer needs more drugs"</a>. <a href="/wiki/CNN.com" title="CNN.com" class="mw-redirect">CNNMoney.com</a><span class="printonly">. <a href="http://money.cnn.com/2006/07/17/news/companies/pfizer/index.htm" class="external free" title="http://money.cnn.com/2006/07/17/news/companies/pfizer/index.htm" rel="nofollow">http://money.cnn.com/2006/07/17/news/companies/pfizer/index.htm</a></span><span class="reference-accessdate">. Retrieved on 2007-01-27</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Pfizer+needs+more+drugs&amp;rft.atitle=&amp;rft.aulast=Smith&amp;rft.aufirst=Aaron&amp;rft.au=Smith%2C+Aaron&amp;rft.date=2006-07-17&amp;rft.pub=%5B%5BCNN.com%7CCNNMoney.com%5D%5D&amp;rft_id=http%3A%2F%2Fmoney.cnn.com%2F2006%2F07%2F17%2Fnews%2Fcompanies%2Fpfizer%2Findex.htm&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid18199864-21"><b><a href="#cite_ref-pmid18199864_21-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFTurner_EH.2C_Matthews_AM.2C_Linardatos_E.2C_Tell_RA.2C_Rosenthal_R2008">Turner EH, Matthews AM, Linardatos E, Tell RA, Rosenthal R (January 2008). "Selective publication of antidepressant trials and its influence on apparent efficacy". <i>N. Engl. J. Med.</i> <b>358</b> (3): 252–60. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1056%2FNEJMsa065779" class="external text" title="http://dx.doi.org/10.1056%2FNEJMsa065779" rel="nofollow">10.1056/NEJMsa065779</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18199864" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/18199864">PMID 18199864</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Selective+publication+of+antidepressant+trials+and+its+influence+on+apparent+efficacy&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.aulast=Turner+EH%2C+Matthews+AM%2C+Linardatos+E%2C+Tell+RA%2C+Rosenthal+R&amp;rft.au=Turner+EH%2C+Matthews+AM%2C+Linardatos+E%2C+Tell+RA%2C+Rosenthal+R&amp;rft.date=January+2008&amp;rft.volume=358&amp;rft.issue=3&amp;rft.pages=252%E2%80%9360&amp;rft_id=info:doi/10.1056%2FNEJMsa065779&amp;rft_id=info:pmid/18199864&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid17475736-22"><b><a href="#cite_ref-pmid17475736_22-0" title="">^</a></b> For example, in this study two-thirds of depressed inpatients were treated with sertraline and only one-third with the TCA amitriptyline. <cite style="font-style:normal" class="" id="CITEREFSchramm_E.2C_van_Calker_D.2C_Dykierek_P.2C_Lieb_K.2C_Kech_S.2C_Zobel_I.2C_Leonhart_R.2C_Berger_M2007">Schramm E, van Calker D, Dykierek P, Lieb K, Kech S, Zobel I, Leonhart R, Berger M (2007). "An intensive treatment program of interpersonal psychotherapy plus pharmacotherapy for depressed inpatients: acute and long-term results". <i>Am J Psychiatry</i> <b>164</b> (5): 768–77. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1176%2Fappi.ajp.164.5.768" class="external text" title="http://dx.doi.org/10.1176%2Fappi.ajp.164.5.768" rel="nofollow">10.1176/appi.ajp.164.5.768</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17475736" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17475736">PMID 17475736</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=An+intensive+treatment+program+of+interpersonal+psychotherapy+plus+pharmacotherapy+for+depressed+inpatients%3A+acute+and+long-term+results&amp;rft.jtitle=Am+J+Psychiatry&amp;rft.aulast=Schramm+E%2C+van+Calker+D%2C+Dykierek+P%2C+Lieb+K%2C+Kech+S%2C+Zobel+I%2C+Leonhart+R%2C+Berger+M&amp;rft.au=Schramm+E%2C+van+Calker+D%2C+Dykierek+P%2C+Lieb+K%2C+Kech+S%2C+Zobel+I%2C+Leonhart+R%2C+Berger+M&amp;rft.date=2007&amp;rft.volume=164&amp;rft.issue=5&amp;rft.pages=768%E2%80%9377&amp;rft_id=info:doi/10.1176%2Fappi.ajp.164.5.768&amp;rft_id=info:pmid/17475736&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid10993128-23">^ <a href="#cite_ref-pmid10993128_23-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid10993128_23-1" title=""><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid10993128_23-2" title=""><sup><i><b>c</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFL.C3.A9pine_JP.2C_Goger_J.2C_Blashko_C.2C_Probst_C.2C_Moles_MF.2C_Kosolowski_J.2C_Scharfetter_B.2C_Lane_RM2000">Lépine JP, Goger J, Blashko C, Probst C, Moles MF, Kosolowski J, Scharfetter B, Lane RM (2000). "A double-blind study of the efficacy and safety of sertraline and clomipramine in outpatients with severe major depression". <i>International Clinical Psychopharmacology</i> <b>15</b> (5): 263–71. <a href="http://www.ncbi.nlm.nih.gov/pubmed/10993128" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/10993128">PMID 10993128</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=A+double-blind+study+of+the+efficacy+and+safety+of+sertraline+and+clomipramine+in+outpatients+with+severe+major+depression&amp;rft.jtitle=International+Clinical+Psychopharmacology&amp;rft.aulast=L%C3%A9pine+JP%2C+Goger+J%2C+Blashko+C%2C+Probst+C%2C+Moles+MF%2C+Kosolowski+J%2C+Scharfetter+B%2C+Lane+RM&amp;rft.au=L%C3%A9pine+JP%2C+Goger+J%2C+Blashko+C%2C+Probst+C%2C+Moles+MF%2C+Kosolowski+J%2C+Scharfetter+B%2C+Lane+RM&amp;rft.date=2000&amp;rft.volume=15&amp;rft.issue=5&amp;rft.pages=263%E2%80%9371&amp;rft_id=info:pmid/10993128&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid11105734-24"><b><a href="#cite_ref-pmid11105734_24-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFRavindran_AV.2C_Guelfi_JD.2C_Lane_RM.2C_Cassano_GB2000">Ravindran AV, Guelfi JD, Lane RM, Cassano GB (2000). "Treatment of dysthymia with sertraline: a double-blind, placebo-controlled trial in dysthymic patients without major depression". <i>The Journal of Clinical Psychiatry</i> <b>61</b> (11): 821–7. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11105734" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11105734">PMID 11105734</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Treatment+of+dysthymia+with+sertraline%3A+a+double-blind%2C+placebo-controlled+trial+in+dysthymic+patients+without+major+depression&amp;rft.jtitle=The+Journal+of+Clinical+Psychiatry&amp;rft.aulast=Ravindran+AV%2C+Guelfi+JD%2C+Lane+RM%2C+Cassano+GB&amp;rft.au=Ravindran+AV%2C+Guelfi+JD%2C+Lane+RM%2C+Cassano+GB&amp;rft.date=2000&amp;rft.volume=61&amp;rft.issue=11&amp;rft.pages=821%E2%80%937&amp;rft_id=info:pmid/11105734&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid8792754-25">^ <a href="#cite_ref-pmid8792754_25-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid8792754_25-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFThase_ME.2C_Fava_M.2C_Halbreich_U.2C_Kocsis_JH.2C_Koran_L.2C_Davidson_J.2C_Rosenbaum_J.2C_Harrison_W1996">Thase ME, Fava M, Halbreich U, Kocsis JH, Koran L, Davidson J, Rosenbaum J, Harrison W (1996). "A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia". <i>Arch. Gen. Psychiatry</i> <b>53</b> (9): 777–84. <a href="http://www.ncbi.nlm.nih.gov/pubmed/8792754" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/8792754">PMID 8792754</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=A+placebo-controlled%2C+randomized+clinical+trial+comparing+sertraline+and+imipramine+for+the+treatment+of+dysthymia&amp;rft.jtitle=Arch.+Gen.+Psychiatry&amp;rft.aulast=Thase+ME%2C+Fava+M%2C+Halbreich+U%2C+Kocsis+JH%2C+Koran+L%2C+Davidson+J%2C+Rosenbaum+J%2C+Harrison+W&amp;rft.au=Thase+ME%2C+Fava+M%2C+Halbreich+U%2C+Kocsis+JH%2C+Koran+L%2C+Davidson+J%2C+Rosenbaum+J%2C+Harrison+W&amp;rft.date=1996&amp;rft.volume=53&amp;rft.issue=9&amp;rft.pages=777%E2%80%9384&amp;rft_id=info:pmid/8792754&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid10518174-26">^ <a href="#cite_ref-pmid10518174_26-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid10518174_26-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFRavindran_AV.2C_Anisman_H.2C_Merali_Z.2C_Charbonneau_Y.2C_Telner_J.2C_Bialik_RJ.2C_Wiens_A.2C_Ellis_J.2C_Griffiths_J1999">Ravindran AV, Anisman H, Merali Z, Charbonneau Y, Telner J, Bialik RJ, Wiens A, Ellis J, Griffiths J (1999). "Treatment of primary dysthymia with group cognitive therapy and pharmacotherapy: clinical symptoms and functional impairments". <i>Am J Psychiatry</i> <b>156</b> (10): 1608–17. <a href="http://www.ncbi.nlm.nih.gov/pubmed/10518174" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/10518174">PMID 10518174</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Treatment+of+primary+dysthymia+with+group+cognitive+therapy+and+pharmacotherapy%3A+clinical+symptoms+and+functional+impairments&amp;rft.jtitle=Am+J+Psychiatry&amp;rft.aulast=Ravindran+AV%2C+Anisman+H%2C+Merali+Z%2C+Charbonneau+Y%2C+Telner+J%2C+Bialik+RJ%2C+Wiens+A%2C+Ellis+J%2C+Griffiths+J&amp;rft.au=Ravindran+AV%2C+Anisman+H%2C+Merali+Z%2C+Charbonneau+Y%2C+Telner+J%2C+Bialik+RJ%2C+Wiens+A%2C+Ellis+J%2C+Griffiths+J&amp;rft.date=1999&amp;rft.volume=156&amp;rft.issue=10&amp;rft.pages=1608%E2%80%9317&amp;rft_id=info:pmid/10518174&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid16263177-27">^ <a href="#cite_ref-pmid16263177_27-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid16263177_27-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFMarkowitz_JC.2C_Kocsis_JH.2C_Bleiberg_KL.2C_Christos_PJ.2C_Sacks_M2005">Markowitz JC, Kocsis JH, Bleiberg KL, Christos PJ, Sacks M (2005). "A comparative trial of psychotherapy and pharmacotherapy for "pure" dysthymic patients". <i>J Affect Disord</i> <b>89</b> (1–3): 167–75. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2Fj.jad.2005.10.001" class="external text" title="http://dx.doi.org/10.1016%2Fj.jad.2005.10.001" rel="nofollow">10.1016/j.jad.2005.10.001</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16263177" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16263177">PMID 16263177</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=A+comparative+trial+of+psychotherapy+and+pharmacotherapy+for+%22pure%22+dysthymic+patients&amp;rft.jtitle=J+Affect+Disord&amp;rft.aulast=Markowitz+JC%2C+Kocsis+JH%2C+Bleiberg+KL%2C+Christos+PJ%2C+Sacks+M&amp;rft.au=Markowitz+JC%2C+Kocsis+JH%2C+Bleiberg+KL%2C+Christos+PJ%2C+Sacks+M&amp;rft.date=2005&amp;rft.volume=89&amp;rft.issue=1%E2%80%933&amp;rft.pages=167%E2%80%9375&amp;rft_id=info:doi/10.1016%2Fj.jad.2005.10.001&amp;rft_id=info:pmid/16263177&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid12063159-28"><b><a href="#cite_ref-pmid12063159_28-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFBrowne_G.2C_Steiner_M.2C_Roberts_J.2C_Gafni_A.2C_Byrne_C.2C_Dunn_E.2C_Bell_B.2C_Mills_M.2C_Chalklin_L.2C_Wallik_D.2C_Kraemer_J2002">Browne G, Steiner M, Roberts J, Gafni A, Byrne C, Dunn E, Bell B, Mills M, Chalklin L, Wallik D, Kraemer J (2002). "Sertraline and/or interpersonal psychotherapy for patients with dysthymic disorder in primary care: 6-month comparison with longitudinal 2-year follow-up of effectiveness and costs". <i>J Affect Disord</i> <b>68</b> (2-3): 317–30. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2FS0165-0327%2801%2900343-3" class="external text" title="http://dx.doi.org/10.1016%2FS0165-0327%2801%2900343-3" rel="nofollow">10.1016/S0165-0327(01)00343-3</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12063159" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12063159">PMID 12063159</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Sertraline+and%2For+interpersonal+psychotherapy+for+patients+with+dysthymic+disorder+in+primary+care%3A+6-month+comparison+with+longitudinal+2-year+follow-up+of+effectiveness+and+costs&amp;rft.jtitle=J+Affect+Disord&amp;rft.aulast=Browne+G%2C+Steiner+M%2C+Roberts+J%2C+Gafni+A%2C+Byrne+C%2C+Dunn+E%2C+Bell+B%2C+Mills+M%2C+Chalklin+L%2C+Wallik+D%2C+Kraemer+J&amp;rft.au=Browne+G%2C+Steiner+M%2C+Roberts+J%2C+Gafni+A%2C+Byrne+C%2C+Dunn+E%2C+Bell+B%2C+Mills+M%2C+Chalklin+L%2C+Wallik+D%2C+Kraemer+J&amp;rft.date=2002&amp;rft.volume=68&amp;rft.issue=2-3&amp;rft.pages=317%E2%80%9330&amp;rft_id=info:doi/10.1016%2FS0165-0327%2801%2900343-3&amp;rft_id=info:pmid/12063159&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid10632236-29"><b><a href="#cite_ref-pmid10632236_29-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFHoehn-Saric_R.2C_Ninan_P.2C_Black_DW.2C_Stahl_S.2C_Greist_JH.2C_Lydiard_B.2C_McElroy_S.2C_Zajecka_J.2C_Chapman_D.2C_Clary_C.2C_Harrison_W2000">Hoehn-Saric R, Ninan P, Black DW, Stahl S, Greist JH, Lydiard B, McElroy S, Zajecka J, Chapman D, Clary C, Harrison W (2000). "Multicenter double-blind comparison of sertraline and desipramine for concurrent obsessive-compulsive and major depressive disorders". <i>Arch. Gen. Psychiatry</i> <b>57</b> (1): 76–82. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1001%2Farchpsyc.57.1.76" class="external text" title="http://dx.doi.org/10.1001%2Farchpsyc.57.1.76" rel="nofollow">10.1001/archpsyc.57.1.76</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/10632236" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/10632236">PMID 10632236</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Multicenter+double-blind+comparison+of+sertraline+and+desipramine+for+concurrent+obsessive-compulsive+and+major+depressive+disorders&amp;rft.jtitle=Arch.+Gen.+Psychiatry&amp;rft.aulast=Hoehn-Saric+R%2C+Ninan+P%2C+Black+DW%2C+Stahl+S%2C+Greist+JH%2C+Lydiard+B%2C+McElroy+S%2C+Zajecka+J%2C+Chapman+D%2C+Clary+C%2C+Harrison+W&amp;rft.au=Hoehn-Saric+R%2C+Ninan+P%2C+Black+DW%2C+Stahl+S%2C+Greist+JH%2C+Lydiard+B%2C+McElroy+S%2C+Zajecka+J%2C+Chapman+D%2C+Clary+C%2C+Harrison+W&amp;rft.date=2000&amp;rft.volume=57&amp;rft.issue=1&amp;rft.pages=76%E2%80%9382&amp;rft_id=info:doi/10.1001%2Farchpsyc.57.1.76&amp;rft_id=info:pmid/10632236&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid12823079-30"><b><a href="#cite_ref-pmid12823079_30-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFLepola_U.2C_Arat.C3.B3_M.2C_Zhu_Y.2C_Austin_C2003">Lepola U, Arató M, Zhu Y, Austin C (2003). "Sertraline versus imipramine treatment of comorbid panic disorder and major depressive disorder". <i>J Clin Psychiatry</i> <b>64</b> (6): 654–62. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12823079" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12823079">PMID 12823079</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Sertraline+versus+imipramine+treatment+of+comorbid+panic+disorder+and+major+depressive+disorder&amp;rft.jtitle=J+Clin+Psychiatry&amp;rft.aulast=Lepola+U%2C+Arat%C3%B3+M%2C+Zhu+Y%2C+Austin+C&amp;rft.au=Lepola+U%2C+Arat%C3%B3+M%2C+Zhu+Y%2C+Austin+C&amp;rft.date=2003&amp;rft.volume=64&amp;rft.issue=6&amp;rft.pages=654%E2%80%9362&amp;rft_id=info:pmid/12823079&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid9817625-31"><b><a href="#cite_ref-pmid9817625_31-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFEkselius_L.2C_von_Knorring_L1998">Ekselius L, von Knorring L (1998). "Personality disorder comorbidity with major depression and response to treatment with sertraline or citalopram". <i>Int Clin Psychopharmacol</i> <b>13</b> (5): 205–11. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1097%2F00004850-199809000-00003" class="external text" title="http://dx.doi.org/10.1097%2F00004850-199809000-00003" rel="nofollow">10.1097/00004850-199809000-00003</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/9817625" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/9817625">PMID 9817625</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Personality+disorder+comorbidity+with+major+depression+and+response+to+treatment+with+sertraline+or+citalopram&amp;rft.jtitle=Int+Clin+Psychopharmacol&amp;rft.aulast=Ekselius+L%2C+von+Knorring+L&amp;rft.au=Ekselius+L%2C+von+Knorring+L&amp;rft.date=1998&amp;rft.volume=13&amp;rft.issue=5&amp;rft.pages=205%E2%80%9311&amp;rft_id=info:doi/10.1097%2F00004850-199809000-00003&amp;rft_id=info:pmid/9817625&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid2258378-32">^ <a href="#cite_ref-pmid2258378_32-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid2258378_32-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFReimherr_FW.2C_Chouinard_G.2C_Cohn_CK.2C_Cole_JO.2C_Itil_TM.2C_LaPierre_YD.2C_Masco_HL.2C_Mendels_J1990">Reimherr FW, Chouinard G, Cohn CK, Cole JO, Itil TM, LaPierre YD, Masco HL, Mendels J (1990). "Antidepressant efficacy of sertraline: a double-blind, placebo- and amitriptyline-controlled, multicenter comparison study in outpatients with major depression". <i>J Clin Psychiatry</i> <b>51 Suppl B</b>: 18–27. <a href="http://www.ncbi.nlm.nih.gov/pubmed/2258378" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/2258378">PMID 2258378</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Antidepressant+efficacy+of+sertraline%3A+a+double-blind%2C+placebo-+and+amitriptyline-controlled%2C+multicenter+comparison+study+in+outpatients+with+major+depression&amp;rft.jtitle=J+Clin+Psychiatry&amp;rft.aulast=Reimherr+FW%2C+Chouinard+G%2C+Cohn+CK%2C+Cole+JO%2C+Itil+TM%2C+LaPierre+YD%2C+Masco+HL%2C+Mendels+J&amp;rft.au=Reimherr+FW%2C+Chouinard+G%2C+Cohn+CK%2C+Cole+JO%2C+Itil+TM%2C+LaPierre+YD%2C+Masco+HL%2C+Mendels+J&amp;rft.date=1990&amp;rft.volume=51+Suppl+B&amp;rft.pages=18%E2%80%9327&amp;rft_id=info:pmid/2258378&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid9413414-33">^ <a href="#cite_ref-pmid9413414_33-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid9413414_33-1" title=""><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid9413414_33-2" title=""><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid9413414_33-3" title=""><sup><i><b>d</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFLydiard_RB.2C_Stahl_SM.2C_Hertzman_M.2C_Harrison_WM1997">Lydiard RB, Stahl SM, Hertzman M, Harrison WM (1997). "A double-blind, placebo-controlled study comparing the effects of sertraline versus amitriptyline in the treatment of major depression". <i>The Journal of Clinical Psychiatry</i> <b>58</b> (11): 484–91. <a href="http://www.ncbi.nlm.nih.gov/pubmed/9413414" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/9413414">PMID 9413414</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=A+double-blind%2C+placebo-controlled+study+comparing+the+effects+of+sertraline+versus+amitriptyline+in+the+treatment+of+major+depression&amp;rft.jtitle=The+Journal+of+Clinical+Psychiatry&amp;rft.aulast=Lydiard+RB%2C+Stahl+SM%2C+Hertzman+M%2C+Harrison+WM&amp;rft.au=Lydiard+RB%2C+Stahl+SM%2C+Hertzman+M%2C+Harrison+WM&amp;rft.date=1997&amp;rft.volume=58&amp;rft.issue=11&amp;rft.pages=484%E2%80%9391&amp;rft_id=info:pmid/9413414&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid9862605-34"><b><a href="#cite_ref-pmid9862605_34-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFRush_AJ.2C_Koran_LM.2C_Keller_MB.2C_Markowitz_JC.2C_Harrison_WM.2C_Miceli_RJ.2C_Fawcett_JA.2C_Gelenberg_AJ.2C_Hirschfeld_RM.2C_Klein_DN.2C_Kocsis_JH.2C_McCullough_JP.2C_Schatzberg_AF.2C_Thase_ME1998">Rush AJ, Koran LM, Keller MB, Markowitz JC, Harrison WM, Miceli RJ, Fawcett JA, Gelenberg AJ, Hirschfeld RM, Klein DN, Kocsis JH, McCullough JP, Schatzberg AF, Thase ME (1998). "The treatment of chronic depression, part 1: study design and rationale for evaluating the comparative efficacy of sertraline and imipramine as acute, crossover, continuation, and maintenance phase therapies". <i>J Clin Psychiatry</i> <b>59</b> (11): 589–97. <a href="http://www.ncbi.nlm.nih.gov/pubmed/9862605" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/9862605">PMID 9862605</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+treatment+of+chronic+depression%2C+part+1%3A+study+design+and+rationale+for+evaluating+the+comparative+efficacy+of+sertraline+and+imipramine+as+acute%2C+crossover%2C+continuation%2C+and+maintenance+phase+therapies&amp;rft.jtitle=J+Clin+Psychiatry&amp;rft.aulast=Rush+AJ%2C+Koran+LM%2C+Keller+MB%2C+Markowitz+JC%2C+Harrison+WM%2C+Miceli+RJ%2C+Fawcett+JA%2C+Gelenberg+AJ%2C+Hirschfeld+RM%2C+Klein+DN%2C+Kocsis+JH%2C+McCullough+JP%2C+Schatzberg+AF%2C+Thase+ME&amp;rft.au=Rush+AJ%2C+Koran+LM%2C+Keller+MB%2C+Markowitz+JC%2C+Harrison+WM%2C+Miceli+RJ%2C+Fawcett+JA%2C+Gelenberg+AJ%2C+Hirschfeld+RM%2C+Klein+DN%2C+Kocsis+JH%2C+McCullough+JP%2C+Schatzberg+AF%2C+Thase+ME&amp;rft.date=1998&amp;rft.volume=59&amp;rft.issue=11&amp;rft.pages=589%E2%80%9397&amp;rft_id=info:pmid/9862605&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid9862606-35">^ <a href="#cite_ref-pmid9862606_35-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid9862606_35-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFKeller_MB.2C_Gelenberg_AJ.2C_Hirschfeld_RM.2C_Rush_AJ.2C_Thase_ME.2C_Kocsis_JH.2C_Markowitz_JC.2C_Fawcett_JA.2C_Koran_LM.2C_Klein_DN.2C_Russell_JM.2C_Kornstein_SG.2C_McCullough_JP.2C_Davis_SM.2C_Harrison_WM1998">Keller MB, Gelenberg AJ, Hirschfeld RM, Rush AJ, Thase ME, Kocsis JH, Markowitz JC, Fawcett JA, Koran LM, Klein DN, Russell JM, Kornstein SG, McCullough JP, Davis SM, Harrison WM (1998). "The treatment of chronic depression, part 2: a double-blind, randomized trial of sertraline and imipramine". <i>The Journal of Clinical Psychiatry</i> <b>59</b> (11): 598–607. <a href="http://www.ncbi.nlm.nih.gov/pubmed/9862606" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/9862606">PMID 9862606</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+treatment+of+chronic+depression%2C+part+2%3A+a+double-blind%2C+randomized+trial+of+sertraline+and+imipramine&amp;rft.jtitle=The+Journal+of+Clinical+Psychiatry&amp;rft.aulast=Keller+MB%2C+Gelenberg+AJ%2C+Hirschfeld+RM%2C+Rush+AJ%2C+Thase+ME%2C+Kocsis+JH%2C+Markowitz+JC%2C+Fawcett+JA%2C+Koran+LM%2C+Klein+DN%2C+Russell+JM%2C+Kornstein+SG%2C+McCullough+JP%2C+Davis+SM%2C+Harrison+WM&amp;rft.au=Keller+MB%2C+Gelenberg+AJ%2C+Hirschfeld+RM%2C+Rush+AJ%2C+Thase+ME%2C+Kocsis+JH%2C+Markowitz+JC%2C+Fawcett+JA%2C+Koran+LM%2C+Klein+DN%2C+Russell+JM%2C+Kornstein+SG%2C+McCullough+JP%2C+Davis+SM%2C+Harrison+WM&amp;rft.date=1998&amp;rft.volume=59&amp;rft.issue=11&amp;rft.pages=598%E2%80%93607&amp;rft_id=info:pmid/9862606&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid9862607-36">^ <a href="#cite_ref-pmid9862607_36-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid9862607_36-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFMiller_IW.2C_Keitner_GI.2C_Schatzberg_AF.2C_Klein_DN.2C_Thase_ME.2C_Rush_AJ.2C_Markowitz_JC.2C_Schlager_DS.2C_Kornstein_SG.2C_Davis_SM.2C_Harrison_WM.2C_Keller_MB1998">Miller IW, Keitner GI, Schatzberg AF, Klein DN, Thase ME, Rush AJ, Markowitz JC, Schlager DS, Kornstein SG, Davis SM, Harrison WM, Keller MB (1998). "The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline or imipramine". <i>The Journal of Clinical Psychiatry</i> <b>59</b> (11): 608–19. <a href="http://www.ncbi.nlm.nih.gov/pubmed/9862607" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/9862607">PMID 9862607</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+treatment+of+chronic+depression%2C+part+3%3A+psychosocial+functioning+before+and+after+treatment+with+sertraline+or+imipramine&amp;rft.jtitle=The+Journal+of+Clinical+Psychiatry&amp;rft.aulast=Miller+IW%2C+Keitner+GI%2C+Schatzberg+AF%2C+Klein+DN%2C+Thase+ME%2C+Rush+AJ%2C+Markowitz+JC%2C+Schlager+DS%2C+Kornstein+SG%2C+Davis+SM%2C+Harrison+WM%2C+Keller+MB&amp;rft.au=Miller+IW%2C+Keitner+GI%2C+Schatzberg+AF%2C+Klein+DN%2C+Thase+ME%2C+Rush+AJ%2C+Markowitz+JC%2C+Schlager+DS%2C+Kornstein+SG%2C+Davis+SM%2C+Harrison+WM%2C+Keller+MB&amp;rft.date=1998&amp;rft.volume=59&amp;rft.issue=11&amp;rft.pages=608%E2%80%9319&amp;rft_id=info:pmid/9862607&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid11426506-37"><b><a href="#cite_ref-pmid11426506_37-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFKoran_LM.2C_Gelenberg_AJ.2C_Kornstein_SG.2C_Howland_RH.2C_Friedman_RA.2C_DeBattista_C.2C_Klein_D.2C_Kocsis_JH.2C_Schatzberg_AF.2C_Thase_ME.2C_Rush_AJ.2C_Hirschfeld_RM.2C_LaVange_LM.2C_Keller_MB2001">Koran LM, Gelenberg AJ, Kornstein SG, Howland RH, Friedman RA, DeBattista C, Klein D, Kocsis JH, Schatzberg AF, Thase ME, Rush AJ, Hirschfeld RM, LaVange LM, Keller MB (2001). "Sertraline versus imipramine to prevent relapse in chronic depression". <i>Journal of Affective Disorders</i> <b>65</b> (1): 27–36. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2FS0165-0327%2800%2900272-X" class="external text" title="http://dx.doi.org/10.1016%2FS0165-0327%2800%2900272-X" rel="nofollow">10.1016/S0165-0327(00)00272-X</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11426506" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11426506">PMID 11426506</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Sertraline+versus+imipramine+to+prevent+relapse+in+chronic+depression&amp;rft.jtitle=Journal+of+Affective+Disorders&amp;rft.aulast=Koran+LM%2C+Gelenberg+AJ%2C+Kornstein+SG%2C+Howland+RH%2C+Friedman+RA%2C+DeBattista+C%2C+Klein+D%2C+Kocsis+JH%2C+Schatzberg+AF%2C+Thase+ME%2C+Rush+AJ%2C+Hirschfeld+RM%2C+LaVange+LM%2C+Keller+MB&amp;rft.au=Koran+LM%2C+Gelenberg+AJ%2C+Kornstein+SG%2C+Howland+RH%2C+Friedman+RA%2C+DeBattista+C%2C+Klein+D%2C+Kocsis+JH%2C+Schatzberg+AF%2C+Thase+ME%2C+Rush+AJ%2C+Hirschfeld+RM%2C+LaVange+LM%2C+Keller+MB&amp;rft.date=2001&amp;rft.volume=65&amp;rft.issue=1&amp;rft.pages=27%E2%80%9336&amp;rft_id=info:doi/10.1016%2FS0165-0327%2800%2900272-X&amp;rft_id=info:pmid/11426506&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid11247097-38"><b><a href="#cite_ref-pmid11247097_38-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFParker_G.2C_Roy_K.2C_Wilhelm_K.2C_Mitchell_P2001">Parker G, Roy K, Wilhelm K, Mitchell P (2001). "Assessing the comparative effectiveness of antidepressant therapies: a prospective clinical practice study". <i>J Clin Psychiatry</i> <b>62</b> (2): 117–25. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11247097" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11247097">PMID 11247097</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Assessing+the+comparative+effectiveness+of+antidepressant+therapies%3A+a+prospective+clinical+practice+study&amp;rft.jtitle=J+Clin+Psychiatry&amp;rft.aulast=Parker+G%2C+Roy+K%2C+Wilhelm+K%2C+Mitchell+P&amp;rft.au=Parker+G%2C+Roy+K%2C+Wilhelm+K%2C+Mitchell+P&amp;rft.date=2001&amp;rft.volume=62&amp;rft.issue=2&amp;rft.pages=117%E2%80%9325&amp;rft_id=info:pmid/11247097&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid9597346-39"><b><a href="#cite_ref-pmid9597346_39-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFAnderson_IM1998">Anderson IM (1998). "SSRIS versus tricyclic antidepressants in depressed inpatients: a meta-analysis of efficacy and tolerability". <i>Depress Anxiety</i> <b>7 Suppl 1</b>: 11–7. <a href="http://www.ncbi.nlm.nih.gov/pubmed/9597346" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/9597346">PMID 9597346</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=SSRIS+versus+tricyclic+antidepressants+in+depressed+inpatients%3A+a+meta-analysis+of+efficacy+and+tolerability&amp;rft.jtitle=Depress+Anxiety&amp;rft.aulast=Anderson+IM&amp;rft.au=Anderson+IM&amp;rft.date=1998&amp;rft.volume=7+Suppl+1&amp;rft.pages=11%E2%80%937&amp;rft_id=info:pmid/9597346&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid10362442-40"><b><a href="#cite_ref-pmid10362442_40-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFHirschfeld_RM1999">Hirschfeld RM (1999). "Efficacy of SSRIs and newer antidepressants in severe depression: comparison with TCAs". <i>J Clin Psychiatry</i> <b>60</b> (5): 326–35. <a href="http://www.ncbi.nlm.nih.gov/pubmed/10362442" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/10362442">PMID 10362442</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Efficacy+of+SSRIs+and+newer+antidepressants+in+severe+depression%3A+comparison+with+TCAs&amp;rft.jtitle=J+Clin+Psychiatry&amp;rft.aulast=Hirschfeld+RM&amp;rft.au=Hirschfeld+RM&amp;rft.date=1999&amp;rft.volume=60&amp;rft.issue=5&amp;rft.pages=326%E2%80%9335&amp;rft_id=info:pmid/10362442&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid9808081-41"><b><a href="#cite_ref-pmid9808081_41-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFAmsterdam_JD1998">Amsterdam JD (1998). "Selective serotonin reuptake inhibitor efficacy in severe and melancholic depression". <i>J. Psychopharmacol. (Oxford)</i> <b>12</b> (3 Suppl B): S99–111. <a href="http://www.ncbi.nlm.nih.gov/pubmed/9808081" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/9808081">PMID 9808081</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Selective+serotonin+reuptake+inhibitor+efficacy+in+severe+and+melancholic+depression&amp;rft.jtitle=J.+Psychopharmacol.+%28Oxford%29&amp;rft.aulast=Amsterdam+JD&amp;rft.au=Amsterdam+JD&amp;rft.date=1998&amp;rft.volume=12&amp;rft.issue=3+Suppl+B&amp;rft.pages=S99%E2%80%93111&amp;rft_id=info:pmid/9808081&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid15014677-42"><b><a href="#cite_ref-pmid15014677_42-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFLydiard_RB.2C_Perera_P.2C_Batzar_E.2C_Clary_CM1999">Lydiard RB, Perera P, Batzar E, Clary CM (1999). "From the Bench to the Trench: A Comparison of Sertraline Treatment of Major Depression in Clinical and Research Patient Samples". <i>Prim Care Companion J Clin Psychiatry</i> <b>1</b> (5): 154–162. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15014677" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15014677">PMID 15014677</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=From+the+Bench+to+the+Trench%3A+A+Comparison+of+Sertraline+Treatment+of+Major+Depression+in+Clinical+and+Research+Patient+Samples&amp;rft.jtitle=Prim+Care+Companion+J+Clin+Psychiatry&amp;rft.aulast=Lydiard+RB%2C+Perera+P%2C+Batzar+E%2C+Clary+CM&amp;rft.au=Lydiard+RB%2C+Perera+P%2C+Batzar+E%2C+Clary+CM&amp;rft.date=1999&amp;rft.volume=1&amp;rft.issue=5&amp;rft.pages=154%E2%80%93162&amp;rft_id=info:pmid/15014677&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-43"><b><a href="#cite_ref-43" title="">^</a></b> Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis, Andrea Cipriani, Toshiaki A Furukawa, Georgia Salanti, John R Geddes, et al. The Lancet , Published Online, January 29, 2009, DOI:10.1016/S0140-6736(09)60046-5</li>
<li id="cite_note-44"><b><a href="#cite_ref-44" title="">^</a></b> <a href="http://www.washingtonpost.com/wp-dyn/content/article/2009/01/29/AR2009012901774.html" class="external text" title="http://www.washingtonpost.com/wp-dyn/content/article/2009/01/29/AR2009012901774.html" rel="nofollow">Zoloft, Lexapro the Best of Newer Antidepressants,</a> HealthDay News, Washington Post, January 29, 2009</li>
<li id="cite_note-pmid17168253-45"><b><a href="#cite_ref-pmid17168253_45-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFPapakostas_GI.2C_Fava_M2006">Papakostas GI, Fava M (2006). "A metaanalysis of clinical trials comparing moclobemide with selective serotonin reuptake inhibitors for the treatment of major depressive disorder". <i>Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie</i> <b>51</b> (12): 783–90. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17168253" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17168253">PMID 17168253</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=A+metaanalysis+of+clinical+trials+comparing+moclobemide+with+selective+serotonin+reuptake+inhibitors+for+the+treatment+of+major+depressive+disorder&amp;rft.jtitle=Canadian+Journal+of+Psychiatry.+Revue+Canadienne+de+Psychiatrie&amp;rft.aulast=Papakostas+GI%2C+Fava+M&amp;rft.au=Papakostas+GI%2C+Fava+M&amp;rft.date=2006&amp;rft.volume=51&amp;rft.issue=12&amp;rft.pages=783%E2%80%9390&amp;rft_id=info:pmid/17168253&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid8626364-46"><b><a href="#cite_ref-pmid8626364_46-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFFeiger_A.2C_Kiev_A.2C_Shrivastava_RK.2C_Wisselink_PG.2C_Wilcox_CS1996">Feiger A, Kiev A, Shrivastava RK, Wisselink PG, Wilcox CS (1996). "Nefazodone versus sertraline in outpatients with major depression: focus on efficacy, tolerability, and effects on sexual function and satisfaction". <i>The Journal of Clinical Psychiatry</i> <b>57 Suppl 2</b>: 53–62. <a href="http://www.ncbi.nlm.nih.gov/pubmed/8626364" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/8626364">PMID 8626364</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Nefazodone+versus+sertraline+in+outpatients+with+major+depression%3A+focus+on+efficacy%2C+tolerability%2C+and+effects+on+sexual+function+and+satisfaction&amp;rft.jtitle=The+Journal+of+Clinical+Psychiatry&amp;rft.aulast=Feiger+A%2C+Kiev+A%2C+Shrivastava+RK%2C+Wisselink+PG%2C+Wilcox+CS&amp;rft.au=Feiger+A%2C+Kiev+A%2C+Shrivastava+RK%2C+Wisselink+PG%2C+Wilcox+CS&amp;rft.date=1996&amp;rft.volume=57+Suppl+2&amp;rft.pages=53%E2%80%9362&amp;rft_id=info:pmid/8626364&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid17288677-47"><b><a href="#cite_ref-pmid17288677_47-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFVentura_D.2C_Armstrong_EP.2C_Skrepnek_GH.2C_Haim_Erder_M2007">Ventura D, Armstrong EP, Skrepnek GH, Haim Erder M (2007). "Escitalopram versus sertraline in the treatment of major depressive disorder: a randomized clinical trial". <i>Current Medical Research and Opinion</i> <b>23</b> (2): 245–50. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1185%2F030079906X167273" class="external text" title="http://dx.doi.org/10.1185%2F030079906X167273" rel="nofollow">10.1185/030079906X167273</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17288677" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17288677">PMID 17288677</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Escitalopram+versus+sertraline+in+the+treatment+of+major+depressive+disorder%3A+a+randomized+clinical+trial&amp;rft.jtitle=Current+Medical+Research+and+Opinion&amp;rft.aulast=Ventura+D%2C+Armstrong+EP%2C+Skrepnek+GH%2C+Haim+Erder+M&amp;rft.au=Ventura+D%2C+Armstrong+EP%2C+Skrepnek+GH%2C+Haim+Erder+M&amp;rft.date=2007&amp;rft.volume=23&amp;rft.issue=2&amp;rft.pages=245%E2%80%9350&amp;rft_id=info:doi/10.1185%2F030079906X167273&amp;rft_id=info:pmid/17288677&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid9448656-48">^ <a href="#cite_ref-pmid9448656_48-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid9448656_48-1" title=""><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid9448656_48-2" title=""><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid9448656_48-3" title=""><sup><i><b>d</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFKavoussi_RJ.2C_Segraves_RT.2C_Hughes_AR.2C_Ascher_JA.2C_Johnston_JA1997">Kavoussi RJ, Segraves RT, Hughes AR, Ascher JA, Johnston JA (1997). "Double-blind comparison of bupropion sustained release and sertraline in depressed outpatients". <i>The Journal of Clinical Psychiatry</i> <b>58</b> (12): 532–7. <a href="http://www.ncbi.nlm.nih.gov/pubmed/9448656" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/9448656">PMID 9448656</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Double-blind+comparison+of+bupropion+sustained+release+and+sertraline+in+depressed+outpatients&amp;rft.jtitle=The+Journal+of+Clinical+Psychiatry&amp;rft.aulast=Kavoussi+RJ%2C+Segraves+RT%2C+Hughes+AR%2C+Ascher+JA%2C+Johnston+JA&amp;rft.au=Kavoussi+RJ%2C+Segraves+RT%2C+Hughes+AR%2C+Ascher+JA%2C+Johnston+JA&amp;rft.date=1997&amp;rft.volume=58&amp;rft.issue=12&amp;rft.pages=532%E2%80%937&amp;rft_id=info:pmid/9448656&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid16172440-49"><b><a href="#cite_ref-pmid16172440_49-0" title="">^</a></b> For the review, see:<cite style="font-style:normal" class="" id="CITEREFHansen_RA.2C_Gartlehner_G.2C_Lohr_KN.2C_Gaynes_BN.2C_Carey_TS2005">Hansen RA, Gartlehner G, Lohr KN, Gaynes BN, Carey TS (2005). "Efficacy and safety of second-generation antidepressants in the treatment of major depressive disorder". <i>Ann. Intern. Med.</i> <b>143</b> (6): 415–26. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16172440" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16172440">PMID 16172440</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Efficacy+and+safety+of+second-generation+antidepressants+in+the+treatment+of+major+depressive+disorder&amp;rft.jtitle=Ann.+Intern.+Med.&amp;rft.aulast=Hansen+RA%2C+Gartlehner+G%2C+Lohr+KN%2C+Gaynes+BN%2C+Carey+TS&amp;rft.au=Hansen+RA%2C+Gartlehner+G%2C+Lohr+KN%2C+Gaynes+BN%2C+Carey+TS&amp;rft.date=2005&amp;rft.volume=143&amp;rft.issue=6&amp;rft.pages=415%E2%80%9326&amp;rft_id=info:pmid/16172440&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid16235353-50"><b><a href="#cite_ref-pmid16235353_50-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFCipriani_A.2C_Brambilla_P.2C_Furukawa_T.2C_Geddes_J.2C_Gregis_M.2C_Hotopf_M.2C_Malvini_L.2C_Barbui_C2005">Cipriani A, Brambilla P, Furukawa T, Geddes J, Gregis M, Hotopf M, Malvini L, Barbui C (2005). "Fluoxetine versus other types of pharmacotherapy for depression". <i>Cochrane Database of Systematic Reviews (Online)</i> (4): CD004185. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1002%2F14651858.CD004185.pub2" class="external text" title="http://dx.doi.org/10.1002%2F14651858.CD004185.pub2" rel="nofollow">10.1002/14651858.CD004185.pub2</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16235353" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16235353">PMID 16235353</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Fluoxetine+versus+other+types+of+pharmacotherapy+for+depression&amp;rft.jtitle=Cochrane+Database+of+Systematic+Reviews+%28Online%29&amp;rft.aulast=Cipriani+A%2C+Brambilla+P%2C+Furukawa+T%2C+Geddes+J%2C+Gregis+M%2C+Hotopf+M%2C+Malvini+L%2C+Barbui+C&amp;rft.au=Cipriani+A%2C+Brambilla+P%2C+Furukawa+T%2C+Geddes+J%2C+Gregis+M%2C+Hotopf+M%2C+Malvini+L%2C+Barbui+C&amp;rft.date=2005&amp;rft.issue=4&amp;rft.pages=CD004185&amp;rft_id=info:doi/10.1002%2F14651858.CD004185.pub2&amp;rft_id=info:pmid/16235353&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid10732656-51"><b><a href="#cite_ref-pmid10732656_51-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFMehtonen_OP.2C_S.C3.B8gaard_J.2C_Roponen_P.2C_Behnke_K2000">Mehtonen OP, Søgaard J, Roponen P, Behnke K (2000). "Randomized, double-blind comparison of venlafaxine and sertraline in outpatients with major depressive disorder. Venlafaxine 631 Study Group". <i>The Journal of Clinical Psychiatry</i> <b>61</b> (2): 95–100. <a href="http://www.ncbi.nlm.nih.gov/pubmed/10732656" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/10732656">PMID 10732656</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Randomized%2C+double-blind+comparison+of+venlafaxine+and+sertraline+in+outpatients+with+major+depressive+disorder.+Venlafaxine+631+Study+Group&amp;rft.jtitle=The+Journal+of+Clinical+Psychiatry&amp;rft.aulast=Mehtonen+OP%2C+S%C3%B8gaard+J%2C+Roponen+P%2C+Behnke+K&amp;rft.au=Mehtonen+OP%2C+S%C3%B8gaard+J%2C+Roponen+P%2C+Behnke+K&amp;rft.date=2000&amp;rft.volume=61&amp;rft.issue=2&amp;rft.pages=95%E2%80%93100&amp;rft_id=info:pmid/10732656&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid17196045-52"><b><a href="#cite_ref-pmid17196045_52-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFShelton_RC.2C_Haman_KL.2C_Rapaport_MH.2C_Kiev_A.2C_Smith_WT.2C_Hirschfeld_RM.2C_Lydiard_RB.2C_Zajecka_JM.2C_Dunner_DL2006">Shelton RC, Haman KL, Rapaport MH, Kiev A, Smith WT, Hirschfeld RM, Lydiard RB, Zajecka JM, Dunner DL (2006). "A randomized, double-blind, active-control study of sertraline versus venlafaxine XR in major depressive disorder". <i>The Journal of Clinical Psychiatry</i> <b>67</b> (11): 1674–81. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17196045" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17196045">PMID 17196045</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=A+randomized%2C+double-blind%2C+active-control+study+of+sertraline+versus+venlafaxine+XR+in+major+depressive+disorder&amp;rft.jtitle=The+Journal+of+Clinical+Psychiatry&amp;rft.aulast=Shelton+RC%2C+Haman+KL%2C+Rapaport+MH%2C+Kiev+A%2C+Smith+WT%2C+Hirschfeld+RM%2C+Lydiard+RB%2C+Zajecka+JM%2C+Dunner+DL&amp;rft.au=Shelton+RC%2C+Haman+KL%2C+Rapaport+MH%2C+Kiev+A%2C+Smith+WT%2C+Hirschfeld+RM%2C+Lydiard+RB%2C+Zajecka+JM%2C+Dunner+DL&amp;rft.date=2006&amp;rft.volume=67&amp;rft.issue=11&amp;rft.pages=1674%E2%80%9381&amp;rft_id=info:pmid/17196045&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid11105744-53"><b><a href="#cite_ref-pmid11105744_53-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFWise_TN.2C_Sheridan_MJ2000">Wise TN, Sheridan MJ (2000). "Venlafaxine versus sertraline for major depressive disorder". <i>The Journal of Clinical Psychiatry</i> <b>61</b> (11): 873–4. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11105744" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11105744">PMID 11105744</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Venlafaxine+versus+sertraline+for+major+depressive+disorder&amp;rft.jtitle=The+Journal+of+Clinical+Psychiatry&amp;rft.aulast=Wise+TN%2C+Sheridan+MJ&amp;rft.au=Wise+TN%2C+Sheridan+MJ&amp;rft.date=2000&amp;rft.volume=61&amp;rft.issue=11&amp;rft.pages=873%E2%80%934&amp;rft_id=info:pmid/11105744&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid16259546-54"><b><a href="#cite_ref-pmid16259546_54-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFSir_A.2C_D.27Souza_RF.2C_Uguz_S.2C_George_T.2C_Vahip_S.2C_Hopwood_M.2C_Martin_AJ.2C_Lam_W.2C_Burt_T2005">Sir A, D'Souza RF, Uguz S, George T, Vahip S, Hopwood M, Martin AJ, Lam W, Burt T (2005). "Randomized trial of sertraline versus venlafaxine XR in major depression: efficacy and discontinuation symptoms". <i>The Journal of Clinical Psychiatry</i> <b>66</b> (10): 1312–20. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16259546" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16259546">PMID 16259546</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Randomized+trial+of+sertraline+versus+venlafaxine+XR+in+major+depression%3A+efficacy+and+discontinuation+symptoms&amp;rft.jtitle=The+Journal+of+Clinical+Psychiatry&amp;rft.aulast=Sir+A%2C+D%27Souza+RF%2C+Uguz+S%2C+George+T%2C+Vahip+S%2C+Hopwood+M%2C+Martin+AJ%2C+Lam+W%2C+Burt+T&amp;rft.au=Sir+A%2C+D%27Souza+RF%2C+Uguz+S%2C+George+T%2C+Vahip+S%2C+Hopwood+M%2C+Martin+AJ%2C+Lam+W%2C+Burt+T&amp;rft.date=2005&amp;rft.volume=66&amp;rft.issue=10&amp;rft.pages=1312%E2%80%9320&amp;rft_id=info:pmid/16259546&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid12093324-55"><b><a href="#cite_ref-pmid12093324_55-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFMuijsers_RB.2C_Plosker_GL.2C_Noble_S2002">Muijsers RB, Plosker GL, Noble S (2002). "Sertraline: a review of its use in the management of major depressive disorder in elderly patients". <i>Drugs &amp; Aging</i> <b>19</b> (5): 377–92. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12093324" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12093324">PMID 12093324</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Sertraline%3A+a+review+of+its+use+in+the+management+of+major+depressive+disorder+in+elderly+patients&amp;rft.jtitle=Drugs+%26+Aging&amp;rft.aulast=Muijsers+RB%2C+Plosker+GL%2C+Noble+S&amp;rft.au=Muijsers+RB%2C+Plosker+GL%2C+Noble+S&amp;rft.date=2002&amp;rft.volume=19&amp;rft.issue=5&amp;rft.pages=377%E2%80%9392&amp;rft_id=info:pmid/12093324&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid12832242-56"><b><a href="#cite_ref-pmid12832242_56-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFSchneider_LS.2C_Nelson_JC.2C_Clary_CM.2C_Newhouse_P.2C_Krishnan_KR.2C_Shiovitz_T.2C_Weihs_K2003">Schneider LS, Nelson JC, Clary CM, Newhouse P, Krishnan KR, Shiovitz T, Weihs K (2003). "An 8-week multicenter, parallel-group, double-blind, placebo-controlled study of sertraline in elderly outpatients with major depression". <i>Am J Psychiatry</i> <b>160</b> (7): 1277–85. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1176%2Fappi.ajp.160.7.1277" class="external text" title="http://dx.doi.org/10.1176%2Fappi.ajp.160.7.1277" rel="nofollow">10.1176/appi.ajp.160.7.1277</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12832242" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12832242">PMID 12832242</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=An+8-week+multicenter%2C+parallel-group%2C+double-blind%2C+placebo-controlled+study+of+sertraline+in+elderly+outpatients+with+major+depression&amp;rft.jtitle=Am+J+Psychiatry&amp;rft.aulast=Schneider+LS%2C+Nelson+JC%2C+Clary+CM%2C+Newhouse+P%2C+Krishnan+KR%2C+Shiovitz+T%2C+Weihs+K&amp;rft.au=Schneider+LS%2C+Nelson+JC%2C+Clary+CM%2C+Newhouse+P%2C+Krishnan+KR%2C+Shiovitz+T%2C+Weihs+K&amp;rft.date=2003&amp;rft.volume=160&amp;rft.issue=7&amp;rft.pages=1277%E2%80%9385&amp;rft_id=info:doi/10.1176%2Fappi.ajp.160.7.1277&amp;rft_id=info:pmid/12832242&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-57"><b><a href="#cite_ref-57" title="">^</a></b> <cite style="font-style:normal" class="web"><a href="http://web.archive.org/web/20060907224703/http://www.mc.vanderbilt.edu/sc_diglib/archColl/233.html" class="external text" title="http://web.archive.org/web/20060907224703/http://www.mc.vanderbilt.edu/sc_diglib/archColl/233.html" rel="nofollow">"Bernard J. Caroll"</a> (html). Vanderbilt University Medical Center. Archived from <a href="http://www.mc.vanderbilt.edu/sc_diglib/archColl/233.html" class="external text" title="http://www.mc.vanderbilt.edu/sc_diglib/archColl/233.html" rel="nofollow">the original</a> on 2006-09-07<span class="printonly">. <a href="http://web.archive.org/web/20060907224703/http://www.mc.vanderbilt.edu/sc_diglib/archColl/233.html" class="external free" title="http://web.archive.org/web/20060907224703/http://www.mc.vanderbilt.edu/sc_diglib/archColl/233.html" rel="nofollow">http://web.archive.org/web/20060907224703/http://www.mc.vanderbilt.edu/sc_diglib/archColl/233.html</a></span><span class="reference-accessdate">. Retrieved on 2008-07-11</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Bernard+J.+Caroll&amp;rft.atitle=&amp;rft.pub=Vanderbilt+University+Medical+Center&amp;rft_id=http%3A%2F%2Fweb.archive.org%2Fweb%2F20060907224703%2Fhttp%3A%2F%2Fwww.mc.vanderbilt.edu%2Fsc_diglib%2FarchColl%2F233.html&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid15056533-58"><b><a href="#cite_ref-pmid15056533_58-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFCarroll_BJ2004">Carroll BJ (2004). "Sertraline and the Cheshire cat in geriatric depression". <i>Am J Psychiatry</i> <b>161</b> (4): 759; author reply 759–61. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1176%2Fappi.ajp.161.4.759" class="external text" title="http://dx.doi.org/10.1176%2Fappi.ajp.161.4.759" rel="nofollow">10.1176/appi.ajp.161.4.759</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15056533" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15056533">PMID 15056533</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Sertraline+and+the+Cheshire+cat+in+geriatric+depression&amp;rft.jtitle=Am+J+Psychiatry&amp;rft.aulast=Carroll+BJ&amp;rft.au=Carroll+BJ&amp;rft.date=2004&amp;rft.volume=161&amp;rft.issue=4&amp;rft.pages=759%3B+author+reply+759%E2%80%9361&amp;rft_id=info:doi/10.1176%2Fappi.ajp.161.4.759&amp;rft_id=info:pmid/15056533&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-59"><b><a href="#cite_ref-59" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFKronig_MH.2C_Apter_J.2C_Asnis_G.2C_Bystritsky_A.2C_Curtis_G.2C_Ferguson_J.2C_Landbloom_R.2C_Munjack_D.2C_Riesenberg_R.2C_Robinson_D.2C_Roy-Byrne_P.2C_Phillips_K.2C_Du_Pont_IJ.1999">Kronig MH, Apter J, Asnis G, Bystritsky A, Curtis G, Ferguson J, Landbloom R, Munjack D, Riesenberg R, Robinson D, Roy-Byrne P, Phillips K, Du Pont IJ. (1999). "Placebo-controlled, multicenter study of sertraline treatment for obsessive-compulsive disorder". <i>Journal of Clinical Psychopharmacology</i> <b>19</b> (2): 172–176. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1097%2F00004714-199904000-00013" class="external text" title="http://dx.doi.org/10.1097%2F00004714-199904000-00013" rel="nofollow">10.1097/00004714-199904000-00013</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/10211919" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/10211919">PMID 10211919</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Placebo-controlled%2C+multicenter+study+of+sertraline+treatment+for+obsessive-compulsive+disorder&amp;rft.jtitle=Journal+of+Clinical+Psychopharmacology&amp;rft.aulast=Kronig+MH%2C+Apter+J%2C+Asnis+G%2C+Bystritsky+A%2C+Curtis+G%2C+Ferguson+J%2C+Landbloom+R%2C+Munjack+D%2C+Riesenberg+R%2C+Robinson+D%2C+Roy-Byrne+P%2C+Phillips+K%2C+Du+Pont+IJ.&amp;rft.au=Kronig+MH%2C+Apter+J%2C+Asnis+G%2C+Bystritsky+A%2C+Curtis+G%2C+Ferguson+J%2C+Landbloom+R%2C+Munjack+D%2C+Riesenberg+R%2C+Robinson+D%2C+Roy-Byrne+P%2C+Phillips+K%2C+Du+Pont+IJ.&amp;rft.date=1999&amp;rft.volume=19&amp;rft.issue=2&amp;rft.pages=172%E2%80%93176&amp;rft_id=info:doi/10.1097%2F00004714-199904000-00013&amp;rft_id=info:pmid/10211919&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid2274626-60"><b><a href="#cite_ref-pmid2274626_60-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFChouinard_G.2C_Goodman_W.2C_Greist_J.2C_Jenike_M.2C_Rasmussen_S.2C_White_K.2C_Hackett_E.2C_Gaffney_M.2C_Bick_PA1990">Chouinard G, Goodman W, Greist J, Jenike M, Rasmussen S, White K, Hackett E, Gaffney M, Bick PA (1990). "Results of a double-blind placebo controlled trial of a new serotonin uptake inhibitor, sertraline, in the treatment of obsessive-compulsive disorder". <i>Psychopharmacology Bulletin</i> <b>26</b> (3): 279–84. <a href="http://www.ncbi.nlm.nih.gov/pubmed/2274626" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/2274626">PMID 2274626</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Results+of+a+double-blind+placebo+controlled+trial+of+a+new+serotonin+uptake+inhibitor%2C+sertraline%2C+in+the+treatment+of+obsessive-compulsive+disorder&amp;rft.jtitle=Psychopharmacology+Bulletin&amp;rft.aulast=Chouinard+G%2C+Goodman+W%2C+Greist+J%2C+Jenike+M%2C+Rasmussen+S%2C+White+K%2C+Hackett+E%2C+Gaffney+M%2C+Bick+PA&amp;rft.au=Chouinard+G%2C+Goodman+W%2C+Greist+J%2C+Jenike+M%2C+Rasmussen+S%2C+White+K%2C+Hackett+E%2C+Gaffney+M%2C+Bick+PA&amp;rft.date=1990&amp;rft.volume=26&amp;rft.issue=3&amp;rft.pages=279%E2%80%9384&amp;rft_id=info:pmid/2274626&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid7702445-61"><b><a href="#cite_ref-pmid7702445_61-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFGreist_J.2C_Chouinard_G.2C_DuBoff_E.2C_Halaris_A.2C_Kim_SW.2C_Koran_L.2C_Liebowitz_M.2C_Lydiard_RB.2C_Rasmussen_S.2C_White_K1995">Greist J, Chouinard G, DuBoff E, Halaris A, Kim SW, Koran L, Liebowitz M, Lydiard RB, Rasmussen S, White K (1995). "Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder". <i>Arch. Gen. Psychiatry</i> <b>52</b> (4): 289–95. <a href="http://www.ncbi.nlm.nih.gov/pubmed/7702445" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/7702445">PMID 7702445</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Double-blind+parallel+comparison+of+three+dosages+of+sertraline+and+placebo+in+outpatients+with+obsessive-compulsive+disorder&amp;rft.jtitle=Arch.+Gen.+Psychiatry&amp;rft.aulast=Greist+J%2C+Chouinard+G%2C+DuBoff+E%2C+Halaris+A%2C+Kim+SW%2C+Koran+L%2C+Liebowitz+M%2C+Lydiard+RB%2C+Rasmussen+S%2C+White+K&amp;rft.au=Greist+J%2C+Chouinard+G%2C+DuBoff+E%2C+Halaris+A%2C+Kim+SW%2C+Koran+L%2C+Liebowitz+M%2C+Lydiard+RB%2C+Rasmussen+S%2C+White+K&amp;rft.date=1995&amp;rft.volume=52&amp;rft.issue=4&amp;rft.pages=289%E2%80%9395&amp;rft_id=info:pmid/7702445&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid14594734-62"><b><a href="#cite_ref-pmid14594734_62-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFGeller_DA.2C_Biederman_J.2C_Stewart_SE.2C_Mullin_B.2C_Martin_A.2C_Spencer_T.2C_Faraone_SV2003">Geller DA, Biederman J, Stewart SE, Mullin B, Martin A, Spencer T, Faraone SV (2003). "Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder". <i>The American Journal of Psychiatry</i> <b>160</b> (11): 1919–28. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1176%2Fappi.ajp.160.11.1919" class="external text" title="http://dx.doi.org/10.1176%2Fappi.ajp.160.11.1919" rel="nofollow">10.1176/appi.ajp.160.11.1919</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/14594734" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/14594734">PMID 14594734</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Which+SSRI%3F+A+meta-analysis+of+pharmacotherapy+trials+in+pediatric+obsessive-compulsive+disorder&amp;rft.jtitle=The+American+Journal+of+Psychiatry&amp;rft.aulast=Geller+DA%2C+Biederman+J%2C+Stewart+SE%2C+Mullin+B%2C+Martin+A%2C+Spencer+T%2C+Faraone+SV&amp;rft.au=Geller+DA%2C+Biederman+J%2C+Stewart+SE%2C+Mullin+B%2C+Martin+A%2C+Spencer+T%2C+Faraone+SV&amp;rft.date=2003&amp;rft.volume=160&amp;rft.issue=11&amp;rft.pages=1919%E2%80%9328&amp;rft_id=info:doi/10.1176%2Fappi.ajp.160.11.1919&amp;rft_id=info:pmid/14594734&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid9393392-63"><b><a href="#cite_ref-pmid9393392_63-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFFlament_MF.2C_Bisserbe_JC1997">Flament MF, Bisserbe JC (1997). "Pharmacologic treatment of obsessive-compulsive disorder: comparative studies". <i>The Journal of Clinical Psychiatry</i> <b>58 Suppl 12</b>: 18–22. <a href="http://www.ncbi.nlm.nih.gov/pubmed/9393392" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/9393392">PMID 9393392</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Pharmacologic+treatment+of+obsessive-compulsive+disorder%3A+comparative+studies&amp;rft.jtitle=The+Journal+of+Clinical+Psychiatry&amp;rft.aulast=Flament+MF%2C+Bisserbe+JC&amp;rft.au=Flament+MF%2C+Bisserbe+JC&amp;rft.date=1997&amp;rft.volume=58+Suppl+12&amp;rft.pages=18%E2%80%9322&amp;rft_id=info:pmid/9393392&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid11910259-64"><b><a href="#cite_ref-pmid11910259_64-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFBergeron_R.2C_Ravindran_AV.2C_Chaput_Y.2C_Goldner_E.2C_Swinson_R.2C_van_Ameringen_MA.2C_Austin_C.2C_Hadrava_V2002">Bergeron R, Ravindran AV, Chaput Y, Goldner E, Swinson R, van Ameringen MA, Austin C, Hadrava V (2002). "Sertraline and fluoxetine treatment of obsessive-compulsive disorder: results of a double-blind, 6-month treatment study". <i>Journal of Clinical Psychopharmacology</i> <b>22</b> (2): 148–54. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1097%2F00004714-200204000-00007" class="external text" title="http://dx.doi.org/10.1097%2F00004714-200204000-00007" rel="nofollow">10.1097/00004714-200204000-00007</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11910259" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11910259">PMID 11910259</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Sertraline+and+fluoxetine+treatment+of+obsessive-compulsive+disorder%3A+results+of+a+double-blind%2C+6-month+treatment+study&amp;rft.jtitle=Journal+of+Clinical+Psychopharmacology&amp;rft.aulast=Bergeron+R%2C+Ravindran+AV%2C+Chaput+Y%2C+Goldner+E%2C+Swinson+R%2C+van+Ameringen+MA%2C+Austin+C%2C+Hadrava+V&amp;rft.au=Bergeron+R%2C+Ravindran+AV%2C+Chaput+Y%2C+Goldner+E%2C+Swinson+R%2C+van+Ameringen+MA%2C+Austin+C%2C+Hadrava+V&amp;rft.date=2002&amp;rft.volume=22&amp;rft.issue=2&amp;rft.pages=148%E2%80%9354&amp;rft_id=info:doi/10.1097%2F00004714-200204000-00007&amp;rft_id=info:pmid/11910259&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid16426083-65"><b><a href="#cite_ref-pmid16426083_65-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFNinan_PT.2C_Koran_LM.2C_Kiev_A.2C_Davidson_JR.2C_Rasmussen_SA.2C_Zajecka_JM.2C_Robinson_DG.2C_Crits-Christoph_P.2C_Mandel_FS.2C_Austin_C2006">Ninan PT, Koran LM, Kiev A, Davidson JR, Rasmussen SA, Zajecka JM, Robinson DG, Crits-Christoph P, Mandel FS, Austin C (2006). "High-dose sertraline strategy for nonresponders to acute treatment for obsessive-compulsive disorder: a multicenter double-blind trial". <i>The Journal of Clinical Psychiatry</i> <b>67</b> (1): 15–22. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16426083" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16426083">PMID 16426083</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=High-dose+sertraline+strategy+for+nonresponders+to+acute+treatment+for+obsessive-compulsive+disorder%3A+a+multicenter+double-blind+trial&amp;rft.jtitle=The+Journal+of+Clinical+Psychiatry&amp;rft.aulast=Ninan+PT%2C+Koran+LM%2C+Kiev+A%2C+Davidson+JR%2C+Rasmussen+SA%2C+Zajecka+JM%2C+Robinson+DG%2C+Crits-Christoph+P%2C+Mandel+FS%2C+Austin+C&amp;rft.au=Ninan+PT%2C+Koran+LM%2C+Kiev+A%2C+Davidson+JR%2C+Rasmussen+SA%2C+Zajecka+JM%2C+Robinson+DG%2C+Crits-Christoph+P%2C+Mandel+FS%2C+Austin+C&amp;rft.date=2006&amp;rft.volume=67&amp;rft.issue=1&amp;rft.pages=15%E2%80%9322&amp;rft_id=info:pmid/16426083&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid7673657-66"><b><a href="#cite_ref-pmid7673657_66-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFGreist_JH.2C_Jefferson_JW.2C_Kobak_KA.2C_Chouinard_G.2C_DuBoff_E.2C_Halaris_A.2C_Kim_SW.2C_Koran_L.2C_Liebowitz_MR.2C_Lydiard_B1995">Greist JH, Jefferson JW, Kobak KA, Chouinard G, DuBoff E, Halaris A, Kim SW, Koran L, Liebowitz MR, Lydiard B (1995). "A 1 year double-blind placebo-controlled fixed dose study of sertraline in the treatment of obsessive-compulsive disorder". <i>International Clinical Psychopharmacology</i> <b>10</b> (2): 57–65. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1097%2F00004850-199506000-00001" class="external text" title="http://dx.doi.org/10.1097%2F00004850-199506000-00001" rel="nofollow">10.1097/00004850-199506000-00001</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/7673657" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/7673657">PMID 7673657</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=A+1+year+double-blind+placebo-controlled+fixed+dose+study+of+sertraline+in+the+treatment+of+obsessive-compulsive+disorder&amp;rft.jtitle=International+Clinical+Psychopharmacology&amp;rft.aulast=Greist+JH%2C+Jefferson+JW%2C+Kobak+KA%2C+Chouinard+G%2C+DuBoff+E%2C+Halaris+A%2C+Kim+SW%2C+Koran+L%2C+Liebowitz+MR%2C+Lydiard+B&amp;rft.au=Greist+JH%2C+Jefferson+JW%2C+Kobak+KA%2C+Chouinard+G%2C+DuBoff+E%2C+Halaris+A%2C+Kim+SW%2C+Koran+L%2C+Liebowitz+MR%2C+Lydiard+B&amp;rft.date=1995&amp;rft.volume=10&amp;rft.issue=2&amp;rft.pages=57%E2%80%9365&amp;rft_id=info:doi/10.1097%2F00004850-199506000-00001&amp;rft_id=info:pmid/7673657&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid9547132-67"><b><a href="#cite_ref-pmid9547132_67-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFRasmussen_S.2C_Hackett_E.2C_DuBoff_E.2C_Greist_J.2C_Halaris_A.2C_Koran_LM.2C_Liebowitz_M.2C_Lydiard_RB.2C_McElroy_S.2C_Mendels_J.2C_O.27Connor_K1997">Rasmussen S, Hackett E, DuBoff E, Greist J, Halaris A, Koran LM, Liebowitz M, Lydiard RB, McElroy S, Mendels J, O'Connor K (1997). "A 2-year study of sertraline in the treatment of obsessive-compulsive disorder". <i>International Clinical Psychopharmacology</i> <b>12</b> (6): 309–16. <a href="http://www.ncbi.nlm.nih.gov/pubmed/9547132" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/9547132">PMID 9547132</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=A+2-year+study+of+sertraline+in+the+treatment+of+obsessive-compulsive+disorder&amp;rft.jtitle=International+Clinical+Psychopharmacology&amp;rft.aulast=Rasmussen+S%2C+Hackett+E%2C+DuBoff+E%2C+Greist+J%2C+Halaris+A%2C+Koran+LM%2C+Liebowitz+M%2C+Lydiard+RB%2C+McElroy+S%2C+Mendels+J%2C+O%27Connor+K&amp;rft.au=Rasmussen+S%2C+Hackett+E%2C+DuBoff+E%2C+Greist+J%2C+Halaris+A%2C+Koran+LM%2C+Liebowitz+M%2C+Lydiard+RB%2C+McElroy+S%2C+Mendels+J%2C+O%27Connor+K&amp;rft.date=1997&amp;rft.volume=12&amp;rft.issue=6&amp;rft.pages=309%E2%80%9316&amp;rft_id=info:pmid/9547132&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid11772695-68"><b><a href="#cite_ref-pmid11772695_68-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFKoran_LM.2C_Hackett_E.2C_Rubin_A.2C_Wolkow_R.2C_Robinson_D2002">Koran LM, Hackett E, Rubin A, Wolkow R, Robinson D (2002). "Efficacy of sertraline in the long-term treatment of obsessive-compulsive disorder". <i>The American Journal of Psychiatry</i> <b>159</b> (1): 88–95. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1176%2Fappi.ajp.159.1.88" class="external text" title="http://dx.doi.org/10.1176%2Fappi.ajp.159.1.88" rel="nofollow">10.1176/appi.ajp.159.1.88</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11772695" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11772695">PMID 11772695</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Efficacy+of+sertraline+in+the+long-term+treatment+of+obsessive-compulsive+disorder&amp;rft.jtitle=The+American+Journal+of+Psychiatry&amp;rft.aulast=Koran+LM%2C+Hackett+E%2C+Rubin+A%2C+Wolkow+R%2C+Robinson+D&amp;rft.au=Koran+LM%2C+Hackett+E%2C+Rubin+A%2C+Wolkow+R%2C+Robinson+D&amp;rft.date=2002&amp;rft.volume=159&amp;rft.issue=1&amp;rft.pages=88%E2%80%9395&amp;rft_id=info:doi/10.1176%2Fappi.ajp.159.1.88&amp;rft_id=info:pmid/11772695&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid15507582-69"><b><a href="#cite_ref-pmid15507582_69-0" title="">^</a></b> <cite style="font-style:normal" class="">"Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial". <i>JAMA</i> <b>292</b> (16): 1969–76. 2004. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1001%2Fjama.292.16.1969" class="external text" title="http://dx.doi.org/10.1001%2Fjama.292.16.1969" rel="nofollow">10.1001/jama.292.16.1969</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15507582" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15507582">PMID 15507582</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Cognitive-behavior+therapy%2C+sertraline%2C+and+their+combination+for+children+and+adolescents+with+obsessive-compulsive+disorder%3A+the+Pediatric+OCD+Treatment+Study+%28POTS%29+randomized+controlled+trial&amp;rft.jtitle=JAMA&amp;rft.date=2004&amp;rft.volume=292&amp;rft.issue=16&amp;rft.pages=1969%E2%80%9376&amp;rft_id=info:doi/10.1001%2Fjama.292.16.1969&amp;rft_id=info:pmid/15507582&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid16889458-70"><b><a href="#cite_ref-pmid16889458_70-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFSousa_MB.2C_Isolan_LR.2C_Oliveira_RR.2C_Manfro_GG.2C_Cordioli_AV2006">Sousa MB, Isolan LR, Oliveira RR, Manfro GG, Cordioli AV (2006). "A randomized clinical trial of cognitive-behavioral group therapy and sertraline in the treatment of obsessive-compulsive disorder". <i>The Journal of Clinical Psychiatry</i> <b>67</b> (7): 1133–9. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16889458" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16889458">PMID 16889458</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=A+randomized+clinical+trial+of+cognitive-behavioral+group+therapy+and+sertraline+in+the+treatment+of+obsessive-compulsive+disorder&amp;rft.jtitle=The+Journal+of+Clinical+Psychiatry&amp;rft.aulast=Sousa+MB%2C+Isolan+LR%2C+Oliveira+RR%2C+Manfro+GG%2C+Cordioli+AV&amp;rft.au=Sousa+MB%2C+Isolan+LR%2C+Oliveira+RR%2C+Manfro+GG%2C+Cordioli+AV&amp;rft.date=2006&amp;rft.volume=67&amp;rft.issue=7&amp;rft.pages=1133%E2%80%939&amp;rft_id=info:pmid/16889458&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid11772131-71"><b><a href="#cite_ref-pmid11772131_71-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFJim.C3.A9nez-Jim.C3.A9nez_FJ.2C_Garc.C3.ADa-Ruiz_PJ2001">Jiménez-Jiménez FJ, García-Ruiz PJ (2001). "Pharmacological options for the treatment of Tourette's disorder". <i>Drugs</i> <b>61</b> (15): 2207–20. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11772131" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11772131">PMID 11772131</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Pharmacological+options+for+the+treatment+of+Tourette%27s+disorder&amp;rft.jtitle=Drugs&amp;rft.aulast=Jim%C3%A9nez-Jim%C3%A9nez+FJ%2C+Garc%C3%ADa-Ruiz+PJ&amp;rft.au=Jim%C3%A9nez-Jim%C3%A9nez+FJ%2C+Garc%C3%ADa-Ruiz+PJ&amp;rft.date=2001&amp;rft.volume=61&amp;rft.issue=15&amp;rft.pages=2207%E2%80%9320&amp;rft_id=info:pmid/11772131&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid8552129-72"><b><a href="#cite_ref-pmid8552129_72-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFHauser_RA.2C_Zesiewicz_TA1995">Hauser RA, Zesiewicz TA (September 1995). "Sertraline-induced exacerbation of tics in Tourette's syndrome". <i>Mov. Disord.</i> <b>10</b> (5): 682–4. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1002%2Fmds.870100529" class="external text" title="http://dx.doi.org/10.1002%2Fmds.870100529" rel="nofollow">10.1002/mds.870100529</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/8552129" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/8552129">PMID 8552129</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Sertraline-induced+exacerbation+of+tics+in+Tourette%27s+syndrome&amp;rft.jtitle=Mov.+Disord.&amp;rft.aulast=Hauser+RA%2C+Zesiewicz+TA&amp;rft.au=Hauser+RA%2C+Zesiewicz+TA&amp;rft.date=September+1995&amp;rft.volume=10&amp;rft.issue=5&amp;rft.pages=682%E2%80%934&amp;rft_id=info:doi/10.1002%2Fmds.870100529&amp;rft_id=info:pmid/8552129&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid10945134-73">^ <a href="#cite_ref-pmid10945134_73-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid10945134_73-1" title=""><sup><i><b>b</b></i></sup></a> Review: <cite style="font-style:normal" class="" id="CITEREFHirschfeld_RM2000">Hirschfeld RM (2000). "Sertraline in the treatment of anxiety disorders". <i>Depress Anxiety</i> <b>11</b> (4): 139–57. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1002%2F1520-6394%282000%2911%3A4%3C139%3A%3AAID-DA1%3E3.0.CO%3B2-C" class="external text" title="http://dx.doi.org/10.1002%2F1520-6394%282000%2911%3A4%3C139%3A%3AAID-DA1%3E3.0.CO%3B2-C" rel="nofollow">10.1002/1520-6394(2000)11:4&lt;139::AID-DA1&gt;3.0.CO;2-C</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/10945134" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/10945134">PMID 10945134</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Sertraline+in+the+treatment+of+anxiety+disorders&amp;rft.jtitle=Depress+Anxiety&amp;rft.aulast=Hirschfeld+RM&amp;rft.au=Hirschfeld+RM&amp;rft.date=2000&amp;rft.volume=11&amp;rft.issue=4&amp;rft.pages=139%E2%80%9357&amp;rft_id=info:doi/10.1002%2F1520-6394%282000%2911%3A4%3C139%3A%3AAID-DA1%3E3.0.CO%3B2-C&amp;rft_id=info:pmid/10945134&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid16292466-74">^ <a href="#cite_ref-pmid16292466_74-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid16292466_74-1" title=""><sup><i><b>b</b></i></sup></a> Meta-analysis: <cite style="font-style:normal" class="" id="CITEREFClayton_AH.2C_Stewart_RS.2C_Fayyad_R.2C_Clary_CM2006">Clayton AH, Stewart RS, Fayyad R, Clary CM (2006). "Sex differences in clinical presentation and response in panic disorder: pooled data from sertraline treatment studies". <i>Arch Womens Ment Health</i> <b>9</b> (3): 151–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1007%2Fs00737-005-0111-y" class="external text" title="http://dx.doi.org/10.1007%2Fs00737-005-0111-y" rel="nofollow">10.1007/s00737-005-0111-y</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16292466" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16292466">PMID 16292466</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Sex+differences+in+clinical+presentation+and+response+in+panic+disorder%3A+pooled+data+from+sertraline+treatment+studies&amp;rft.jtitle=Arch+Womens+Ment+Health&amp;rft.aulast=Clayton+AH%2C+Stewart+RS%2C+Fayyad+R%2C+Clary+CM&amp;rft.au=Clayton+AH%2C+Stewart+RS%2C+Fayyad+R%2C+Clary+CM&amp;rft.date=2006&amp;rft.volume=9&amp;rft.issue=3&amp;rft.pages=151%E2%80%937&amp;rft_id=info:doi/10.1007%2Fs00737-005-0111-y&amp;rft_id=info:pmid/16292466&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid11206597-75">^ <a href="#cite_ref-pmid11206597_75-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid11206597_75-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFPollack_MH.2C_Rapaport_MH.2C_Clary_CM.2C_Mardekian_J.2C_Wolkow_R2000">Pollack MH, Rapaport MH, Clary CM, Mardekian J, Wolkow R (2000). "Sertraline treatment of panic disorder: response in patients at risk for poor outcome". <i>J Clin Psychiatry</i> <b>61</b> (12): 922–7. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11206597" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11206597">PMID 11206597</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Sertraline+treatment+of+panic+disorder%3A+response+in+patients+at+risk+for+poor+outcome&amp;rft.jtitle=J+Clin+Psychiatry&amp;rft.aulast=Pollack+MH%2C+Rapaport+MH%2C+Clary+CM%2C+Mardekian+J%2C+Wolkow+R&amp;rft.au=Pollack+MH%2C+Rapaport+MH%2C+Clary+CM%2C+Mardekian+J%2C+Wolkow+R&amp;rft.date=2000&amp;rft.volume=61&amp;rft.issue=12&amp;rft.pages=922%E2%80%937&amp;rft_id=info:pmid/11206597&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid11199932-76"><b><a href="#cite_ref-pmid11199932_76-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFRapaport_MH.2C_Pollack_MH.2C_Clary_CM.2C_Mardekian_J.2C_Wolkow_R2001">Rapaport MH, Pollack MH, Clary CM, Mardekian J, Wolkow R (2001). "Panic disorder and response to sertraline: the effect of previous treatment with benzodiazepines". <i>J Clin Psychopharmacol</i> <b>21</b> (1): 104–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1097%2F00004714-200102000-00019" class="external text" title="http://dx.doi.org/10.1097%2F00004714-200102000-00019" rel="nofollow">10.1097/00004714-200102000-00019</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11199932" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11199932">PMID 11199932</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Panic+disorder+and+response+to+sertraline%3A+the+effect+of+previous+treatment+with+benzodiazepines&amp;rft.jtitle=J+Clin+Psychopharmacol&amp;rft.aulast=Rapaport+MH%2C+Pollack+MH%2C+Clary+CM%2C+Mardekian+J%2C+Wolkow+R&amp;rft.au=Rapaport+MH%2C+Pollack+MH%2C+Clary+CM%2C+Mardekian+J%2C+Wolkow+R&amp;rft.date=2001&amp;rft.volume=21&amp;rft.issue=1&amp;rft.pages=104%E2%80%937&amp;rft_id=info:doi/10.1097%2F00004714-200102000-00019&amp;rft_id=info:pmid/11199932&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid15096081-77">^ <a href="#cite_ref-pmid15096081_77-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid15096081_77-1" title=""><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid15096081_77-2" title=""><sup><i><b>c</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFBandelow_B.2C_Behnke_K.2C_Lenoir_S.2C_Hendriks_GJ.2C_Alkin_T.2C_Goebel_C.2C_Clary_CM2004">Bandelow B, Behnke K, Lenoir S, Hendriks GJ, Alkin T, Goebel C, Clary CM (2004). "Sertraline versus paroxetine in the treatment of panic disorder: an acute, double-blind noninferiority comparison". <i>J Clin Psychiatry</i> <b>65</b> (3): 405–13. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15096081" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15096081">PMID 15096081</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Sertraline+versus+paroxetine+in+the+treatment+of+panic+disorder%3A+an+acute%2C+double-blind+noninferiority+comparison&amp;rft.jtitle=J+Clin+Psychiatry&amp;rft.aulast=Bandelow+B%2C+Behnke+K%2C+Lenoir+S%2C+Hendriks+GJ%2C+Alkin+T%2C+Goebel+C%2C+Clary+CM&amp;rft.au=Bandelow+B%2C+Behnke+K%2C+Lenoir+S%2C+Hendriks+GJ%2C+Alkin+T%2C+Goebel+C%2C+Clary+CM&amp;rft.date=2004&amp;rft.volume=65&amp;rft.issue=3&amp;rft.pages=405%E2%80%9313&amp;rft_id=info:pmid/15096081&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid16053461-78"><b><a href="#cite_ref-pmid16053461_78-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFFisekovi.C4.87_S.2C_Loga-Zec_S2005">Fiseković S, Loga-Zec S (2005). "Sertraline and alprazolam in the treatment of panic desorder [<i><a href="/wiki/Sic" title="Sic">sic</a></i>]". <i>Bosn J Basic Med Sci</i> <b>5</b> (2): 78–81. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16053461" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16053461">PMID 16053461</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Sertraline+and+alprazolam+in+the+treatment+of+panic+desorder%26%2332%3B%26%2391%3B%27%27%5B%5Bsic%5D%5D%27%27%26%2393%3B&amp;rft.jtitle=Bosn+J+Basic+Med+Sci&amp;rft.aulast=Fisekovi%C4%87+S%2C+Loga-Zec+S&amp;rft.au=Fisekovi%C4%87+S%2C+Loga-Zec+S&amp;rft.date=2005&amp;rft.volume=5&amp;rft.issue=2&amp;rft.pages=78%E2%80%9381&amp;rft_id=info:pmid/16053461&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid11722304-79">^ <a href="#cite_ref-pmid11722304_79-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid11722304_79-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFRapaport_MH.2C_Wolkow_R.2C_Rubin_A.2C_Hackett_E.2C_Pollack_M.2C_Ota_KY2001">Rapaport MH, Wolkow R, Rubin A, Hackett E, Pollack M, Ota KY (2001). "Sertraline treatment of panic disorder: results of a long-term study". <i>Acta Psychiatr Scand</i> <b>104</b> (4): 289–98. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1034%2Fj.1600-0447.2001.00263.x" class="external text" title="http://dx.doi.org/10.1034%2Fj.1600-0447.2001.00263.x" rel="nofollow">10.1034/j.1600-0447.2001.00263.x</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11722304" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11722304">PMID 11722304</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Sertraline+treatment+of+panic+disorder%3A+results+of+a+long-term+study&amp;rft.jtitle=Acta+Psychiatr+Scand&amp;rft.aulast=Rapaport+MH%2C+Wolkow+R%2C+Rubin+A%2C+Hackett+E%2C+Pollack+M%2C+Ota+KY&amp;rft.au=Rapaport+MH%2C+Wolkow+R%2C+Rubin+A%2C+Hackett+E%2C+Pollack+M%2C+Ota+KY&amp;rft.date=2001&amp;rft.volume=104&amp;rft.issue=4&amp;rft.pages=289%E2%80%9398&amp;rft_id=info:doi/10.1034%2Fj.1600-0447.2001.00263.x&amp;rft_id=info:pmid/11722304&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid17092192-80"><b><a href="#cite_ref-pmid17092192_80-0" title="">^</a></b> Review: <cite style="font-style:normal" class="" id="CITEREFDavidson_JR2006">Davidson JR (2006). "Pharmacotherapy of social anxiety disorder: what does the evidence tell us?". <i>J Clin Psychiatry</i> <b>67 Suppl 12</b>: 20–6. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17092192" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17092192">PMID 17092192</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Pharmacotherapy+of+social+anxiety+disorder%3A+what+does+the+evidence+tell+us%3F&amp;rft.jtitle=J+Clin+Psychiatry&amp;rft.aulast=Davidson+JR&amp;rft.au=Davidson+JR&amp;rft.date=2006&amp;rft.volume=67+Suppl+12&amp;rft.pages=20%E2%80%936&amp;rft_id=info:pmid/17092192&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid12934979-81">^ <a href="#cite_ref-pmid12934979_81-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid12934979_81-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFLiebowitz_MR.2C_DeMartinis_NA.2C_Weihs_K.2C_Londborg_PD.2C_Smith_WT.2C_Chung_H.2C_Fayyad_R.2C_Clary_CM2003">Liebowitz MR, DeMartinis NA, Weihs K, Londborg PD, Smith WT, Chung H, Fayyad R, Clary CM (2003). "Efficacy of sertraline in severe generalized social anxiety disorder: results of a double-blind, placebo-controlled study". <i>J Clin Psychiatry</i> <b>64</b> (7): 785–92. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12934979" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12934979">PMID 12934979</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Efficacy+of+sertraline+in+severe+generalized+social+anxiety+disorder%3A+results+of+a+double-blind%2C+placebo-controlled+study&amp;rft.jtitle=J+Clin+Psychiatry&amp;rft.aulast=Liebowitz+MR%2C+DeMartinis+NA%2C+Weihs+K%2C+Londborg+PD%2C+Smith+WT%2C+Chung+H%2C+Fayyad+R%2C+Clary+CM&amp;rft.au=Liebowitz+MR%2C+DeMartinis+NA%2C+Weihs+K%2C+Londborg+PD%2C+Smith+WT%2C+Chung+H%2C+Fayyad+R%2C+Clary+CM&amp;rft.date=2003&amp;rft.volume=64&amp;rft.issue=7&amp;rft.pages=785%E2%80%9392&amp;rft_id=info:pmid/12934979&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid16216019-82"><b><a href="#cite_ref-pmid16216019_82-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFConnor_KM.2C_Davidson_JR.2C_Chung_H.2C_Yang_R.2C_Clary_CM2006">Connor KM, Davidson JR, Chung H, Yang R, Clary CM (2006). "Multidimensional effects of sertraline in social anxiety disorder". <i>Depress Anxiety</i> <b>23</b> (1): 6–10. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1002%2Fda.20086" class="external text" title="http://dx.doi.org/10.1002%2Fda.20086" rel="nofollow">10.1002/da.20086</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16216019" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16216019">PMID 16216019</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Multidimensional+effects+of+sertraline+in+social+anxiety+disorder&amp;rft.jtitle=Depress+Anxiety&amp;rft.aulast=Connor+KM%2C+Davidson+JR%2C+Chung+H%2C+Yang+R%2C+Clary+CM&amp;rft.au=Connor+KM%2C+Davidson+JR%2C+Chung+H%2C+Yang+R%2C+Clary+CM&amp;rft.date=2006&amp;rft.volume=23&amp;rft.issue=1&amp;rft.pages=6%E2%80%9310&amp;rft_id=info:doi/10.1002%2Fda.20086&amp;rft_id=info:pmid/16216019&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid11435264-83"><b><a href="#cite_ref-pmid11435264_83-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFBlomhoff_S.2C_Haug_TT.2C_Hellstr.C3.B6m_K.2C_Holme_I.2C_Humble_M.2C_Madsbu_HP.2C_Wold_JE2001">Blomhoff S, Haug TT, Hellström K, Holme I, Humble M, Madsbu HP, Wold JE (2001). "Randomised controlled general practice trial of sertraline, exposure therapy and combined treatment in generalised social phobia". <i>Br J Psychiatry</i> <b>179</b>: 23–30. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1192%2Fbjp.179.1.23" class="external text" title="http://dx.doi.org/10.1192%2Fbjp.179.1.23" rel="nofollow">10.1192/bjp.179.1.23</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11435264" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11435264">PMID 11435264</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Randomised+controlled+general+practice+trial+of+sertraline%2C+exposure+therapy+and+combined+treatment+in+generalised+social+phobia&amp;rft.jtitle=Br+J+Psychiatry&amp;rft.aulast=Blomhoff+S%2C+Haug+TT%2C+Hellstr%C3%B6m+K%2C+Holme+I%2C+Humble+M%2C+Madsbu+HP%2C+Wold+JE&amp;rft.au=Blomhoff+S%2C+Haug+TT%2C+Hellstr%C3%B6m+K%2C+Holme+I%2C+Humble+M%2C+Madsbu+HP%2C+Wold+JE&amp;rft.date=2001&amp;rft.volume=179&amp;rft.pages=23%E2%80%9330&amp;rft_id=info:doi/10.1192%2Fbjp.179.1.23&amp;rft_id=info:pmid/11435264&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-84"><b><a href="#cite_ref-84" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFYonkers_KA.2C_Halbreich_U.2C_Freeman_E.2C_Brown_C.2C_Endicott_J.2C_Frank_E.2C_Parry_B.2C_Pearlstein_T.2C_Severino_S.2C_Stout_A.2C_Stone_A.2C_Harrison_W.1997">Yonkers KA, Halbreich U, Freeman E, Brown C, Endicott J, Frank E, Parry B, Pearlstein T, Severino S, Stout A, Stone A, Harrison W. (1997). "Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. A randomized controlled trial. Sertraline Premenstrual Dysphoric Collaborative Study Group". <i>The Journal of the American Medical Association</i> <b>278</b> (12): 983–988. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1001%2Fjama.278.12.983" class="external text" title="http://dx.doi.org/10.1001%2Fjama.278.12.983" rel="nofollow">10.1001/jama.278.12.983</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/9307345" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/9307345">PMID 9307345</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Symptomatic+improvement+of+premenstrual+dysphoric+disorder+with+sertraline+treatment.+A+randomized+controlled+trial.+Sertraline+Premenstrual+Dysphoric+Collaborative+Study+Group&amp;rft.jtitle=The+Journal+of+the+American+Medical+Association&amp;rft.aulast=Yonkers+KA%2C+Halbreich+U%2C+Freeman+E%2C+Brown+C%2C+Endicott+J%2C+Frank+E%2C+Parry+B%2C+Pearlstein+T%2C+Severino+S%2C+Stout+A%2C+Stone+A%2C+Harrison+W.&amp;rft.au=Yonkers+KA%2C+Halbreich+U%2C+Freeman+E%2C+Brown+C%2C+Endicott+J%2C+Frank+E%2C+Parry+B%2C+Pearlstein+T%2C+Severino+S%2C+Stout+A%2C+Stone+A%2C+Harrison+W.&amp;rft.date=1997&amp;rft.volume=278&amp;rft.issue=12&amp;rft.pages=983%E2%80%93988&amp;rft_id=info:doi/10.1001%2Fjama.278.12.983&amp;rft_id=info:pmid/9307345&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid12215058-85"><b><a href="#cite_ref-pmid12215058_85-0" title="">^</a></b> Review: <cite style="font-style:normal" class="" id="CITEREFPearlstein_T2002">Pearlstein T (2002). "Selective serotonin reuptake inhibitors for premenstrual dysphoric disorder: the emerging gold standard?". <i>Drugs</i> <b>62</b> (13): 1869–85. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.2165%2F00003495-200262130-00004" class="external text" title="http://dx.doi.org/10.2165%2F00003495-200262130-00004" rel="nofollow">10.2165/00003495-200262130-00004</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12215058" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12215058">PMID 12215058</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Selective+serotonin+reuptake+inhibitors+for+premenstrual+dysphoric+disorder%3A+the+emerging+gold+standard%3F&amp;rft.jtitle=Drugs&amp;rft.aulast=Pearlstein+T&amp;rft.au=Pearlstein+T&amp;rft.date=2002&amp;rft.volume=62&amp;rft.issue=13&amp;rft.pages=1869%E2%80%9385&amp;rft_id=info:doi/10.2165%2F00003495-200262130-00004&amp;rft_id=info:pmid/12215058&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid11972726-86"><b><a href="#cite_ref-pmid11972726_86-0" title="">^</a></b> Review: <cite style="font-style:normal" class="" id="CITEREFAckermann_RT.2C_Williams_JW2002">Ackermann RT, Williams JW (2002). "Rational treatment choices for non-major depressions in primary care: an evidence-based review". <i>J Gen Intern Med</i> <b>17</b> (4): 293–301. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1046%2Fj.1525-1497.2002.10350.x" class="external text" title="http://dx.doi.org/10.1046%2Fj.1525-1497.2002.10350.x" rel="nofollow">10.1046/j.1525-1497.2002.10350.x</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11972726" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11972726">PMID 11972726</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Rational+treatment+choices+for+non-major+depressions+in+primary+care%3A+an+evidence-based+review&amp;rft.jtitle=J+Gen+Intern+Med&amp;rft.aulast=Ackermann+RT%2C+Williams+JW&amp;rft.au=Ackermann+RT%2C+Williams+JW&amp;rft.date=2002&amp;rft.volume=17&amp;rft.issue=4&amp;rft.pages=293%E2%80%93301&amp;rft_id=info:doi/10.1046%2Fj.1525-1497.2002.10350.x&amp;rft_id=info:pmid/11972726&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid14754784-87">^ <a href="#cite_ref-pmid14754784_87-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid14754784_87-1" title=""><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid14754784_87-2" title=""><sup><i><b>c</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFFreeman_EW.2C_Rickels_K.2C_Sondheimer_SJ.2C_Polansky_M.2C_Xiao_S2004">Freeman EW, Rickels K, Sondheimer SJ, Polansky M, Xiao S (2004). "Continuous or intermittent dosing with sertraline for patients with severe premenstrual syndrome or premenstrual dysphoric disorder". <i>Am J Psychiatry</i> <b>161</b> (2): 343–51. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1176%2Fappi.ajp.161.2.343" class="external text" title="http://dx.doi.org/10.1176%2Fappi.ajp.161.2.343" rel="nofollow">10.1176/appi.ajp.161.2.343</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/14754784" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/14754784">PMID 14754784</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Continuous+or+intermittent+dosing+with+sertraline+for+patients+with+severe+premenstrual+syndrome+or+premenstrual+dysphoric+disorder&amp;rft.jtitle=Am+J+Psychiatry&amp;rft.aulast=Freeman+EW%2C+Rickels+K%2C+Sondheimer+SJ%2C+Polansky+M%2C+Xiao+S&amp;rft.au=Freeman+EW%2C+Rickels+K%2C+Sondheimer+SJ%2C+Polansky+M%2C+Xiao+S&amp;rft.date=2004&amp;rft.volume=161&amp;rft.issue=2&amp;rft.pages=343%E2%80%9351&amp;rft_id=info:doi/10.1176%2Fappi.ajp.161.2.343&amp;rft_id=info:pmid/14754784&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid10530636-88"><b><a href="#cite_ref-pmid10530636_88-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFFreeman_EW.2C_Rickels_K.2C_Sondheimer_SJ.2C_Polansky_M1999">Freeman EW, Rickels K, Sondheimer SJ, Polansky M (1999). "Differential response to antidepressants in women with premenstrual syndrome/premenstrual dysphoric disorder: a randomized controlled trial". <i>Arch. Gen. Psychiatry</i> <b>56</b> (10): 932–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1001%2Farchpsyc.56.10.932" class="external text" title="http://dx.doi.org/10.1001%2Farchpsyc.56.10.932" rel="nofollow">10.1001/archpsyc.56.10.932</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/10530636" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/10530636">PMID 10530636</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Differential+response+to+antidepressants+in+women+with+premenstrual+syndrome%2Fpremenstrual+dysphoric+disorder%3A+a+randomized+controlled+trial&amp;rft.jtitle=Arch.+Gen.+Psychiatry&amp;rft.aulast=Freeman+EW%2C+Rickels+K%2C+Sondheimer+SJ%2C+Polansky+M&amp;rft.au=Freeman+EW%2C+Rickels+K%2C+Sondheimer+SJ%2C+Polansky+M&amp;rft.date=1999&amp;rft.volume=56&amp;rft.issue=10&amp;rft.pages=932%E2%80%939&amp;rft_id=info:doi/10.1001%2Farchpsyc.56.10.932&amp;rft_id=info:pmid/10530636&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid10418540-89"><b><a href="#cite_ref-pmid10418540_89-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFJermain_DM.2C_Preece_CK.2C_Sykes_RL.2C_Kuehl_TJ.2C_Sulak_PJ1999">Jermain DM, Preece CK, Sykes RL, Kuehl TJ, Sulak PJ (1999). "Luteal phase sertraline treatment for premenstrual dysphoric disorder. Results of a double-blind, placebo-controlled, crossover study". <i>Arch Fam Med</i> <b>8</b> (4): 328–32. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1001%2Farchfami.8.4.328" class="external text" title="http://dx.doi.org/10.1001%2Farchfami.8.4.328" rel="nofollow">10.1001/archfami.8.4.328</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/10418540" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/10418540">PMID 10418540</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Luteal+phase+sertraline+treatment+for+premenstrual+dysphoric+disorder.+Results+of+a+double-blind%2C+placebo-controlled%2C+crossover+study&amp;rft.jtitle=Arch+Fam+Med&amp;rft.aulast=Jermain+DM%2C+Preece+CK%2C+Sykes+RL%2C+Kuehl+TJ%2C+Sulak+PJ&amp;rft.au=Jermain+DM%2C+Preece+CK%2C+Sykes+RL%2C+Kuehl+TJ%2C+Sulak+PJ&amp;rft.date=1999&amp;rft.volume=8&amp;rft.issue=4&amp;rft.pages=328%E2%80%9332&amp;rft_id=info:doi/10.1001%2Farchfami.8.4.328&amp;rft_id=info:pmid/10418540&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid12468166-90"><b><a href="#cite_ref-pmid12468166_90-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFHalbreich_U.2C_Bergeron_R.2C_Yonkers_KA.2C_Freeman_E.2C_Stout_AL.2C_Cohen_L2002">Halbreich U, Bergeron R, Yonkers KA, Freeman E, Stout AL, Cohen L (2002). "Efficacy of intermittent, luteal phase sertraline treatment of premenstrual dysphoric disorder". <i>Obstet Gynecol</i> <b>100</b> (6): 1219–29. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2FS0029-7844%2802%2902326-8" class="external text" title="http://dx.doi.org/10.1016%2FS0029-7844%2802%2902326-8" rel="nofollow">10.1016/S0029-7844(02)02326-8</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12468166" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12468166">PMID 12468166</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Efficacy+of+intermittent%2C+luteal+phase+sertraline+treatment+of+premenstrual+dysphoric+disorder&amp;rft.jtitle=Obstet+Gynecol&amp;rft.aulast=Halbreich+U%2C+Bergeron+R%2C+Yonkers+KA%2C+Freeman+E%2C+Stout+AL%2C+Cohen+L&amp;rft.au=Halbreich+U%2C+Bergeron+R%2C+Yonkers+KA%2C+Freeman+E%2C+Stout+AL%2C+Cohen+L&amp;rft.date=2002&amp;rft.volume=100&amp;rft.issue=6&amp;rft.pages=1219%E2%80%9329&amp;rft_id=info:doi/10.1016%2FS0029-7844%2802%2902326-8&amp;rft_id=info:pmid/12468166&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid17107257-91"><b><a href="#cite_ref-pmid17107257_91-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFKornstein_SG.2C_Pearlstein_TB.2C_Fayyad_R.2C_Farfel_GM.2C_Gillespie_JA2006">Kornstein SG, Pearlstein TB, Fayyad R, Farfel GM, Gillespie JA (2006). "Low-dose sertraline in the treatment of moderate-to-severe premenstrual syndrome: efficacy of 3 dosing strategies". <i>J Clin Psychiatry</i> <b>67</b> (10): 1624–32. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17107257" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17107257">PMID 17107257</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Low-dose+sertraline+in+the+treatment+of+moderate-to-severe+premenstrual+syndrome%3A+efficacy+of+3+dosing+strategies&amp;rft.jtitle=J+Clin+Psychiatry&amp;rft.aulast=Kornstein+SG%2C+Pearlstein+TB%2C+Fayyad+R%2C+Farfel+GM%2C+Gillespie+JA&amp;rft.au=Kornstein+SG%2C+Pearlstein+TB%2C+Fayyad+R%2C+Farfel+GM%2C+Gillespie+JA&amp;rft.date=2006&amp;rft.volume=67&amp;rft.issue=10&amp;rft.pages=1624%E2%80%9332&amp;rft_id=info:pmid/17107257&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid10770145-92"><b><a href="#cite_ref-pmid10770145_92-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFBrady_K.2C_Pearlstein_T.2C_Asnis_GM.2C_Baker_D.2C_Rothbaum_B.2C_Sikes_CR.2C_Farfel_GM2000">Brady K, Pearlstein T, Asnis GM, Baker D, Rothbaum B, Sikes CR, Farfel GM (2000). "Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial". <i>JAMA</i> <b>283</b> (14): 1837–44. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1001%2Fjama.283.14.1837" class="external text" title="http://dx.doi.org/10.1001%2Fjama.283.14.1837" rel="nofollow">10.1001/jama.283.14.1837</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/10770145" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/10770145">PMID 10770145</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Efficacy+and+safety+of+sertraline+treatment+of+posttraumatic+stress+disorder%3A+a+randomized+controlled+trial&amp;rft.jtitle=JAMA&amp;rft.aulast=Brady+K%2C+Pearlstein+T%2C+Asnis+GM%2C+Baker+D%2C+Rothbaum+B%2C+Sikes+CR%2C+Farfel+GM&amp;rft.au=Brady+K%2C+Pearlstein+T%2C+Asnis+GM%2C+Baker+D%2C+Rothbaum+B%2C+Sikes+CR%2C+Farfel+GM&amp;rft.date=2000&amp;rft.volume=283&amp;rft.issue=14&amp;rft.pages=1837%E2%80%9344&amp;rft_id=info:doi/10.1001%2Fjama.283.14.1837&amp;rft_id=info:pmid/10770145&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid11411812-93"><b><a href="#cite_ref-pmid11411812_93-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFLondborg_PD.2C_Hegel_MT.2C_Goldstein_S.2C_Goldstein_D.2C_Himmelhoch_JM.2C_Maddock_R.2C_Patterson_WM.2C_Rausch_J.2C_Farfel_GM2001">Londborg PD, Hegel MT, Goldstein S, Goldstein D, Himmelhoch JM, Maddock R, Patterson WM, Rausch J, Farfel GM (2001). "Sertraline treatment of posttraumatic stress disorder: results of 24 weeks of open-label continuation treatment". <i>The Journal of Clinical Psychiatry</i> <b>62</b> (5): 325–31. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11411812" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11411812">PMID 11411812</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Sertraline+treatment+of+posttraumatic+stress+disorder%3A+results+of+24+weeks+of+open-label+continuation+treatment&amp;rft.jtitle=The+Journal+of+Clinical+Psychiatry&amp;rft.aulast=Londborg+PD%2C+Hegel+MT%2C+Goldstein+S%2C+Goldstein+D%2C+Himmelhoch+JM%2C+Maddock+R%2C+Patterson+WM%2C+Rausch+J%2C+Farfel+GM&amp;rft.au=Londborg+PD%2C+Hegel+MT%2C+Goldstein+S%2C+Goldstein+D%2C+Himmelhoch+JM%2C+Maddock+R%2C+Patterson+WM%2C+Rausch+J%2C+Farfel+GM&amp;rft.date=2001&amp;rft.volume=62&amp;rft.issue=5&amp;rft.pages=325%E2%80%9331&amp;rft_id=info:pmid/11411812&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid16734498-94">^ <a href="#cite_ref-pmid16734498_94-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid16734498_94-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFDavis_LL.2C_Frazier_EC.2C_Williford_RB.2C_Newell_JM2006">Davis LL, Frazier EC, Williford RB, Newell JM (2006). "Long-term pharmacotherapy for post-traumatic stress disorder". <i>CNS Drugs</i> <b>20</b> (6): 465–76. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.2165%2F00023210-200620060-00003" class="external text" title="http://dx.doi.org/10.2165%2F00023210-200620060-00003" rel="nofollow">10.2165/00023210-200620060-00003</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16734498" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16734498">PMID 16734498</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Long-term+pharmacotherapy+for+post-traumatic+stress+disorder&amp;rft.jtitle=CNS+Drugs&amp;rft.aulast=Davis+LL%2C+Frazier+EC%2C+Williford+RB%2C+Newell+JM&amp;rft.au=Davis+LL%2C+Frazier+EC%2C+Williford+RB%2C+Newell+JM&amp;rft.date=2006&amp;rft.volume=20&amp;rft.issue=6&amp;rft.pages=465%E2%80%9376&amp;rft_id=info:doi/10.2165%2F00023210-200620060-00003&amp;rft_id=info:pmid/16734498&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid11729012-95"><b><a href="#cite_ref-pmid11729012_95-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFDavidson_J.2C_Pearlstein_T.2C_Londborg_P.2C_Brady_KT.2C_Rothbaum_B.2C_Bell_J.2C_Maddock_R.2C_Hegel_MT.2C_Farfel_G2001">Davidson J, Pearlstein T, Londborg P, Brady KT, Rothbaum B, Bell J, Maddock R, Hegel MT, Farfel G (2001). "Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study". <i>The American Journal of Psychiatry</i> <b>158</b> (12): 1974–81. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1176%2Fappi.ajp.158.12.1974" class="external text" title="http://dx.doi.org/10.1176%2Fappi.ajp.158.12.1974" rel="nofollow">10.1176/appi.ajp.158.12.1974</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11729012" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11729012">PMID 11729012</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Efficacy+of+sertraline+in+preventing+relapse+of+posttraumatic+stress+disorder%3A+results+of+a+28-week+double-blind%2C+placebo-controlled+study&amp;rft.jtitle=The+American+Journal+of+Psychiatry&amp;rft.aulast=Davidson+J%2C+Pearlstein+T%2C+Londborg+P%2C+Brady+KT%2C+Rothbaum+B%2C+Bell+J%2C+Maddock+R%2C+Hegel+MT%2C+Farfel+G&amp;rft.au=Davidson+J%2C+Pearlstein+T%2C+Londborg+P%2C+Brady+KT%2C+Rothbaum+B%2C+Bell+J%2C+Maddock+R%2C+Hegel+MT%2C+Farfel+G&amp;rft.date=2001&amp;rft.volume=158&amp;rft.issue=12&amp;rft.pages=1974%E2%80%9381&amp;rft_id=info:doi/10.1176%2Fappi.ajp.158.12.1974&amp;rft_id=info:pmid/11729012&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid16702890-96"><b><a href="#cite_ref-pmid16702890_96-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFDavidson_J.2C_Rothbaum_BO.2C_Tucker_P.2C_Asnis_G.2C_Benattia_I.2C_Musgnung_JJ2006">Davidson J, Rothbaum BO, Tucker P, Asnis G, Benattia I, Musgnung JJ (2006). "Venlafaxine extended release in posttraumatic stress disorder: a sertraline- and placebo-controlled study". <i>Journal of Clinical Psychopharmacology</i> <b>26</b> (3): 259–67. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1097%2F01.jcp.0000222514.71390.c1" class="external text" title="http://dx.doi.org/10.1097%2F01.jcp.0000222514.71390.c1" rel="nofollow">10.1097/01.jcp.0000222514.71390.c1</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16702890" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16702890">PMID 16702890</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Venlafaxine+extended+release+in+posttraumatic+stress+disorder%3A+a+sertraline-+and+placebo-controlled+study&amp;rft.jtitle=Journal+of+Clinical+Psychopharmacology&amp;rft.aulast=Davidson+J%2C+Rothbaum+BO%2C+Tucker+P%2C+Asnis+G%2C+Benattia+I%2C+Musgnung+JJ&amp;rft.au=Davidson+J%2C+Rothbaum+BO%2C+Tucker+P%2C+Asnis+G%2C+Benattia+I%2C+Musgnung+JJ&amp;rft.date=2006&amp;rft.volume=26&amp;rft.issue=3&amp;rft.pages=259%E2%80%9367&amp;rft_id=info:doi/10.1097%2F01.jcp.0000222514.71390.c1&amp;rft_id=info:pmid/16702890&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid14608246-97"><b><a href="#cite_ref-pmid14608246_97-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFTucker_P.2C_Potter-Kimball_R.2C_Wyatt_DB.2C_Parker_DE.2C_Burgin_C.2C_Jones_DE.2C_Masters_BK2003">Tucker P, Potter-Kimball R, Wyatt DB, Parker DE, Burgin C, Jones DE, Masters BK (2003). "Can physiologic assessment and side effects tease out differences in PTSD trials? A double-blind comparison of citalopram, sertraline, and placebo". <i>Psychopharmacology Bulletin</i> <b>37</b> (3): 135–49. <a href="http://www.ncbi.nlm.nih.gov/pubmed/14608246" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/14608246">PMID 14608246</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Can+physiologic+assessment+and+side+effects+tease+out+differences+in+PTSD+trials%3F+A+double-blind+comparison+of+citalopram%2C+sertraline%2C+and+placebo&amp;rft.jtitle=Psychopharmacology+Bulletin&amp;rft.aulast=Tucker+P%2C+Potter-Kimball+R%2C+Wyatt+DB%2C+Parker+DE%2C+Burgin+C%2C+Jones+DE%2C+Masters+BK&amp;rft.au=Tucker+P%2C+Potter-Kimball+R%2C+Wyatt+DB%2C+Parker+DE%2C+Burgin+C%2C+Jones+DE%2C+Masters+BK&amp;rft.date=2003&amp;rft.volume=37&amp;rft.issue=3&amp;rft.pages=135%E2%80%9349&amp;rft_id=info:pmid/14608246&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid15129422-98"><b><a href="#cite_ref-pmid15129422_98-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFMcRae_AL.2C_Brady_KT.2C_Mellman_TA.2C_Sonne_SC.2C_Killeen_TK.2C_Timmerman_MA.2C_Bayles-Dazet_W2004">McRae AL, Brady KT, Mellman TA, Sonne SC, Killeen TK, Timmerman MA, Bayles-Dazet W (2004). "Comparison of nefazodone and sertraline for the treatment of posttraumatic stress disorder". <i>Depression and Anxiety</i> <b>19</b> (3): 190–6. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1002%2Fda.20008" class="external text" title="http://dx.doi.org/10.1002%2Fda.20008" rel="nofollow">10.1002/da.20008</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15129422" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15129422">PMID 15129422</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Comparison+of+nefazodone+and+sertraline+for+the+treatment+of+posttraumatic+stress+disorder&amp;rft.jtitle=Depression+and+Anxiety&amp;rft.aulast=McRae+AL%2C+Brady+KT%2C+Mellman+TA%2C+Sonne+SC%2C+Killeen+TK%2C+Timmerman+MA%2C+Bayles-Dazet+W&amp;rft.au=McRae+AL%2C+Brady+KT%2C+Mellman+TA%2C+Sonne+SC%2C+Killeen+TK%2C+Timmerman+MA%2C+Bayles-Dazet+W&amp;rft.date=2004&amp;rft.volume=19&amp;rft.issue=3&amp;rft.pages=190%E2%80%936&amp;rft_id=info:doi/10.1002%2Fda.20008&amp;rft_id=info:pmid/15129422&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid11910265-99"><b><a href="#cite_ref-pmid11910265_99-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFZohar_J.2C_Amital_D.2C_Miodownik_C.2C_Kotler_M.2C_Bleich_A.2C_Lane_RM.2C_Austin_C2002">Zohar J, Amital D, Miodownik C, Kotler M, Bleich A, Lane RM, Austin C (2002). "Double-blind placebo-controlled pilot study of sertraline in military veterans with posttraumatic stress disorder". <i>Journal of Clinical Psychopharmacology</i> <b>22</b> (2): 190–5. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1097%2F00004714-200204000-00013" class="external text" title="http://dx.doi.org/10.1097%2F00004714-200204000-00013" rel="nofollow">10.1097/00004714-200204000-00013</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11910265" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11910265">PMID 11910265</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Double-blind+placebo-controlled+pilot+study+of+sertraline+in+military+veterans+with+posttraumatic+stress+disorder&amp;rft.jtitle=Journal+of+Clinical+Psychopharmacology&amp;rft.aulast=Zohar+J%2C+Amital+D%2C+Miodownik+C%2C+Kotler+M%2C+Bleich+A%2C+Lane+RM%2C+Austin+C&amp;rft.au=Zohar+J%2C+Amital+D%2C+Miodownik+C%2C+Kotler+M%2C+Bleich+A%2C+Lane+RM%2C+Austin+C&amp;rft.date=2002&amp;rft.volume=22&amp;rft.issue=2&amp;rft.pages=190%E2%80%935&amp;rft_id=info:doi/10.1097%2F00004714-200204000-00013&amp;rft_id=info:pmid/11910265&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid17503980-100"><b><a href="#cite_ref-pmid17503980_100-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFFriedman_MJ.2C_Marmar_CR.2C_Baker_DG.2C_Sikes_CR.2C_Farfel_GM2007">Friedman MJ, Marmar CR, Baker DG, Sikes CR, Farfel GM (2007). "Randomized, double-blind comparison of sertraline and placebo for posttraumatic stress disorder in a Department of Veterans Affairs setting". <i>The Journal of Clinical Psychiatry</i> <b>68</b> (5): 711–20. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17503980" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17503980">PMID 17503980</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Randomized%2C+double-blind+comparison+of+sertraline+and+placebo+for+posttraumatic+stress+disorder+in+a+Department+of+Veterans+Affairs+setting&amp;rft.jtitle=The+Journal+of+Clinical+Psychiatry&amp;rft.aulast=Friedman+MJ%2C+Marmar+CR%2C+Baker+DG%2C+Sikes+CR%2C+Farfel+GM&amp;rft.au=Friedman+MJ%2C+Marmar+CR%2C+Baker+DG%2C+Sikes+CR%2C+Farfel+GM&amp;rft.date=2007&amp;rft.volume=68&amp;rft.issue=5&amp;rft.pages=711%E2%80%9320&amp;rft_id=info:pmid/17503980&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-101"><b><a href="#cite_ref-101" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFAllgulander_C.2C_Dahl_AA.2C_Austin_C.2C_Morris_PL.2C_Sogaard_JA.2C_Fayyad_R.2C_Kutcher_SP.2C_Clary_CM.2004">Allgulander C, Dahl AA, Austin C, Morris PL, Sogaard JA, Fayyad R, Kutcher SP, Clary CM. (2004). "Efficacy of sertraline in a 12-week trial for generalized anxiety disorder". <i>The American Journal of Psychiatry</i> <b>161</b>: 1642–1649. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1176%2Fappi.ajp.161.9.1642" class="external text" title="http://dx.doi.org/10.1176%2Fappi.ajp.161.9.1642" rel="nofollow">10.1176/appi.ajp.161.9.1642</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15337655" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15337655">PMID 15337655</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Efficacy+of+sertraline+in+a+12-week+trial+for+generalized+anxiety+disorder&amp;rft.jtitle=The+American+Journal+of+Psychiatry&amp;rft.aulast=Allgulander+C%2C+Dahl+AA%2C+Austin+C%2C+Morris+PL%2C+Sogaard+JA%2C+Fayyad+R%2C+Kutcher+SP%2C+Clary+CM.&amp;rft.au=Allgulander+C%2C+Dahl+AA%2C+Austin+C%2C+Morris+PL%2C+Sogaard+JA%2C+Fayyad+R%2C+Kutcher+SP%2C+Clary+CM.&amp;rft.date=2004&amp;rft.volume=161&amp;rft.pages=1642%E2%80%931649&amp;rft_id=info:doi/10.1176%2Fappi.ajp.161.9.1642&amp;rft_id=info:pmid/15337655&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid16848646-102"><b><a href="#cite_ref-pmid16848646_102-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFBrawman-Mintzer_O.2C_Knapp_RG.2C_Rynn_M.2C_Carter_RE.2C_Rickels_K2006">Brawman-Mintzer O, Knapp RG, Rynn M, Carter RE, Rickels K (2006). "Sertraline treatment for generalized anxiety disorder: a randomized, double-blind, placebo-controlled study". <i>J Clin Psychiatry</i> <b>67</b> (6): 874–81. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16848646" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16848646">PMID 16848646</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Sertraline+treatment+for+generalized+anxiety+disorder%3A+a+randomized%2C+double-blind%2C+placebo-controlled+study&amp;rft.jtitle=J+Clin+Psychiatry&amp;rft.aulast=Brawman-Mintzer+O%2C+Knapp+RG%2C+Rynn+M%2C+Carter+RE%2C+Rickels+K&amp;rft.au=Brawman-Mintzer+O%2C+Knapp+RG%2C+Rynn+M%2C+Carter+RE%2C+Rickels+K&amp;rft.date=2006&amp;rft.volume=67&amp;rft.issue=6&amp;rft.pages=874%E2%80%9381&amp;rft_id=info:pmid/16848646&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-103"><b><a href="#cite_ref-103" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFMcElroy_SL.2C_Casuto_LS.2C_Nelson_EB.2C_Lake_KA.2C_Soutullo_CA.2C_Keck_PE_Jr.2C_Hudson_JI.2000">McElroy SL, Casuto LS, Nelson EB, Lake KA, Soutullo CA, Keck PE Jr, Hudson JI. (2000). "Placebo-controlled trial of sertraline in the treatment of binge eating disorder". <i>The American Journal of Psychiatry</i> <b>157</b> (6): 1004–1006. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1176%2Fappi.ajp.157.6.1004" class="external text" title="http://dx.doi.org/10.1176%2Fappi.ajp.157.6.1004" rel="nofollow">10.1176/appi.ajp.157.6.1004</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/10831483" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/10831483">PMID 10831483</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Placebo-controlled+trial+of+sertraline+in+the+treatment+of+binge+eating+disorder&amp;rft.jtitle=The+American+Journal+of+Psychiatry&amp;rft.aulast=McElroy+SL%2C+Casuto+LS%2C+Nelson+EB%2C+Lake+KA%2C+Soutullo+CA%2C+Keck+PE+Jr%2C+Hudson+JI.&amp;rft.au=McElroy+SL%2C+Casuto+LS%2C+Nelson+EB%2C+Lake+KA%2C+Soutullo+CA%2C+Keck+PE+Jr%2C+Hudson+JI.&amp;rft.date=2000&amp;rft.volume=157&amp;rft.issue=6&amp;rft.pages=1004%E2%80%931006&amp;rft_id=info:doi/10.1176%2Fappi.ajp.157.6.1004&amp;rft_id=info:pmid/10831483&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid18598735-104"><b><a href="#cite_ref-pmid18598735_104-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFLeombruni_P.2C_Pier.C3.B2_A.2C_Lavagnino_L.2C_Brustolin_A.2C_Campisi_S.2C_Fassino_S2008">Leombruni P, Pierò A, Lavagnino L, Brustolin A, Campisi S, Fassino S (June 2008). "A randomized, double-blind trial comparing sertraline and fluoxetine 6-month treatment in obese patients with Binge Eating Disorder". <i>Prog. Neuropsychopharmacol. Biol. Psychiatry</i>. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2Fj.pnpbp.2008.06.005" class="external text" title="http://dx.doi.org/10.1016%2Fj.pnpbp.2008.06.005" rel="nofollow">10.1016/j.pnpbp.2008.06.005</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18598735" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/18598735">PMID 18598735</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=A+randomized%2C+double-blind+trial+comparing+sertraline+and+fluoxetine+6-month+treatment+in+obese+patients+with+Binge+Eating+Disorder&amp;rft.jtitle=Prog.+Neuropsychopharmacol.+Biol.+Psychiatry&amp;rft.aulast=Leombruni+P%2C+Pier%C3%B2+A%2C+Lavagnino+L%2C+Brustolin+A%2C+Campisi+S%2C+Fassino+S&amp;rft.au=Leombruni+P%2C+Pier%C3%B2+A%2C+Lavagnino+L%2C+Brustolin+A%2C+Campisi+S%2C+Fassino+S&amp;rft.date=June+2008&amp;rft_id=info:doi/10.1016%2Fj.pnpbp.2008.06.005&amp;rft_id=info:pmid/18598735&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid16648332-105"><b><a href="#cite_ref-pmid16648332_105-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFO.27Reardon_JP.2C_Allison_KC.2C_Martino_NS.2C_Lundgren_JD.2C_Heo_M.2C_Stunkard_AJ2006">O'Reardon JP, Allison KC, Martino NS, Lundgren JD, Heo M, Stunkard AJ (2006). "A randomized, placebo-controlled trial of sertraline in the treatment of night eating syndrome". <i>Am J Psychiatry</i> <b>163</b> (5): 893–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1176%2Fappi.ajp.163.5.893" class="external text" title="http://dx.doi.org/10.1176%2Fappi.ajp.163.5.893" rel="nofollow">10.1176/appi.ajp.163.5.893</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16648332" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16648332">PMID 16648332</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=A+randomized%2C+placebo-controlled+trial+of+sertraline+in+the+treatment+of+night+eating+syndrome&amp;rft.jtitle=Am+J+Psychiatry&amp;rft.aulast=O%27Reardon+JP%2C+Allison+KC%2C+Martino+NS%2C+Lundgren+JD%2C+Heo+M%2C+Stunkard+AJ&amp;rft.au=O%27Reardon+JP%2C+Allison+KC%2C+Martino+NS%2C+Lundgren+JD%2C+Heo+M%2C+Stunkard+AJ&amp;rft.date=2006&amp;rft.volume=163&amp;rft.issue=5&amp;rft.pages=893%E2%80%938&amp;rft_id=info:doi/10.1176%2Fappi.ajp.163.5.893&amp;rft_id=info:pmid/16648332&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid15605617-106"><b><a href="#cite_ref-pmid15605617_106-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFMilano_W.2C_Petrella_C.2C_Sabatino_C.2C_Capasso_A2004">Milano W, Petrella C, Sabatino C, Capasso A (2004). "Treatment of bulimia nervosa with sertraline: a randomized controlled trial". <i>Adv Ther</i> <b>21</b> (4): 232–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1007%2FBF02850155" class="external text" title="http://dx.doi.org/10.1007%2FBF02850155" rel="nofollow">10.1007/BF02850155</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15605617" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15605617">PMID 15605617</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Treatment+of+bulimia+nervosa+with+sertraline%3A+a+randomized+controlled+trial&amp;rft.jtitle=Adv+Ther&amp;rft.aulast=Milano+W%2C+Petrella+C%2C+Sabatino+C%2C+Capasso+A&amp;rft.au=Milano+W%2C+Petrella+C%2C+Sabatino+C%2C+Capasso+A&amp;rft.date=2004&amp;rft.volume=21&amp;rft.issue=4&amp;rft.pages=232%E2%80%937&amp;rft_id=info:doi/10.1007%2FBF02850155&amp;rft_id=info:pmid/15605617&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-107"><b><a href="#cite_ref-107" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFMcMahon_CG.1998">McMahon CG. (1998). "Treatment of premature ejaculation with sertraline hydrochloride: a single-blind placebo controlled crossover study". <i>The Journal of Urology</i> <b>159</b> (6): 1935–1938. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2FS0022-5347%2801%2963201-4" class="external text" title="http://dx.doi.org/10.1016%2FS0022-5347%2801%2963201-4" rel="nofollow">10.1016/S0022-5347(01)63201-4</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/9598491" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/9598491">PMID 9598491</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Treatment+of+premature+ejaculation+with+sertraline+hydrochloride%3A+a+single-blind+placebo+controlled+crossover+study&amp;rft.jtitle=The+Journal+of+Urology&amp;rft.aulast=McMahon+CG.&amp;rft.au=McMahon+CG.&amp;rft.date=1998&amp;rft.volume=159&amp;rft.issue=6&amp;rft.pages=1935%E2%80%931938&amp;rft_id=info:doi/10.1016%2FS0022-5347%2801%2963201-4&amp;rft_id=info:pmid/9598491&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid9690692-108"><b><a href="#cite_ref-pmid9690692_108-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFWaldinger_MD.2C_Hengeveld_MW.2C_Zwinderman_AH.2C_Olivier_B1998">Waldinger MD, Hengeveld MW, Zwinderman AH, Olivier B (1998). "Effect of SSRI antidepressants on ejaculation: a double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline". <i>J Clin Psychopharmacol</i> <b>18</b> (4): 274–81. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1097%2F00004714-199808000-00004" class="external text" title="http://dx.doi.org/10.1097%2F00004714-199808000-00004" rel="nofollow">10.1097/00004714-199808000-00004</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/9690692" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/9690692">PMID 9690692</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Effect+of+SSRI+antidepressants+on+ejaculation%3A+a+double-blind%2C+randomized%2C+placebo-controlled+study+with+fluoxetine%2C+fluvoxamine%2C+paroxetine%2C+and+sertraline&amp;rft.jtitle=J+Clin+Psychopharmacol&amp;rft.aulast=Waldinger+MD%2C+Hengeveld+MW%2C+Zwinderman+AH%2C+Olivier+B&amp;rft.au=Waldinger+MD%2C+Hengeveld+MW%2C+Zwinderman+AH%2C+Olivier+B&amp;rft.date=1998&amp;rft.volume=18&amp;rft.issue=4&amp;rft.pages=274%E2%80%9381&amp;rft_id=info:doi/10.1097%2F00004714-199808000-00004&amp;rft_id=info:pmid/9690692&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid17983899-109"><b><a href="#cite_ref-pmid17983899_109-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFWaldinger_MD2007">Waldinger MD (2007). "Premature ejaculation: state of the art". <i>Urol. Clin. North Am.</i> <b>34</b> (4): 591–9, vii–viii. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2Fj.ucl.2007.08.011" class="external text" title="http://dx.doi.org/10.1016%2Fj.ucl.2007.08.011" rel="nofollow">10.1016/j.ucl.2007.08.011</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17983899" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17983899">PMID 17983899</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Premature+ejaculation%3A+state+of+the+art&amp;rft.jtitle=Urol.+Clin.+North+Am.&amp;rft.aulast=Waldinger+MD&amp;rft.au=Waldinger+MD&amp;rft.date=2007&amp;rft.volume=34&amp;rft.issue=4&amp;rft.pages=591%E2%80%939%2C+vii%E2%80%93viii&amp;rft_id=info:doi/10.1016%2Fj.ucl.2007.08.011&amp;rft_id=info:pmid/17983899&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid15363569-110"><b><a href="#cite_ref-pmid15363569_110-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFWaldinger_MD.2C_Zwinderman_AH.2C_Olivier_B2004">Waldinger MD, Zwinderman AH, Olivier B (2004). "On-demand treatment of premature ejaculation with clomipramine and paroxetine: a randomized, double-blind fixed-dose study with stopwatch assessment". <i>Eur. Urol.</i> <b>46</b> (4): 510–5; discussion 516. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2Fj.eururo.2004.05.005" class="external text" title="http://dx.doi.org/10.1016%2Fj.eururo.2004.05.005" rel="nofollow">10.1016/j.eururo.2004.05.005</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15363569" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15363569">PMID 15363569</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=On-demand+treatment+of+premature+ejaculation+with+clomipramine+and+paroxetine%3A+a+randomized%2C+double-blind+fixed-dose+study+with+stopwatch+assessment&amp;rft.jtitle=Eur.+Urol.&amp;rft.aulast=Waldinger+MD%2C+Zwinderman+AH%2C+Olivier+B&amp;rft.au=Waldinger+MD%2C+Zwinderman+AH%2C+Olivier+B&amp;rft.date=2004&amp;rft.volume=46&amp;rft.issue=4&amp;rft.pages=510%E2%80%935%3B+discussion+516&amp;rft_id=info:doi/10.1016%2Fj.eururo.2004.05.005&amp;rft_id=info:pmid/15363569&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid11313839-111">^ <a href="#cite_ref-pmid11313839_111-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid11313839_111-1" title=""><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid11313839_111-2" title=""><sup><i><b>c</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFAbdel-Hamid_IA.2C_El_Naggar_EA.2C_El_Gilany_AH2001">Abdel-Hamid IA, El Naggar EA, El Gilany AH (2001). "Assessment of as needed use of pharmacotherapy and the pause-squeeze technique in premature ejaculation". <i>Int. J. Impot. Res.</i> <b>13</b> (1): 41–5. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1038%2Fsj.ijir.3900630" class="external text" title="http://dx.doi.org/10.1038%2Fsj.ijir.3900630" rel="nofollow">10.1038/sj.ijir.3900630</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11313839" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11313839">PMID 11313839</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Assessment+of+as+needed+use+of+pharmacotherapy+and+the+pause-squeeze+technique+in+premature+ejaculation&amp;rft.jtitle=Int.+J.+Impot.+Res.&amp;rft.aulast=Abdel-Hamid+IA%2C+El+Naggar+EA%2C+El+Gilany+AH&amp;rft.au=Abdel-Hamid+IA%2C+El+Naggar+EA%2C+El+Gilany+AH&amp;rft.date=2001&amp;rft.volume=13&amp;rft.issue=1&amp;rft.pages=41%E2%80%935&amp;rft_id=info:doi/10.1038%2Fsj.ijir.3900630&amp;rft_id=info:pmid/11313839&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid17470165-112">^ <a href="#cite_ref-pmid17470165_112-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid17470165_112-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFWang_WF.2C_Wang_Y.2C_Minhas_S.2C_Ralph_DJ2007">Wang WF, Wang Y, Minhas S, Ralph DJ (2007). "Can sildenafil treat primary premature ejaculation? A prospective clinical study". <i>Int. J. Urol.</i> <b>14</b> (4): 331–5. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1111%2Fj.1442-2042.2007.01606.x" class="external text" title="http://dx.doi.org/10.1111%2Fj.1442-2042.2007.01606.x" rel="nofollow">10.1111/j.1442-2042.2007.01606.x</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17470165" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17470165">PMID 17470165</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Can+sildenafil+treat+primary+premature+ejaculation%3F+A+prospective+clinical+study&amp;rft.jtitle=Int.+J.+Urol.&amp;rft.aulast=Wang+WF%2C+Wang+Y%2C+Minhas+S%2C+Ralph+DJ&amp;rft.au=Wang+WF%2C+Wang+Y%2C+Minhas+S%2C+Ralph+DJ&amp;rft.date=2007&amp;rft.volume=14&amp;rft.issue=4&amp;rft.pages=331%E2%80%935&amp;rft_id=info:doi/10.1111%2Fj.1442-2042.2007.01606.x&amp;rft_id=info:pmid/17470165&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-113"><b><a href="#cite_ref-113" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFGrubb_BP.2C_Samoil_D.2C_Kosinski_D.2C_Kip_K.2C_Brewster_P.1994">Grubb BP, Samoil D, Kosinski D, Kip K, Brewster P. (1994). "Use of sertraline hydrochloride in the treatment of refractory neurocardiogenic syncope in children and adolescents". <i>Journal of the American College of Cardiology</i> <b>24</b> (2): 490–494. <a href="http://www.ncbi.nlm.nih.gov/pubmed/8034887" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/8034887">PMID 8034887</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Use+of+sertraline+hydrochloride+in+the+treatment+of+refractory+neurocardiogenic+syncope+in+children+and+adolescents&amp;rft.jtitle=Journal+of+the+American+College+of+Cardiology&amp;rft.aulast=Grubb+BP%2C+Samoil+D%2C+Kosinski+D%2C+Kip+K%2C+Brewster+P.&amp;rft.au=Grubb+BP%2C+Samoil+D%2C+Kosinski+D%2C+Kip+K%2C+Brewster+P.&amp;rft.date=1994&amp;rft.volume=24&amp;rft.issue=2&amp;rft.pages=490%E2%80%93494&amp;rft_id=info:pmid/8034887&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid9433163-114"><b><a href="#cite_ref-pmid9433163_114-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFLenk_MK.2C_Alehan_D.2C_Ozme_S.2C_Celiker_A.2C_Ozer_S1997">Lenk MK, Alehan D, Ozme S, Celiker A, Ozer S (1997). "Vasovagal syncope: asystole provoked by head-up tilt testing under sertraline therapy". <i>Turk. J. Pediatr.</i> <b>39</b> (4): 573–7. <a href="http://www.ncbi.nlm.nih.gov/pubmed/9433163" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/9433163">PMID 9433163</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Vasovagal+syncope%3A+asystole+provoked+by+head-up+tilt+testing+under+sertraline+therapy&amp;rft.jtitle=Turk.+J.+Pediatr.&amp;rft.aulast=Lenk+MK%2C+Alehan+D%2C+Ozme+S%2C+Celiker+A%2C+Ozer+S&amp;rft.au=Lenk+MK%2C+Alehan+D%2C+Ozme+S%2C+Celiker+A%2C+Ozer+S&amp;rft.date=1997&amp;rft.volume=39&amp;rft.issue=4&amp;rft.pages=573%E2%80%937&amp;rft_id=info:pmid/9433163&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid9365060-115"><b><a href="#cite_ref-pmid9365060_115-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFLenk_M.2C_Alehan_D.2C_Ozme_S.2C_Celiker_A.2C_Ozer_S1997">Lenk M, Alehan D, Ozme S, Celiker A, Ozer S (1997). "The role of serotonin re-uptake inhibitors in preventing recurrent unexplained childhood syncope -- a preliminary report". <i>Eur. J. Pediatr.</i> <b>156</b> (10): 747–50. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1007%2Fs004310050704" class="external text" title="http://dx.doi.org/10.1007%2Fs004310050704" rel="nofollow">10.1007/s004310050704</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/9365060" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/9365060">PMID 9365060</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+role+of+serotonin+re-uptake+inhibitors+in+preventing+recurrent+unexplained+childhood+syncope+--+a+preliminary+report&amp;rft.jtitle=Eur.+J.+Pediatr.&amp;rft.aulast=Lenk+M%2C+Alehan+D%2C+Ozme+S%2C+Celiker+A%2C+Ozer+S&amp;rft.au=Lenk+M%2C+Alehan+D%2C+Ozme+S%2C+Celiker+A%2C+Ozer+S&amp;rft.date=1997&amp;rft.volume=156&amp;rft.issue=10&amp;rft.pages=747%E2%80%9350&amp;rft_id=info:doi/10.1007%2Fs004310050704&amp;rft_id=info:pmid/9365060&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid9113018-116"><b><a href="#cite_ref-pmid9113018_116-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFTandan_T.2C_Giuffre_M.2C_Sheldon_R1997">Tandan T, Giuffre M, Sheldon R (1997). "Exacerbations of neurally mediated syncope associated with sertraline". <i>Lancet</i> <b>349</b> (9059): 1145–6. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2FS0140-6736%2805%2963021-8" class="external text" title="http://dx.doi.org/10.1016%2FS0140-6736%2805%2963021-8" rel="nofollow">10.1016/S0140-6736(05)63021-8</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/9113018" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/9113018">PMID 9113018</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Exacerbations+of+neurally+mediated+syncope+associated+with+sertraline&amp;rft.jtitle=Lancet&amp;rft.aulast=Tandan+T%2C+Giuffre+M%2C+Sheldon+R&amp;rft.au=Tandan+T%2C+Giuffre+M%2C+Sheldon+R&amp;rft.date=1997&amp;rft.volume=349&amp;rft.issue=9059&amp;rft.pages=1145%E2%80%936&amp;rft_id=info:doi/10.1016%2FS0140-6736%2805%2963021-8&amp;rft_id=info:pmid/9113018&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-zoloftpi-117">^ <a href="#cite_ref-zoloftpi_117-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-zoloftpi_117-1" title=""><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-zoloftpi_117-2" title=""><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-zoloftpi_117-3" title=""><sup><i><b>d</b></i></sup></a> <cite style="font-style:normal" class="web"><a href="http://www.zoloft.com" class="external text" title="http://www.zoloft.com" rel="nofollow">"Zoloft Prescribing Information for the U.S."</a> (PDF). Pfizer<span class="printonly">. <a href="http://www.zoloft.com" class="external free" title="http://www.zoloft.com" rel="nofollow">http://www.zoloft.com</a></span><span class="reference-accessdate">. Retrieved on 2008-04-26</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Zoloft+Prescribing+Information+for+the+U.S.&amp;rft.atitle=&amp;rft.pub=Pfizer&amp;rft_id=http%3A%2F%2Fwww.zoloft.com&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid17100977-118"><b><a href="#cite_ref-pmid17100977_118-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFFern.C3.A1ndez-Ba.C3.B1ares_F.2C_Esteve_M.2C_Espin.C3.B3s_JC.2C_Rosinach_M.2C_Forn.C3.A9_M.2C_Salas_A.2C_Viver_JM2007">Fernández-Bañares F, Esteve M, Espinós JC, Rosinach M, Forné M, Salas A, Viver JM (2007). "Drug consumption and the risk of microscopic colitis". <i>Am. J. Gastroenterol.</i> <b>102</b> (2): 324–30. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1111%2Fj.1572-0241.2006.00902.x" class="external text" title="http://dx.doi.org/10.1111%2Fj.1572-0241.2006.00902.x" rel="nofollow">10.1111/j.1572-0241.2006.00902.x</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17100977" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17100977">PMID 17100977</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Drug+consumption+and+the+risk+of+microscopic+colitis&amp;rft.jtitle=Am.+J.+Gastroenterol.&amp;rft.aulast=Fern%C3%A1ndez-Ba%C3%B1ares+F%2C+Esteve+M%2C+Espin%C3%B3s+JC%2C+Rosinach+M%2C+Forn%C3%A9+M%2C+Salas+A%2C+Viver+JM&amp;rft.au=Fern%C3%A1ndez-Ba%C3%B1ares+F%2C+Esteve+M%2C+Espin%C3%B3s+JC%2C+Rosinach+M%2C+Forn%C3%A9+M%2C+Salas+A%2C+Viver+JM&amp;rft.date=2007&amp;rft.volume=102&amp;rft.issue=2&amp;rft.pages=324%E2%80%9330&amp;rft_id=info:doi/10.1111%2Fj.1572-0241.2006.00902.x&amp;rft_id=info:pmid/17100977&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid9018398-119"><b><a href="#cite_ref-pmid9018398_119-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFOlivera_AO1997">Olivera AO (1997). "Sertraline and akathisia: spontaneous resolution". <i>Biol. Psychiatry</i> <b>41</b> (2): 241–2. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2FS0006-3223%2896%2900384-8" class="external text" title="http://dx.doi.org/10.1016%2FS0006-3223%2896%2900384-8" rel="nofollow">10.1016/S0006-3223(96)00384-8</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/9018398" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/9018398">PMID 9018398</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Sertraline+and+akathisia%3A+spontaneous+resolution&amp;rft.jtitle=Biol.+Psychiatry&amp;rft.aulast=Olivera+AO&amp;rft.au=Olivera+AO&amp;rft.date=1997&amp;rft.volume=41&amp;rft.issue=2&amp;rft.pages=241%E2%80%932&amp;rft_id=info:doi/10.1016%2FS0006-3223%2896%2900384-8&amp;rft_id=info:pmid/9018398&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid8909330-120"><b><a href="#cite_ref-pmid8909330_120-0" title="">^</a></b> Review:<cite style="font-style:normal" class="" id="CITEREFLeo_RJ1996">Leo RJ (1996). "Movement disorders associated with the serotonin selective reuptake inhibitors". <i>The Journal of Clinical Psychiatry</i> <b>57</b> (10): 449–54. <a href="http://www.ncbi.nlm.nih.gov/pubmed/8909330" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/8909330">PMID 8909330</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Movement+disorders+associated+with+the+serotonin+selective+reuptake+inhibitors&amp;rft.jtitle=The+Journal+of+Clinical+Psychiatry&amp;rft.aulast=Leo+RJ&amp;rft.au=Leo+RJ&amp;rft.date=1996&amp;rft.volume=57&amp;rft.issue=10&amp;rft.pages=449%E2%80%9354&amp;rft_id=info:pmid/8909330&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid9378692-121"><b><a href="#cite_ref-pmid9378692_121-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFLauterbach_EC.2C_Meyer_JM.2C_Simpson_GM1997">Lauterbach EC, Meyer JM, Simpson GM (1997). "Clinical manifestations of dystonia and dyskinesia after SSRI administration". <i>The Journal of Clinical Psychiatry</i> <b>58</b> (9): 403–4. <a href="http://www.ncbi.nlm.nih.gov/pubmed/9378692" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/9378692">PMID 9378692</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Clinical+manifestations+of+dystonia+and+dyskinesia+after+SSRI+administration&amp;rft.jtitle=The+Journal+of+Clinical+Psychiatry&amp;rft.aulast=Lauterbach+EC%2C+Meyer+JM%2C+Simpson+GM&amp;rft.au=Lauterbach+EC%2C+Meyer+JM%2C+Simpson+GM&amp;rft.date=1997&amp;rft.volume=58&amp;rft.issue=9&amp;rft.pages=403%E2%80%934&amp;rft_id=info:pmid/9378692&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid12407283-122">^ <a href="#cite_ref-pmid12407283_122-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid12407283_122-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFWalker_L2002">Walker L (2002). "Sertraline-induced akathisia and dystonia misinterpreted as a panic attack". <i>Psychiatric Services (Washington, D.C.)</i> <b>53</b> (11): 1477–8. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12407283" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12407283">PMID 12407283</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Sertraline-induced+akathisia+and+dystonia+misinterpreted+as+a+panic+attack&amp;rft.jtitle=Psychiatric+Services+%28Washington%2C+D.C.%29&amp;rft.aulast=Walker+L&amp;rft.au=Walker+L&amp;rft.date=2002&amp;rft.volume=53&amp;rft.issue=11&amp;rft.pages=1477%E2%80%938&amp;rft_id=info:pmid/12407283&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid12404546-123"><b><a href="#cite_ref-pmid12404546_123-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFHansen_L2001">Hansen L (October 2001). "A critical review of akathisia, and its possible association with suicidal behaviour". <i>Hum Psychopharmacol</i> <b>16</b> (7): 495–505. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1002%2Fhup.325" class="external text" title="http://dx.doi.org/10.1002%2Fhup.325" rel="nofollow">10.1002/hup.325</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12404546" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12404546">PMID 12404546</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=A+critical+review+of+akathisia%2C+and+its+possible+association+with+suicidal+behaviour&amp;rft.jtitle=Hum+Psychopharmacol&amp;rft.aulast=Hansen+L&amp;rft.au=Hansen+L&amp;rft.date=October+2001&amp;rft.volume=16&amp;rft.issue=7&amp;rft.pages=495%E2%80%93505&amp;rft_id=info:doi/10.1002%2Fhup.325&amp;rft_id=info:pmid/12404546&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid16449715-124"><b><a href="#cite_ref-pmid16449715_124-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFHansen_L.2C_Kingdom_D2006">Hansen L, Kingdom D (2006). "Akathisia as a risk factor for suicide". <i>The <a href="/wiki/British_Journal_of_Psychiatry" title="British Journal of Psychiatry">British Journal of Psychiatry</a>&#160;: the journal of mental science</i> <b>188</b>: 192. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1192%2Fbjp.188.2.192" class="external text" title="http://dx.doi.org/10.1192%2Fbjp.188.2.192" rel="nofollow">10.1192/bjp.188.2.192</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16449715" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16449715">PMID 16449715</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Akathisia+as+a+risk+factor+for+suicide&amp;rft.jtitle=The+%5B%5BBritish+Journal+of+Psychiatry%5D%5D+%3A+the+journal+of+mental+science&amp;rft.aulast=Hansen+L%2C+Kingdom+D&amp;rft.au=Hansen+L%2C+Kingdom+D&amp;rft.date=2006&amp;rft.volume=188&amp;rft.pages=192&amp;rft_id=info:doi/10.1192%2Fbjp.188.2.192&amp;rft_id=info:pmid/16449715&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid11105740-125"><b><a href="#cite_ref-pmid11105740_125-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFFava_M.2C_Judge_R.2C_Hoog_SL.2C_Nilsson_ME.2C_Koke_SC2000">Fava M, Judge R, Hoog SL, Nilsson ME, Koke SC (2000). "Fluoxetine versus sertraline and paroxetine in major depressive disorder: changes in weight with long-term treatment". <i>The Journal of Clinical Psychiatry</i> <b>61</b> (11): 863–7. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11105740" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11105740">PMID 11105740</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Fluoxetine+versus+sertraline+and+paroxetine+in+major+depressive+disorder%3A+changes+in+weight+with+long-term+treatment&amp;rft.jtitle=The+Journal+of+Clinical+Psychiatry&amp;rft.aulast=Fava+M%2C+Judge+R%2C+Hoog+SL%2C+Nilsson+ME%2C+Koke+SC&amp;rft.au=Fava+M%2C+Judge+R%2C+Hoog+SL%2C+Nilsson+ME%2C+Koke+SC&amp;rft.date=2000&amp;rft.volume=61&amp;rft.issue=11&amp;rft.pages=863%E2%80%937&amp;rft_id=info:pmid/11105740&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid15491240-126">^ <a href="#cite_ref-pmid15491240_126-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid15491240_126-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFMaina_G.2C_Albert_U.2C_Salvi_V.2C_Bogetto_F2004">Maina G, Albert U, Salvi V, Bogetto F (2004). "Weight gain during long-term treatment of obsessive-compulsive disorder: a prospective comparison between serotonin reuptake inhibitors". <i>The Journal of Clinical Psychiatry</i> <b>65</b> (10): 1365–71. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15491240" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15491240">PMID 15491240</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Weight+gain+during+long-term+treatment+of+obsessive-compulsive+disorder%3A+a+prospective+comparison+between+serotonin+reuptake+inhibitors&amp;rft.jtitle=The+Journal+of+Clinical+Psychiatry&amp;rft.aulast=Maina+G%2C+Albert+U%2C+Salvi+V%2C+Bogetto+F&amp;rft.au=Maina+G%2C+Albert+U%2C+Salvi+V%2C+Bogetto+F&amp;rft.date=2004&amp;rft.volume=65&amp;rft.issue=10&amp;rft.pages=1365%E2%80%9371&amp;rft_id=info:pmid/15491240&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid11565624-127"><b><a href="#cite_ref-pmid11565624_127-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFSchmitt_JA.2C_Kruizinga_MJ.2C_Riedel_WJ2001">Schmitt JA, Kruizinga MJ, Riedel WJ (2001). "Non-serotonergic pharmacological profiles and associated cognitive effects of serotonin reuptake inhibitors". <i>J. Psychopharmacol. (Oxford)</i> <b>15</b> (3): 173–9. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11565624" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11565624">PMID 11565624</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Non-serotonergic+pharmacological+profiles+and+associated+cognitive+effects+of+serotonin+reuptake+inhibitors&amp;rft.jtitle=J.+Psychopharmacol.+%28Oxford%29&amp;rft.aulast=Schmitt+JA%2C+Kruizinga+MJ%2C+Riedel+WJ&amp;rft.au=Schmitt+JA%2C+Kruizinga+MJ%2C+Riedel+WJ&amp;rft.date=2001&amp;rft.volume=15&amp;rft.issue=3&amp;rft.pages=173%E2%80%939&amp;rft_id=info:pmid/11565624&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid12692706-128"><b><a href="#cite_ref-pmid12692706_128-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFSiepmann_M.2C_Grossmann_J.2C_M.C3.BCck-Weymann_M.2C_Kirch_W2003">Siepmann M, Grossmann J, Mück-Weymann M, Kirch W (2003). "Effects of sertraline on autonomic and cognitive functions in healthy volunteers". <i>Psychopharmacology (Berl.)</i> <b>168</b> (3): 293–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1007%2Fs00213-003-1448-4" class="external text" title="http://dx.doi.org/10.1007%2Fs00213-003-1448-4" rel="nofollow">10.1007/s00213-003-1448-4</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12692706" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12692706">PMID 12692706</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Effects+of+sertraline+on+autonomic+and+cognitive+functions+in+healthy+volunteers&amp;rft.jtitle=Psychopharmacology+%28Berl.%29&amp;rft.aulast=Siepmann+M%2C+Grossmann+J%2C+M%C3%BCck-Weymann+M%2C+Kirch+W&amp;rft.au=Siepmann+M%2C+Grossmann+J%2C+M%C3%BCck-Weymann+M%2C+Kirch+W&amp;rft.date=2003&amp;rft.volume=168&amp;rft.issue=3&amp;rft.pages=293%E2%80%938&amp;rft_id=info:doi/10.1007%2Fs00213-003-1448-4&amp;rft_id=info:pmid/12692706&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid16485140-129"><b><a href="#cite_ref-pmid16485140_129-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFGorenstein_C.2C_de_Carvalho_SC.2C_Artes_R.2C_Moreno_RA.2C_Marcourakis_T2006">Gorenstein C, de Carvalho SC, Artes R, Moreno RA, Marcourakis T (2006). "Cognitive performance in depressed patients after chronic use of antidepressants". <i>Psychopharmacology (Berl.)</i> <b>185</b> (1): 84–92. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1007%2Fs00213-005-0274-2" class="external text" title="http://dx.doi.org/10.1007%2Fs00213-005-0274-2" rel="nofollow">10.1007/s00213-005-0274-2</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16485140" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16485140">PMID 16485140</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Cognitive+performance+in+depressed+patients+after+chronic+use+of+antidepressants&amp;rft.jtitle=Psychopharmacology+%28Berl.%29&amp;rft.aulast=Gorenstein+C%2C+de+Carvalho+SC%2C+Artes+R%2C+Moreno+RA%2C+Marcourakis+T&amp;rft.au=Gorenstein+C%2C+de+Carvalho+SC%2C+Artes+R%2C+Moreno+RA%2C+Marcourakis+T&amp;rft.date=2006&amp;rft.volume=185&amp;rft.issue=1&amp;rft.pages=84%E2%80%9392&amp;rft_id=info:doi/10.1007%2Fs00213-005-0274-2&amp;rft_id=info:pmid/16485140&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid16190792-130"><b><a href="#cite_ref-pmid16190792_130-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFG.C3.BCnther_T.2C_Holtkamp_K.2C_Jolles_J.2C_Herpertz-Dahlmann_B.2C_Konrad_K2005">Günther T, Holtkamp K, Jolles J, Herpertz-Dahlmann B, Konrad K (2005). "The influence of sertraline on attention and verbal memory in children and adolescents with anxiety disorders". <i>J Child Adolesc Psychopharmacol</i> <b>15</b> (4): 608–18. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1089%2Fcap.2005.15.608" class="external text" title="http://dx.doi.org/10.1089%2Fcap.2005.15.608" rel="nofollow">10.1089/cap.2005.15.608</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16190792" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16190792">PMID 16190792</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+influence+of+sertraline+on+attention+and+verbal+memory+in+children+and+adolescents+with+anxiety+disorders&amp;rft.jtitle=J+Child+Adolesc+Psychopharmacol&amp;rft.aulast=G%C3%BCnther+T%2C+Holtkamp+K%2C+Jolles+J%2C+Herpertz-Dahlmann+B%2C+Konrad+K&amp;rft.au=G%C3%BCnther+T%2C+Holtkamp+K%2C+Jolles+J%2C+Herpertz-Dahlmann+B%2C+Konrad+K&amp;rft.date=2005&amp;rft.volume=15&amp;rft.issue=4&amp;rft.pages=608%E2%80%9318&amp;rft_id=info:doi/10.1089%2Fcap.2005.15.608&amp;rft_id=info:pmid/16190792&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid11082480-131"><b><a href="#cite_ref-pmid11082480_131-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFHostetter_A.2C_Ritchie_JC.2C_Stowe_ZN2000">Hostetter A, Ritchie JC, Stowe ZN (2000). "Amniotic fluid and umbilical cord blood concentrations of antidepressants in three women". <i>Biol. Psychiatry</i> <b>48</b> (10): 1032–4. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2FS0006-3223%2800%2900958-6" class="external text" title="http://dx.doi.org/10.1016%2FS0006-3223%2800%2900958-6" rel="nofollow">10.1016/S0006-3223(00)00958-6</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11082480" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11082480">PMID 11082480</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Amniotic+fluid+and+umbilical+cord+blood+concentrations+of+antidepressants+in+three+women&amp;rft.jtitle=Biol.+Psychiatry&amp;rft.aulast=Hostetter+A%2C+Ritchie+JC%2C+Stowe+ZN&amp;rft.au=Hostetter+A%2C+Ritchie+JC%2C+Stowe+ZN&amp;rft.date=2000&amp;rft.volume=48&amp;rft.issue=10&amp;rft.pages=1032%E2%80%934&amp;rft_id=info:doi/10.1016%2FS0006-3223%2800%2900958-6&amp;rft_id=info:pmid/11082480&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid12727706-132"><b><a href="#cite_ref-pmid12727706_132-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFHendrick_V.2C_Stowe_ZN.2C_Altshuler_LL.2C_Hwang_S.2C_Lee_E.2C_Haynes_D2003">Hendrick V, Stowe ZN, Altshuler LL, Hwang S, Lee E, Haynes D (2003). "Placental passage of antidepressant medications". <i>The American Journal of Psychiatry</i> <b>160</b> (5): 993–6. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1176%2Fappi.ajp.160.5.993" class="external text" title="http://dx.doi.org/10.1176%2Fappi.ajp.160.5.993" rel="nofollow">10.1176/appi.ajp.160.5.993</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12727706" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12727706">PMID 12727706</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Placental+passage+of+antidepressant+medications&amp;rft.jtitle=The+American+Journal+of+Psychiatry&amp;rft.aulast=Hendrick+V%2C+Stowe+ZN%2C+Altshuler+LL%2C+Hwang+S%2C+Lee+E%2C+Haynes+D&amp;rft.au=Hendrick+V%2C+Stowe+ZN%2C+Altshuler+LL%2C+Hwang+S%2C+Lee+E%2C+Haynes+D&amp;rft.date=2003&amp;rft.volume=160&amp;rft.issue=5&amp;rft.pages=993%E2%80%936&amp;rft_id=info:doi/10.1176%2Fappi.ajp.160.5.993&amp;rft_id=info:pmid/12727706&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid17596601-133"><b><a href="#cite_ref-pmid17596601_133-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFLouik_C.2C_Lin_AE.2C_Werler_MM.2C_Hern.C3.A1ndez-D.C3.ADaz_S.2C_Mitchell_AA2007">Louik C, Lin AE, Werler MM, Hernández-Díaz S, Mitchell AA (2007). "First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects". <i>N. Engl. J. Med.</i> <b>356</b> (26): 2675–83. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1056%2FNEJMoa067407" class="external text" title="http://dx.doi.org/10.1056%2FNEJMoa067407" rel="nofollow">10.1056/NEJMoa067407</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17596601" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17596601">PMID 17596601</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=First-trimester+use+of+selective+serotonin-reuptake+inhibitors+and+the+risk+of+birth+defects&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.aulast=Louik+C%2C+Lin+AE%2C+Werler+MM%2C+Hern%C3%A1ndez-D%C3%ADaz+S%2C+Mitchell+AA&amp;rft.au=Louik+C%2C+Lin+AE%2C+Werler+MM%2C+Hern%C3%A1ndez-D%C3%ADaz+S%2C+Mitchell+AA&amp;rft.date=2007&amp;rft.volume=356&amp;rft.issue=26&amp;rft.pages=2675%E2%80%9383&amp;rft_id=info:doi/10.1056%2FNEJMoa067407&amp;rft_id=info:pmid/17596601&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid12590627-134"><b><a href="#cite_ref-pmid12590627_134-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFStowe_ZN.2C_Hostetter_AL.2C_Owens_MJ.2C_Ritchie_JC.2C_Sternberg_K.2C_Cohen_LS.2C_Nemeroff_CB2003">Stowe ZN, Hostetter AL, Owens MJ, Ritchie JC, Sternberg K, Cohen LS, Nemeroff CB (2003). "The pharmacokinetics of sertraline excretion into human breast milk: determinants of infant serum concentrations". <i>The Journal of Clinical Psychiatry</i> <b>64</b> (1): 73–80. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12590627" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12590627">PMID 12590627</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+pharmacokinetics+of+sertraline+excretion+into+human+breast+milk%3A+determinants+of+infant+serum+concentrations&amp;rft.jtitle=The+Journal+of+Clinical+Psychiatry&amp;rft.aulast=Stowe+ZN%2C+Hostetter+AL%2C+Owens+MJ%2C+Ritchie+JC%2C+Sternberg+K%2C+Cohen+LS%2C+Nemeroff+CB&amp;rft.au=Stowe+ZN%2C+Hostetter+AL%2C+Owens+MJ%2C+Ritchie+JC%2C+Sternberg+K%2C+Cohen+LS%2C+Nemeroff+CB&amp;rft.date=2003&amp;rft.volume=64&amp;rft.issue=1&amp;rft.pages=73%E2%80%9380&amp;rft_id=info:pmid/12590627&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid11578995-135"><b><a href="#cite_ref-pmid11578995_135-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFEpperson_N.2C_Czarkowski_KA.2C_Ward-O.27Brien_D.2C_Weiss_E.2C_Gueorguieva_R.2C_Jatlow_P.2C_Anderson_GM2001">Epperson N, Czarkowski KA, Ward-O'Brien D, Weiss E, Gueorguieva R, Jatlow P, Anderson GM (2001). "Maternal sertraline treatment and serotonin transport in breast-feeding mother-infant pairs". <i>The American Journal of Psychiatry</i> <b>158</b> (10): 1631–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1176%2Fappi.ajp.158.10.1631" class="external text" title="http://dx.doi.org/10.1176%2Fappi.ajp.158.10.1631" rel="nofollow">10.1176/appi.ajp.158.10.1631</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11578995" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11578995">PMID 11578995</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Maternal+sertraline+treatment+and+serotonin+transport+in+breast-feeding+mother-infant+pairs&amp;rft.jtitle=The+American+Journal+of+Psychiatry&amp;rft.aulast=Epperson+N%2C+Czarkowski+KA%2C+Ward-O%27Brien+D%2C+Weiss+E%2C+Gueorguieva+R%2C+Jatlow+P%2C+Anderson+GM&amp;rft.au=Epperson+N%2C+Czarkowski+KA%2C+Ward-O%27Brien+D%2C+Weiss+E%2C+Gueorguieva+R%2C+Jatlow+P%2C+Anderson+GM&amp;rft.date=2001&amp;rft.volume=158&amp;rft.issue=10&amp;rft.pages=1631%E2%80%937&amp;rft_id=info:doi/10.1176%2Fappi.ajp.158.10.1631&amp;rft_id=info:pmid/11578995&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid11229450-136">^ <a href="#cite_ref-pmid11229450_136-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid11229450_136-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFFerguson_JM2001">Ferguson JM (2001). "The effects of antidepressants on sexual functioning in depressed patients: a review". <i>The Journal of Clinical Psychiatry</i> <b>62 Suppl 3</b>: 22–34. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11229450" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11229450">PMID 11229450</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+effects+of+antidepressants+on+sexual+functioning+in+depressed+patients%3A+a+review&amp;rft.jtitle=The+Journal+of+Clinical+Psychiatry&amp;rft.aulast=Ferguson+JM&amp;rft.au=Ferguson+JM&amp;rft.date=2001&amp;rft.volume=62+Suppl+3&amp;rft.pages=22%E2%80%9334&amp;rft_id=info:pmid/11229450&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid10363731-137">^ <a href="#cite_ref-pmid10363731_137-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid10363731_137-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFCroft_H.2C_Settle_E.2C_Houser_T.2C_Batey_SR.2C_Donahue_RM.2C_Ascher_JA1999">Croft H, Settle E, Houser T, Batey SR, Donahue RM, Ascher JA (1999). "A placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertraline". <i>Clinical Therapeutics</i> <b>21</b> (4): 643–58. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2FS0149-2918%2800%2988317-4" class="external text" title="http://dx.doi.org/10.1016%2FS0149-2918%2800%2988317-4" rel="nofollow">10.1016/S0149-2918(00)88317-4</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/10363731" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/10363731">PMID 10363731</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=A+placebo-controlled+comparison+of+the+antidepressant+efficacy+and+effects+on+sexual+functioning+of+sustained-release+bupropion+and+sertraline&amp;rft.jtitle=Clinical+Therapeutics&amp;rft.aulast=Croft+H%2C+Settle+E%2C+Houser+T%2C+Batey+SR%2C+Donahue+RM%2C+Ascher+JA&amp;rft.au=Croft+H%2C+Settle+E%2C+Houser+T%2C+Batey+SR%2C+Donahue+RM%2C+Ascher+JA&amp;rft.date=1999&amp;rft.volume=21&amp;rft.issue=4&amp;rft.pages=643%E2%80%9358&amp;rft_id=info:doi/10.1016%2FS0149-2918%2800%2988317-4&amp;rft_id=info:pmid/10363731&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-FDA-138"><b><a href="#cite_ref-FDA_138-0" title="">^</a></b> <cite style="font-style:normal" class="web" id="CITEREFLevenson_M.2C_Holland_C">Levenson M, Holland C. <a href="http://www.fda.gov/ohrms/dockets/ac/06/slides/2006-4272s1-04-FDA.ppt" class="external text" title="http://www.fda.gov/ohrms/dockets/ac/06/slides/2006-4272s1-04-FDA.ppt" rel="nofollow">"Antidepressants and Suicidality in Adults: Statistical Evaluation. (Presentation at Psychopharmacologic Drugs Advisory Committee; December 13, 2006)"</a>. FDA<span class="printonly">. <a href="http://www.fda.gov/ohrms/dockets/ac/06/slides/2006-4272s1-04-FDA.ppt" class="external free" title="http://www.fda.gov/ohrms/dockets/ac/06/slides/2006-4272s1-04-FDA.ppt" rel="nofollow">http://www.fda.gov/ohrms/dockets/ac/06/slides/2006-4272s1-04-FDA.ppt</a></span><span class="reference-accessdate">. Retrieved on 2008-07-11</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Antidepressants+and+Suicidality+in+Adults%3A+Statistical+Evaluation.+%28Presentation+at+Psychopharmacologic+Drugs+Advisory+Committee%3B+December+13%2C+2006%29&amp;rft.atitle=&amp;rft.aulast=Levenson+M%2C+Holland+C&amp;rft.au=Levenson+M%2C+Holland+C&amp;rft.pub=FDA&amp;rft_id=http%3A%2F%2Fwww.fda.gov%2Fohrms%2Fdockets%2Fac%2F06%2Fslides%2F2006-4272s1-04-FDA.ppt&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-FDA2-139">^ <a href="#cite_ref-FDA2_139-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-FDA2_139-1" title=""><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-FDA2_139-2" title=""><sup><i><b>c</b></i></sup></a> <cite style="font-style:normal" class="web" id="CITEREFStone_MB.2C_Jones_ML2006">Stone MB, Jones ML (2006-11-17). <a href="http://www.fda.gov/ohrms/dockets/ac/06/briefing/2006-4272b1-01-FDA.pdf" class="external text" title="http://www.fda.gov/ohrms/dockets/ac/06/briefing/2006-4272b1-01-FDA.pdf" rel="nofollow">"Clinical review: relationship between antidepressant drugs and suicidality in adults"</a> (PDF). <i>Overview for December 13 Meeting of Psychopharmacologic Drugs Advisory Committee (PDAC)</i>. FDA. 11–74<span class="printonly">. <a href="http://www.fda.gov/ohrms/dockets/ac/06/briefing/2006-4272b1-01-FDA.pdf" class="external free" title="http://www.fda.gov/ohrms/dockets/ac/06/briefing/2006-4272b1-01-FDA.pdf" rel="nofollow">http://www.fda.gov/ohrms/dockets/ac/06/briefing/2006-4272b1-01-FDA.pdf</a></span><span class="reference-accessdate">. Retrieved on 2008-07-11</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Clinical+review%3A+relationship+between+antidepressant+drugs+and+suicidality+in+adults&amp;rft.atitle=Overview+for+December+13+Meeting+of+Psychopharmacologic+Drugs+Advisory+Committee+%28PDAC%29&amp;rft.aulast=Stone+MB%2C+Jones+ML&amp;rft.au=Stone+MB%2C+Jones+ML&amp;rft.date=2006-11-17&amp;rft.pages=11%E2%80%9374&amp;rft.pub=FDA&amp;rft_id=http%3A%2F%2Fwww.fda.gov%2Fohrms%2Fdockets%2Fac%2F06%2Fbriefing%2F2006-4272b1-01-FDA.pdf&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-FDA3-140">^ <a href="#cite_ref-FDA3_140-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-FDA3_140-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="web" id="CITEREFLevenson_M.2C_Holland_C2006">Levenson M, Holland C (2006-11-17). <a href="http://www.fda.gov/ohrms/dockets/ac/06/briefing/2006-4272b1-01-FDA.pdf" class="external text" title="http://www.fda.gov/ohrms/dockets/ac/06/briefing/2006-4272b1-01-FDA.pdf" rel="nofollow">"Statistical Evaluation of Suicidality in Adults Treated with Antidepressants"</a> (PDF). <i>Overview for December 13 Meeting of Psychopharmacologic Drugs Advisory Committee (PDAC)</i>. FDA. 75–140<span class="printonly">. <a href="http://www.fda.gov/ohrms/dockets/ac/06/briefing/2006-4272b1-01-FDA.pdf" class="external free" title="http://www.fda.gov/ohrms/dockets/ac/06/briefing/2006-4272b1-01-FDA.pdf" rel="nofollow">http://www.fda.gov/ohrms/dockets/ac/06/briefing/2006-4272b1-01-FDA.pdf</a></span><span class="reference-accessdate">. Retrieved on 2008-07-11</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Statistical+Evaluation+of+Suicidality+in+Adults+Treated+with+Antidepressants&amp;rft.atitle=Overview+for+December+13+Meeting+of+Psychopharmacologic+Drugs+Advisory+Committee+%28PDAC%29&amp;rft.aulast=Levenson+M%2C+Holland+C&amp;rft.au=Levenson+M%2C+Holland+C&amp;rft.date=2006-11-17&amp;rft.pages=75%E2%80%93140&amp;rft.pub=FDA&amp;rft_id=http%3A%2F%2Fwww.fda.gov%2Fohrms%2Fdockets%2Fac%2F06%2Fbriefing%2F2006-4272b1-01-FDA.pdf&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-141"><b><a href="#cite_ref-141" title="">^</a></b> <cite style="font-style:normal" class="web" id="CITEREFPfizer_Inc.2006">Pfizer Inc. (2006-11-30). <a href="http://www.fda.gov/ohrms/dockets/dockets/06n0414/06N-0414-EC32-Attach-1.pdf" class="external text" title="http://www.fda.gov/ohrms/dockets/dockets/06n0414/06N-0414-EC32-Attach-1.pdf" rel="nofollow">"Memorandum from Pfizer Global Pharmaceuticals Re: DOCKET: 2006N-0414&#160;–"Suicidality data from adult antidepressant trials" Background package for December 13 Advisory Committee"</a> (PDF). <i>FDA DOCKET 2006N-0414</i>. FDA<span class="printonly">. <a href="http://www.fda.gov/ohrms/dockets/dockets/06n0414/06N-0414-EC32-Attach-1.pdf" class="external free" title="http://www.fda.gov/ohrms/dockets/dockets/06n0414/06N-0414-EC32-Attach-1.pdf" rel="nofollow">http://www.fda.gov/ohrms/dockets/dockets/06n0414/06N-0414-EC32-Attach-1.pdf</a></span><span class="reference-accessdate">. Retrieved on 2008-07-11</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Memorandum+from+Pfizer+Global+Pharmaceuticals+Re%3A+DOCKET%3A+2006N-0414%26nbsp%3B%E2%80%93%22Suicidality+data+from+adult+antidepressant+trials%22+Background+package+for+December+13+Advisory+Committee&amp;rft.atitle=FDA+DOCKET+2006N-0414&amp;rft.aulast=Pfizer+Inc.&amp;rft.au=Pfizer+Inc.&amp;rft.date=2006-11-30&amp;rft.pub=FDA&amp;rft_id=http%3A%2F%2Fwww.fda.gov%2Fohrms%2Fdockets%2Fdockets%2F06n0414%2F06N-0414-EC32-Attach-1.pdf&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-142"><b><a href="#cite_ref-142" title="">^</a></b> <cite style="font-style:normal" class="web"><a href="http://www.mhra.gov.uk/home/groups/pl-p/documents/drugsafetymessage/con019472.pdf" class="external text" title="http://www.mhra.gov.uk/home/groups/pl-p/documents/drugsafetymessage/con019472.pdf" rel="nofollow">"Report of the CSM expert working group on the safety of selective serotonin reuptake inhibitor antidepressants"</a> (PDF). MHRA. 2004-12<span class="printonly">. <a href="http://www.mhra.gov.uk/home/groups/pl-p/documents/drugsafetymessage/con019472.pdf" class="external free" title="http://www.mhra.gov.uk/home/groups/pl-p/documents/drugsafetymessage/con019472.pdf" rel="nofollow">http://www.mhra.gov.uk/home/groups/pl-p/documents/drugsafetymessage/con019472.pdf</a></span><span class="reference-accessdate">. Retrieved on 2008-07-11</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Report+of+the+CSM+expert+working+group+on+the+safety+of+selective+serotonin+reuptake+inhibitor+antidepressants&amp;rft.atitle=&amp;rft.date=2004-12&amp;rft.pub=MHRA&amp;rft_id=http%3A%2F%2Fwww.mhra.gov.uk%2Fhome%2Fgroups%2Fpl-p%2Fdocuments%2Fdrugsafetymessage%2Fcon019472.pdf&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid15718537-143"><b><a href="#cite_ref-pmid15718537_143-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFGunnell_D.2C_Saperia_J.2C_Ashby_D2005">Gunnell D, Saperia J, Ashby D (2005). "Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review". <i>BMJ</i> <b>330</b> (7488): 385. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1136%2Fbmj.330.7488.385" class="external text" title="http://dx.doi.org/10.1136%2Fbmj.330.7488.385" rel="nofollow">10.1136/bmj.330.7488.385</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15718537" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15718537">PMID 15718537</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Selective+serotonin+reuptake+inhibitors+%28SSRIs%29+and+suicide+in+adults%3A+meta-analysis+of+drug+company+data+from+placebo+controlled%2C+randomised+controlled+trials+submitted+to+the+MHRA%27s+safety+review&amp;rft.jtitle=BMJ&amp;rft.aulast=Gunnell+D%2C+Saperia+J%2C+Ashby+D&amp;rft.au=Gunnell+D%2C+Saperia+J%2C+Ashby+D&amp;rft.date=2005&amp;rft.volume=330&amp;rft.issue=7488&amp;rft.pages=385&amp;rft_id=info:doi/10.1136%2Fbmj.330.7488.385&amp;rft_id=info:pmid/15718537&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid9646889-144">^ <a href="#cite_ref-pmid9646889_144-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid9646889_144-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFRosenbaum_JF.2C_Fava_M.2C_Hoog_SL.2C_Ascroft_RC.2C_Krebs_WB1998">Rosenbaum JF, Fava M, Hoog SL, Ascroft RC, Krebs WB (1998). "Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial". <i>Biol. Psychiatry</i> <b>44</b> (2): 77–87. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2FS0006-3223%2898%2900126-7" class="external text" title="http://dx.doi.org/10.1016%2FS0006-3223%2898%2900126-7" rel="nofollow">10.1016/S0006-3223(98)00126-7</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/9646889" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/9646889">PMID 9646889</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Selective+serotonin+reuptake+inhibitor+discontinuation+syndrome%3A+a+randomized+clinical+trial&amp;rft.jtitle=Biol.+Psychiatry&amp;rft.aulast=Rosenbaum+JF%2C+Fava+M%2C+Hoog+SL%2C+Ascroft+RC%2C+Krebs+WB&amp;rft.au=Rosenbaum+JF%2C+Fava+M%2C+Hoog+SL%2C+Ascroft+RC%2C+Krebs+WB&amp;rft.date=1998&amp;rft.volume=44&amp;rft.issue=2&amp;rft.pages=77%E2%80%9387&amp;rft_id=info:doi/10.1016%2FS0006-3223%2898%2900126-7&amp;rft_id=info:pmid/9646889&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid15121647-145"><b><a href="#cite_ref-pmid15121647_145-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFMeyer_JH.2C_Wilson_AA.2C_Sagrati_S.2C_Hussey_D.2C_Carella_A.2C_Potter_WZ.2C_Ginovart_N.2C_Spencer_EP.2C_Cheok_A.2C_Houle_S2004">Meyer JH, Wilson AA, Sagrati S, Hussey D, Carella A, Potter WZ, Ginovart N, Spencer EP, Cheok A, Houle S (2004). "Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [<sup>11</sup>C]DASB positron emission tomography study". <i>The American Journal of Psychiatry</i> <b>161</b> (5): 826–35. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15121647" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15121647">PMID 15121647</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Serotonin+transporter+occupancy+of+five+selective+serotonin+reuptake+inhibitors+at+different+doses%3A+an+%5B%3Csup%3E11%3C%2Fsup%3EC%5DDASB+positron+emission+tomography+study&amp;rft.jtitle=The+American+Journal+of+Psychiatry&amp;rft.aulast=Meyer+JH%2C+Wilson+AA%2C+Sagrati+S%2C+Hussey+D%2C+Carella+A%2C+Potter+WZ%2C+Ginovart+N%2C+Spencer+EP%2C+Cheok+A%2C+Houle+S&amp;rft.au=Meyer+JH%2C+Wilson+AA%2C+Sagrati+S%2C+Hussey+D%2C+Carella+A%2C+Potter+WZ%2C+Ginovart+N%2C+Spencer+EP%2C+Cheok+A%2C+Houle+S&amp;rft.date=2004&amp;rft.volume=161&amp;rft.issue=5&amp;rft.pages=826%E2%80%9335&amp;rft_id=info:pmid/15121647&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid11543737-146">^ <a href="#cite_ref-pmid11543737_146-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid11543737_146-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFOwens_MJ.2C_Knight_DL.2C_Nemeroff_CB2001">Owens MJ, Knight DL, Nemeroff CB (2001). "Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine". <i>Biol. Psychiatry</i> <b>50</b> (5): 345–50. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2FS0006-3223%2801%2901145-3" class="external text" title="http://dx.doi.org/10.1016%2FS0006-3223%2801%2901145-3" rel="nofollow">10.1016/S0006-3223(01)01145-3</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11543737" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11543737">PMID 11543737</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Second-generation+SSRIs%3A+human+monoamine+transporter+binding+profile+of+escitalopram+and+R-fluoxetine&amp;rft.jtitle=Biol.+Psychiatry&amp;rft.aulast=Owens+MJ%2C+Knight+DL%2C+Nemeroff+CB&amp;rft.au=Owens+MJ%2C+Knight+DL%2C+Nemeroff+CB&amp;rft.date=2001&amp;rft.volume=50&amp;rft.issue=5&amp;rft.pages=345%E2%80%9350&amp;rft_id=info:doi/10.1016%2FS0006-3223%2801%2901145-3&amp;rft_id=info:pmid/11543737&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid8831113-147"><b><a href="#cite_ref-pmid8831113_147-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFNarita_N.2C_Hashimoto_K.2C_Tomitaka_S.2C_Minabe_Y1996">Narita N, Hashimoto K, Tomitaka S, Minabe Y (1996). "Interactions of selective serotonin reuptake inhibitors with subtypes of sigma receptors in rat brain". <i>Eur. J. Pharmacol.</i> <b>307</b> (1): 117–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2F0014-2999%2896%2900254-3" class="external text" title="http://dx.doi.org/10.1016%2F0014-2999%2896%2900254-3" rel="nofollow">10.1016/0014-2999(96)00254-3</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/8831113" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/8831113">PMID 8831113</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Interactions+of+selective+serotonin+reuptake+inhibitors+with+subtypes+of+sigma+receptors+in+rat+brain&amp;rft.jtitle=Eur.+J.+Pharmacol.&amp;rft.aulast=Narita+N%2C+Hashimoto+K%2C+Tomitaka+S%2C+Minabe+Y&amp;rft.au=Narita+N%2C+Hashimoto+K%2C+Tomitaka+S%2C+Minabe+Y&amp;rft.date=1996&amp;rft.volume=307&amp;rft.issue=1&amp;rft.pages=117%E2%80%939&amp;rft_id=info:doi/10.1016%2F0014-2999%2896%2900254-3&amp;rft_id=info:pmid/8831113&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid9400006-148">^ <a href="#cite_ref-pmid9400006_148-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid9400006_148-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFOwens_MJ.2C_Morgan_WN.2C_Plott_SJ.2C_Nemeroff_CB1997">Owens MJ, Morgan WN, Plott SJ, Nemeroff CB (1997). "Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites". <i>J. Pharmacol. Exp. Ther.</i> <b>283</b> (3): 1305–22. <a href="http://www.ncbi.nlm.nih.gov/pubmed/9400006" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/9400006">PMID 9400006</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Neurotransmitter+receptor+and+transporter+binding+profile+of+antidepressants+and+their+metabolites&amp;rft.jtitle=J.+Pharmacol.+Exp.+Ther.&amp;rft.aulast=Owens+MJ%2C+Morgan+WN%2C+Plott+SJ%2C+Nemeroff+CB&amp;rft.au=Owens+MJ%2C+Morgan+WN%2C+Plott+SJ%2C+Nemeroff+CB&amp;rft.date=1997&amp;rft.volume=283&amp;rft.issue=3&amp;rft.pages=1305%E2%80%9322&amp;rft_id=info:pmid/9400006&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid12452737-149">^ <a href="#cite_ref-pmid12452737_149-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid12452737_149-1" title=""><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid12452737_149-2" title=""><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid12452737_149-3" title=""><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-pmid12452737_149-4" title=""><sup><i><b>e</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFDeVane_CL.2C_Liston_HL.2C_Markowitz_JS2002">DeVane CL, Liston HL, Markowitz JS (2002). "Clinical pharmacokinetics of sertraline". <i>Clinical Pharmacokinetics</i> <b>41</b> (15): 1247–66. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.2165%2F00003088-200241150-00002" class="external text" title="http://dx.doi.org/10.2165%2F00003088-200241150-00002" rel="nofollow">10.2165/00003088-200241150-00002</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12452737" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12452737">PMID 12452737</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Clinical+pharmacokinetics+of+sertraline&amp;rft.jtitle=Clinical+Pharmacokinetics&amp;rft.aulast=DeVane+CL%2C+Liston+HL%2C+Markowitz+JS&amp;rft.au=DeVane+CL%2C+Liston+HL%2C+Markowitz+JS&amp;rft.date=2002&amp;rft.volume=41&amp;rft.issue=15&amp;rft.pages=1247%E2%80%9366&amp;rft_id=info:doi/10.2165%2F00003088-200241150-00002&amp;rft_id=info:pmid/12452737&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid10383917-150"><b><a href="#cite_ref-pmid10383917_150-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFKobayashi_K.2C_Ishizuka_T.2C_Shimada_N.2C_Yoshimura_Y.2C_Kamijima_K.2C_Chiba_K1999">Kobayashi K, Ishizuka T, Shimada N, Yoshimura Y, Kamijima K, Chiba K (1999). "Sertraline N-demethylation is catalyzed by multiple isoforms of human cytochrome P-450 in vitro". <i>Drug Metab. Dispos.</i> <b>27</b> (7): 763–6. <a href="http://www.ncbi.nlm.nih.gov/pubmed/10383917" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/10383917">PMID 10383917</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Sertraline+N-demethylation+is+catalyzed+by+multiple+isoforms+of+human+cytochrome+P-450+in+vitro&amp;rft.jtitle=Drug+Metab.+Dispos.&amp;rft.aulast=Kobayashi+K%2C+Ishizuka+T%2C+Shimada+N%2C+Yoshimura+Y%2C+Kamijima+K%2C+Chiba+K&amp;rft.au=Kobayashi+K%2C+Ishizuka+T%2C+Shimada+N%2C+Yoshimura+Y%2C+Kamijima+K%2C+Chiba+K&amp;rft.date=1999&amp;rft.volume=27&amp;rft.issue=7&amp;rft.pages=763%E2%80%936&amp;rft_id=info:pmid/10383917&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid15547048-151">^ <a href="#cite_ref-pmid15547048_151-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid15547048_151-1" title=""><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid15547048_151-2" title=""><sup><i><b>c</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFObach_RS.2C_Cox_LM.2C_Tremaine_LM2005">Obach RS, Cox LM, Tremaine LM (2005). "Sertraline is metabolized by multiple cytochrome P450 enzymes, monoamine oxidases, and glucuronyl transferases in human: an in vitro study". <i>Drug Metab. Dispos.</i> <b>33</b> (2): 262–70. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1124%2Fdmd.104.002428" class="external text" title="http://dx.doi.org/10.1124%2Fdmd.104.002428" rel="nofollow">10.1124/dmd.104.002428</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15547048" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15547048">PMID 15547048</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Sertraline+is+metabolized+by+multiple+cytochrome+P450+enzymes%2C+monoamine+oxidases%2C+and+glucuronyl+transferases+in+human%3A+an+in+vitro+study&amp;rft.jtitle=Drug+Metab.+Dispos.&amp;rft.aulast=Obach+RS%2C+Cox+LM%2C+Tremaine+LM&amp;rft.au=Obach+RS%2C+Cox+LM%2C+Tremaine+LM&amp;rft.date=2005&amp;rft.volume=33&amp;rft.issue=2&amp;rft.pages=262%E2%80%9370&amp;rft_id=info:doi/10.1124%2Fdmd.104.002428&amp;rft_id=info:pmid/15547048&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid8941024-152"><b><a href="#cite_ref-pmid8941024_152-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFHamelin_BA.2C_Turgeon_J.2C_Vall.C3.A9e_F.2C_B.C3.A9langer_PM.2C_Paquet_F.2C_LeBel_M1996">Hamelin BA, Turgeon J, Vallée F, Bélanger PM, Paquet F, LeBel M (1996). "The disposition of fluoxetine but not sertraline is altered in poor metabolizers of debrisoquin". <i>Clin. Pharmacol. Ther.</i> <b>60</b> (5): 512–21. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2FS0009-9236%2896%2990147-2" class="external text" title="http://dx.doi.org/10.1016%2FS0009-9236%2896%2990147-2" rel="nofollow">10.1016/S0009-9236(96)90147-2</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/8941024" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/8941024">PMID 8941024</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+disposition+of+fluoxetine+but+not+sertraline+is+altered+in+poor+metabolizers+of+debrisoquin&amp;rft.jtitle=Clin.+Pharmacol.+Ther.&amp;rft.aulast=Hamelin+BA%2C+Turgeon+J%2C+Vall%C3%A9e+F%2C+B%C3%A9langer+PM%2C+Paquet+F%2C+LeBel+M&amp;rft.au=Hamelin+BA%2C+Turgeon+J%2C+Vall%C3%A9e+F%2C+B%C3%A9langer+PM%2C+Paquet+F%2C+LeBel+M&amp;rft.date=1996&amp;rft.volume=60&amp;rft.issue=5&amp;rft.pages=512%E2%80%9321&amp;rft_id=info:doi/10.1016%2FS0009-9236%2896%2990147-2&amp;rft_id=info:pmid/8941024&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid11452243-153"><b><a href="#cite_ref-pmid11452243_153-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFWang_JH.2C_Liu_ZQ.2C_Wang_W.2C_Chen_XP.2C_Shu_Y.2C_He_N.2C_Zhou_HH2001">Wang JH, Liu ZQ, Wang W, Chen XP, Shu Y, He N, Zhou HH (2001). "Pharmacokinetics of sertraline in relation to genetic polymorphism of CYP2C19". <i>Clin. Pharmacol. Ther.</i> <b>70</b> (1): 42–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1067%2Fmcp.2001.116513" class="external text" title="http://dx.doi.org/10.1067%2Fmcp.2001.116513" rel="nofollow">10.1067/mcp.2001.116513</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11452243" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11452243">PMID 11452243</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Pharmacokinetics+of+sertraline+in+relation+to+genetic+polymorphism+of+CYP2C19&amp;rft.jtitle=Clin.+Pharmacol.+Ther.&amp;rft.aulast=Wang+JH%2C+Liu+ZQ%2C+Wang+W%2C+Chen+XP%2C+Shu+Y%2C+He+N%2C+Zhou+HH&amp;rft.au=Wang+JH%2C+Liu+ZQ%2C+Wang+W%2C+Chen+XP%2C+Shu+Y%2C+He+N%2C+Zhou+HH&amp;rft.date=2001&amp;rft.volume=70&amp;rft.issue=1&amp;rft.pages=42%E2%80%937&amp;rft_id=info:doi/10.1067%2Fmcp.2001.116513&amp;rft_id=info:pmid/11452243&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid16192315-154">^ <a href="#cite_ref-pmid16192315_154-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid16192315_154-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFObach_RS.2C_Walsky_RL.2C_Venkatakrishnan_K.2C_Gaman_EA.2C_Houston_JB.2C_Tremaine_LM2006">Obach RS, Walsky RL, Venkatakrishnan K, Gaman EA, Houston JB, Tremaine LM (2006). "The utility of in vitro cytochrome P450 inhibition data in the prediction of drug-drug interactions". <i>J. Pharmacol. Exp. Ther.</i> <b>316</b> (1): 336–48. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1124%2Fjpet.105.093229" class="external text" title="http://dx.doi.org/10.1124%2Fjpet.105.093229" rel="nofollow">10.1124/jpet.105.093229</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16192315" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16192315">PMID 16192315</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+utility+of+in+vitro+cytochrome+P450+inhibition+data+in+the+prediction+of+drug-drug+interactions&amp;rft.jtitle=J.+Pharmacol.+Exp.+Ther.&amp;rft.aulast=Obach+RS%2C+Walsky+RL%2C+Venkatakrishnan+K%2C+Gaman+EA%2C+Houston+JB%2C+Tremaine+LM&amp;rft.au=Obach+RS%2C+Walsky+RL%2C+Venkatakrishnan+K%2C+Gaman+EA%2C+Houston+JB%2C+Tremaine+LM&amp;rft.date=2006&amp;rft.volume=316&amp;rft.issue=1&amp;rft.pages=336%E2%80%9348&amp;rft_id=info:doi/10.1124%2Fjpet.105.093229&amp;rft_id=info:pmid/16192315&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid9472843-155"><b><a href="#cite_ref-pmid9472843_155-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFOzdemir_V.2C_Naranjo_CA.2C_Herrmann_N.2C_Shulman_RW.2C_Sellers_EM.2C_Reed_K.2C_Kalow_W1998">Ozdemir V, Naranjo CA, Herrmann N, Shulman RW, Sellers EM, Reed K, Kalow W (1998). "The extent and determinants of changes in CYP2D6 and CYP1A2 activities with therapeutic doses of sertraline". <i>Journal of Clinical Psychopharmacology</i> <b>18</b> (1): 55–61. <a href="http://www.ncbi.nlm.nih.gov/pubmed/9472843" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/9472843">PMID 9472843</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+extent+and+determinants+of+changes+in+CYP2D6+and+CYP1A2+activities+with+therapeutic+doses+of+sertraline&amp;rft.jtitle=Journal+of+Clinical+Psychopharmacology&amp;rft.aulast=Ozdemir+V%2C+Naranjo+CA%2C+Herrmann+N%2C+Shulman+RW%2C+Sellers+EM%2C+Reed+K%2C+Kalow+W&amp;rft.au=Ozdemir+V%2C+Naranjo+CA%2C+Herrmann+N%2C+Shulman+RW%2C+Sellers+EM%2C+Reed+K%2C+Kalow+W&amp;rft.date=1998&amp;rft.volume=18&amp;rft.issue=1&amp;rft.pages=55%E2%80%9361&amp;rft_id=info:pmid/9472843&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid10211917-156"><b><a href="#cite_ref-pmid10211917_156-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFAlfaro_CL.2C_Lam_YW.2C_Simpson_J.2C_Ereshefsky_L1999">Alfaro CL, Lam YW, Simpson J, Ereshefsky L (1999). "CYP2D6 status of extensive metabolizers after multiple-dose fluoxetine, fluvoxamine, paroxetine, or sertraline". <i>Journal of Clinical Psychopharmacology</i> <b>19</b> (2): 155–63. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1097%2F00004714-199904000-00011" class="external text" title="http://dx.doi.org/10.1097%2F00004714-199904000-00011" rel="nofollow">10.1097/00004714-199904000-00011</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/10211917" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/10211917">PMID 10211917</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=CYP2D6+status+of+extensive+metabolizers+after+multiple-dose+fluoxetine%2C+fluvoxamine%2C+paroxetine%2C+or+sertraline&amp;rft.jtitle=Journal+of+Clinical+Psychopharmacology&amp;rft.aulast=Alfaro+CL%2C+Lam+YW%2C+Simpson+J%2C+Ereshefsky+L&amp;rft.au=Alfaro+CL%2C+Lam+YW%2C+Simpson+J%2C+Ereshefsky+L&amp;rft.date=1999&amp;rft.volume=19&amp;rft.issue=2&amp;rft.pages=155%E2%80%9363&amp;rft_id=info:doi/10.1097%2F00004714-199904000-00011&amp;rft_id=info:pmid/10211917&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid10631623-157"><b><a href="#cite_ref-pmid10631623_157-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFAlfaro_CL.2C_Lam_YW.2C_Simpson_J.2C_Ereshefsky_L2000">Alfaro CL, Lam YW, Simpson J, Ereshefsky L (2000). "CYP2D6 inhibition by fluoxetine, paroxetine, sertraline, and venlafaxine in a crossover study: intraindividual variability and plasma concentration correlations". <i>Journal of Clinical Pharmacology</i> <b>40</b> (1): 58–66. <a href="http://www.ncbi.nlm.nih.gov/pubmed/10631623" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/10631623">PMID 10631623</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=CYP2D6+inhibition+by+fluoxetine%2C+paroxetine%2C+sertraline%2C+and+venlafaxine+in+a+crossover+study%3A+intraindividual+variability+and+plasma+concentration+correlations&amp;rft.jtitle=Journal+of+Clinical+Pharmacology&amp;rft.aulast=Alfaro+CL%2C+Lam+YW%2C+Simpson+J%2C+Ereshefsky+L&amp;rft.au=Alfaro+CL%2C+Lam+YW%2C+Simpson+J%2C+Ereshefsky+L&amp;rft.date=2000&amp;rft.volume=40&amp;rft.issue=1&amp;rft.pages=58%E2%80%9366&amp;rft_id=info:pmid/10631623&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid17224709-158"><b><a href="#cite_ref-pmid17224709_158-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFPreskorn_SH.2C_Greenblatt_DJ.2C_Flockhart_D.2C_Luo_Y.2C_Perloff_ES.2C_Harmatz_JS.2C_Baker_B.2C_Klick-Davis_A.2C_Desta_Z.2C_Burt_T2007">Preskorn SH, Greenblatt DJ, Flockhart D, Luo Y, Perloff ES, Harmatz JS, Baker B, Klick-Davis A, Desta Z, Burt T (2007). "Comparison of duloxetine, escitalopram, and sertraline effects on cytochrome P450 2D6 function in healthy volunteers". <i>Journal of Clinical Psychopharmacology</i> <b>27</b> (1): 28–34. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1097%2F00004714-200702000-00005" class="external text" title="http://dx.doi.org/10.1097%2F00004714-200702000-00005" rel="nofollow">10.1097/00004714-200702000-00005</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17224709" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17224709">PMID 17224709</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Comparison+of+duloxetine%2C+escitalopram%2C+and+sertraline+effects+on+cytochrome+P450+2D6+function+in+healthy+volunteers&amp;rft.jtitle=Journal+of+Clinical+Psychopharmacology&amp;rft.aulast=Preskorn+SH%2C+Greenblatt+DJ%2C+Flockhart+D%2C+Luo+Y%2C+Perloff+ES%2C+Harmatz+JS%2C+Baker+B%2C+Klick-Davis+A%2C+Desta+Z%2C+Burt+T&amp;rft.au=Preskorn+SH%2C+Greenblatt+DJ%2C+Flockhart+D%2C+Luo+Y%2C+Perloff+ES%2C+Harmatz+JS%2C+Baker+B%2C+Klick-Davis+A%2C+Desta+Z%2C+Burt+T&amp;rft.date=2007&amp;rft.volume=27&amp;rft.issue=1&amp;rft.pages=28%E2%80%9334&amp;rft_id=info:doi/10.1097%2F00004714-200702000-00005&amp;rft_id=info:pmid/17224709&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid10914294-159"><b><a href="#cite_ref-pmid10914294_159-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFHamilton_SP.2C_Nunes_EV.2C_Janal_M.2C_Weber_L2000">Hamilton SP, Nunes EV, Janal M, Weber L (2000). "The effect of sertraline on methadone plasma levels in methadone-maintenance patients". <i>The American Journal on Addictions / American Academy of Psychiatrists in Alcoholism and Addictions</i> <b>9</b> (1): 63–9. <a href="http://www.ncbi.nlm.nih.gov/pubmed/10914294" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/10914294">PMID 10914294</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+effect+of+sertraline+on+methadone+plasma+levels+in+methadone-maintenance+patients&amp;rft.jtitle=The+American+Journal+on+Addictions+%2F+American+Academy+of+Psychiatrists+in+Alcoholism+and+Addictions&amp;rft.aulast=Hamilton+SP%2C+Nunes+EV%2C+Janal+M%2C+Weber+L&amp;rft.au=Hamilton+SP%2C+Nunes+EV%2C+Janal+M%2C+Weber+L&amp;rft.date=2000&amp;rft.volume=9&amp;rft.issue=1&amp;rft.pages=63%E2%80%939&amp;rft_id=info:pmid/10914294&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid14709940-160"><b><a href="#cite_ref-pmid14709940_160-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFDeVane_CL.2C_Donovan_JL.2C_Liston_HL.2C_Markowitz_JS.2C_Cheng_KT.2C_Risch_SC.2C_Willard_L2004">DeVane CL, Donovan JL, Liston HL, Markowitz JS, Cheng KT, Risch SC, Willard L (2004). "Comparative CYP3A4 inhibitory effects of venlafaxine, fluoxetine, sertraline, and nefazodone in healthy volunteers". <i>Journal of Clinical Psychopharmacology</i> <b>24</b> (1): 4–10. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1097%2F01.jcp.0000104908.75206.26" class="external text" title="http://dx.doi.org/10.1097%2F01.jcp.0000104908.75206.26" rel="nofollow">10.1097/01.jcp.0000104908.75206.26</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/14709940" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/14709940">PMID 14709940</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Comparative+CYP3A4+inhibitory+effects+of+venlafaxine%2C+fluoxetine%2C+sertraline%2C+and+nefazodone+in+healthy+volunteers&amp;rft.jtitle=Journal+of+Clinical+Psychopharmacology&amp;rft.aulast=DeVane+CL%2C+Donovan+JL%2C+Liston+HL%2C+Markowitz+JS%2C+Cheng+KT%2C+Risch+SC%2C+Willard+L&amp;rft.au=DeVane+CL%2C+Donovan+JL%2C+Liston+HL%2C+Markowitz+JS%2C+Cheng+KT%2C+Risch+SC%2C+Willard+L&amp;rft.date=2004&amp;rft.volume=24&amp;rft.issue=1&amp;rft.pages=4%E2%80%9310&amp;rft_id=info:doi/10.1097%2F01.jcp.0000104908.75206.26&amp;rft_id=info:pmid/14709940&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-PLoS-161"><b><a href="#cite_ref-PLoS_161-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFLacasse_J.2C_Leo_J2005">Lacasse J, Leo J (2005). "Serotonin and depression: a disconnect between the advertisements and the scientific literature". <i><a href="/wiki/PLoS_Medicine" title="PLoS Medicine">PLoS Med</a></i> <b>2</b> (12): e392. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1371%2Fjournal.pmed.0020392.g001" class="external text" title="http://dx.doi.org/10.1371%2Fjournal.pmed.0020392.g001" rel="nofollow">10.1371/journal.pmed.0020392.g001</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16268734" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16268734">PMID 16268734</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Serotonin+and+depression%3A+a+disconnect+between+the+advertisements+and+the+scientific+literature&amp;rft.jtitle=%5B%5BPLoS+Medicine%7CPLoS+Med%5D%5D&amp;rft.aulast=Lacasse+J%2C+Leo+J&amp;rft.au=Lacasse+J%2C+Leo+J&amp;rft.date=2005&amp;rft.volume=2&amp;rft.issue=12&amp;rft.pages=e392&amp;rft_id=info:doi/10.1371%2Fjournal.pmed.0020392.g001&amp;rft_id=info:pmid/16268734&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span> <a href="http://medicine.plosjournals.org/perlserv/?request=get-document&amp;doi=10.1371/journal.pmed.0020392" class="external text" title="http://medicine.plosjournals.org/perlserv/?request=get-document&amp;doi=10.1371/journal.pmed.0020392" rel="nofollow">Free full text, open-access source</a></li>
<li id="cite_note-162"><b><a href="#cite_ref-162" title="">^</a></b> <cite style="font-style:normal" class="web"><a href="http://www.fda.gov/cder/warn/2005/zoloft_letter.pdf" class="external text" title="http://www.fda.gov/cder/warn/2005/zoloft_letter.pdf" rel="nofollow">"Food and Drug Administration Division of Drug Marketing Advertising and Communications. (2005) Zoloft warning letter."</a> (PDF). FDA<span class="printonly">. <a href="http://www.fda.gov/cder/warn/2005/zoloft_letter.pdf" class="external free" title="http://www.fda.gov/cder/warn/2005/zoloft_letter.pdf" rel="nofollow">http://www.fda.gov/cder/warn/2005/zoloft_letter.pdf</a></span><span class="reference-accessdate">. Retrieved on 2008-07-11</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Food+and+Drug+Administration+Division+of+Drug+Marketing+Advertising+and+Communications.+%282005%29+Zoloft+warning+letter.&amp;rft.atitle=&amp;rft.pub=FDA&amp;rft_id=http%3A%2F%2Fwww.fda.gov%2Fcder%2Fwarn%2F2005%2Fzoloft_letter.pdf&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-163"><b><a href="#cite_ref-163" title="">^</a></b> <cite style="font-style:normal" class="web"><a href="http://www.lawlink.nsw.gov.au/scjudgments/2001nswsc.nsf/27602436db586906ca256983001e137a/bd5c743050325110ca256a54007de04f?opendocument" class="external text" title="http://www.lawlink.nsw.gov.au/scjudgments/2001nswsc.nsf/27602436db586906ca256983001e137a/bd5c743050325110ca256a54007de04f?opendocument" rel="nofollow">"Regina v Hawkins [2001] NSWSC 420"</a>. New South Wales Supreme Court. 2001-05-24<span class="printonly">. <a href="http://www.lawlink.nsw.gov.au/scjudgments/2001nswsc.nsf/27602436db586906ca256983001e137a/bd5c743050325110ca256a54007de04f?opendocument" class="external free" title="http://www.lawlink.nsw.gov.au/scjudgments/2001nswsc.nsf/27602436db586906ca256983001e137a/bd5c743050325110ca256a54007de04f?opendocument" rel="nofollow">http://www.lawlink.nsw.gov.au/scjudgments/2001nswsc.nsf/27602436db586906ca256983001e137a/bd5c743050325110ca256a54007de04f?opendocument</a></span><span class="reference-accessdate">. Retrieved on 2008-07-11</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Regina+v+Hawkins+%7FUNIQ6550be5d6fb33606-nowiki-0000036D-QINU%7F+NSWSC+420&amp;rft.atitle=&amp;rft.date=2001-05-24&amp;rft.pub=New+South+Wales+Supreme+Court&amp;rft_id=http%3A%2F%2Fwww.lawlink.nsw.gov.au%2Fscjudgments%2F2001nswsc.nsf%2F27602436db586906ca256983001e137a%2Fbd5c743050325110ca256a54007de04f%3Fopendocument&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-164"><b><a href="#cite_ref-164" title="">^</a></b> <cite style="font-style:normal" class="press release" id="CITEREFBusiness_Wire.2FFindarticles.com2004">Business Wire/Findarticles.com (2004-07-23). <i><a href="http://findarticles.com/p/articles/mi_m0EIN/is_2004_July_23/ai_n6122283" class="external text" title="http://findarticles.com/p/articles/mi_m0EIN/is_2004_July_23/ai_n6122283" rel="nofollow">Suit Claims Pfizer Conceals Evidence and Misleads Doctors and Patients About Safety and Effectiveness of Zoloft</a></i>. <a href="/wiki/News_release" title="News release">Press release</a><span class="printonly">. <a href="http://findarticles.com/p/articles/mi_m0EIN/is_2004_July_23/ai_n6122283" class="external free" title="http://findarticles.com/p/articles/mi_m0EIN/is_2004_July_23/ai_n6122283" rel="nofollow">http://findarticles.com/p/articles/mi_m0EIN/is_2004_July_23/ai_n6122283</a></span><span class="reference-accessdate">. Retrieved on 2008-07-11</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Suit+Claims+Pfizer+Conceals+Evidence+and+Misleads+Doctors+and+Patients+About+Safety+and+Effectiveness+of+Zoloft&amp;rft.aulast=Business+Wire%2FFindarticles.com&amp;rft.au=Business+Wire%2FFindarticles.com&amp;rft.date=2004-07-23&amp;rft.series=%5B%5BNews+release%7CPress+release%5D%5D&amp;rft_id=http%3A%2F%2Ffindarticles.com%2Fp%2Farticles%2Fmi_m0EIN%2Fis_2004_July_23%2Fai_n6122283&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-lasc-165"><b><a href="#cite_ref-lasc_165-0" title="">^</a></b> Enter the case number "BC 318871" into the form to see the summary of the case stating that the suit was dismissed. The images of the case documents are available for a nominal price. <cite style="font-style:normal" class="web"><a href="http://www.lasuperiorcourt.org/civilCaseSummary/index.asp?CaseType=Civil" class="external text" title="http://www.lasuperiorcourt.org/civilCaseSummary/index.asp?CaseType=Civil" rel="nofollow">"Los Angeles Superior Court&#160;— Civil Case Summary"</a>. Los Angeles Superior Court. 2005-05-31<span class="printonly">. <a href="http://www.lasuperiorcourt.org/civilCaseSummary/index.asp?CaseType=Civil" class="external free" title="http://www.lasuperiorcourt.org/civilCaseSummary/index.asp?CaseType=Civil" rel="nofollow">http://www.lasuperiorcourt.org/civilCaseSummary/index.asp?CaseType=Civil</a></span><span class="reference-accessdate">. Retrieved on 2007-11-04</span>.  "It is thereby ordered, adjudged and decreed that this action is dismissed and that Defendant Pfizer Inc is awarded its costs of suit incurred therein."</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Los+Angeles+Superior+Court%26nbsp%3B%E2%80%94+Civil+Case+Summary&amp;rft.atitle=&amp;rft.date=2005-05-31&amp;rft.pub=Los+Angeles+Superior+Court&amp;rft_id=http%3A%2F%2Fwww.lasuperiorcourt.org%2FcivilCaseSummary%2Findex.asp%3FCaseType%3DCivil&amp;rfr_id=info:sid/en.wikipedia.org:Sertraline"><span style="display: none;">&#160;</span></span></li>
</ol>
</div>
<p><a name="External_links" id="External_links"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Sertraline&amp;action=edit&amp;section=24" title="Edit section: External links">edit</a>]</span> <span class="mw-headline">External links</span></h2>
<table class="metadata plainlinks mbox-small" style="border:1px solid #aaa; background-color:#f9f9f9;">
<tr>
<td class="mbox-image"><a href="http://commons.wikimedia.org/wiki/Special:Search/Sertraline" title="commons:Special:Search/Sertraline"><img alt="Sister project" src="http://upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/40px-Commons-logo.svg.png" width="40" height="54" border="0" /></a></td>
<td class="mbox-text" style=""><a href="/wiki/Wikimedia_Commons" title="Wikimedia Commons">Wikimedia Commons</a> has media related to: <b><i><a href="http://commons.wikimedia.org/wiki/Category:Sertraline" class="extiw" title="commons:Category:Sertraline">Sertraline</a> </i></b></td>
</tr>
</table>
<div class="noprint tright portal" style="border:solid #aaa 1px;margin:0.5em 0 0.5em 0.5em;">
<table style="background:#f9f9f9; font-size:85%; line-height:110%;">
<tr>
<td><a href="/wiki/File:Tabletten.JPG" class="image" title="Tabletten.JPG"><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/thumb/5/5f/Tabletten.JPG/32px-Tabletten.JPG" width="32" height="26" border="0" /></a></td>
<td style="padding:0 0.2em;"><i><b><a href="/wiki/Portal:Pharmacy_and_Pharmacology" title="Portal:Pharmacy and Pharmacology">Pharmacy and Pharmacology portal</a></b></i></td>
</tr>
</table>
</div>
<ul>
<li><a href="http://www.merck.com/mmpe/lexicomp/sertraline.html" class="external text" title="http://www.merck.com/mmpe/lexicomp/sertraline.html" rel="nofollow">List of international brand names for sertraline</a></li>
<li>Prescribing information from <a href="http://www.zoloft.com/" class="external text" title="http://www.zoloft.com/" rel="nofollow">Zoloft</a> manufacturer</li>
</ul>
<p><br clear="all" /></p>
<table class="navbox" cellspacing="0" style=";">
<tr>
<td style="padding:2px;">
<table cellspacing="0" class="nowraplinks collapsible autocollapse" style="width:100%;background:transparent;color:inherit;;">
<tr>
<th style=";" colspan="2" class="navbox-title">
<div style="float:left; width:6em;text-align:left;">
<div class="noprint plainlinksneverexpand navbar" style="background:none; padding:0; font-weight:normal;;;border:none;; font-size:xx-small;"><a href="/wiki/Template:Antidepressants" title="Template:Antidepressants"><span title="View this template" style=";;border:none;">v</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="/wiki/Template_talk:Antidepressants" title="Template talk:Antidepressants"><span title="Discussion about this template" style=";;border:none;">d</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="http://en.wikipedia.org/w/index.php?title=Template:Antidepressants&amp;action=edit" class="external text" title="http://en.wikipedia.org/w/index.php?title=Template:Antidepressants&amp;action=edit" rel="nofollow"><span title="Edit this template" style=";;border:none;;">e</span></a></div>
</div>
<span style="font-size:110%;"><a href="/wiki/Psychoanaleptic" title="Psychoanaleptic">Psychoanaleptics</a>: <a href="/wiki/Antidepressant" title="Antidepressant">antidepressants</a> (<a href="/wiki/ATC_code_N06#N06A_Antidepressants" title="ATC code N06">N06A</a>)</span></th>
</tr>
<tr style="height:2px;">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background: LightYellow;"><a href="/wiki/Monoamine_oxidase_inhibitor" title="Monoamine oxidase inhibitor">MAOIs</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><i>nonselective:</i> <i>non-reversible</i> (<a href="/wiki/Isocarboxazid" title="Isocarboxazid">Isocarboxazid</a>, <a href="/wiki/Iproclozide" title="Iproclozide">Iproclozide</a>, <a href="/wiki/Iproniazid" title="Iproniazid">Iproniazid</a>, <a href="/wiki/Nialamide" title="Nialamide">Nialamide</a>, <a href="/wiki/Phenelzine" title="Phenelzine">Phenelzine</a>, <a href="/wiki/Pheniprazine" title="Pheniprazine">Pheniprazine</a>) • <i>reversible</i> (<a href="/wiki/Tranylcypromine" title="Tranylcypromine">Tranylcypromine</a>)
<p><i><a href="/wiki/Monoamine_oxidase_A" title="Monoamine oxidase A">MAOA</a> (<a href="/wiki/Norepinephrine" title="Norepinephrine">N</a>/<a href="/wiki/Serotonin" title="Serotonin">S</a>):</i> <a href="/wiki/Clorgiline" title="Clorgiline">Clorgiline</a> • <a href="/wiki/Minaprine" title="Minaprine">Minaprine</a> • <i><a href="/wiki/Reversible_inhibitor_of_monoamine_oxidase_A" title="Reversible inhibitor of monoamine oxidase A">RIMAs</a></i> (<a href="/wiki/Befloxatone" title="Befloxatone">Befloxatone</a>, <a href="/wiki/Brofaromine" title="Brofaromine">Brofaromine</a>, <a href="/wiki/Cimoxatone" title="Cimoxatone">Cimoxatone</a>, <a href="/wiki/Harmaline" title="Harmaline">Harmaline</a>, <a href="/wiki/Moclobemide" title="Moclobemide">Moclobemide</a>, <a href="/wiki/Pirlindole" title="Pirlindole">Pirlindole</a>, <a href="/wiki/Toloxatone" title="Toloxatone">Toloxatone</a>)</p>
<i><a href="/wiki/Monoamine_oxidase_B" title="Monoamine oxidase B">MAOB</a> (<a href="/wiki/Dopamine" title="Dopamine">D</a>):</i> <a href="/wiki/Rasagiline" title="Rasagiline">Rasagiline</a> • <a href="/wiki/Selegiline" title="Selegiline">Selegiline</a> • <a href="/wiki/Pargyline" title="Pargyline">Pargyline</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background: LightYellow;"><a href="/wiki/Neurotransmitter_uptake_inhibitor" title="Neurotransmitter uptake inhibitor">RIs</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Serotonin_uptake_inhibitor" title="Serotonin uptake inhibitor">S RI</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Selective_serotonin_reuptake_inhibitor" title="Selective serotonin reuptake inhibitor">SS RI</a> (<a href="/wiki/Alaproclate" title="Alaproclate">Alaproclate</a>, <a href="/wiki/Citalopram" title="Citalopram">Citalopram</a>, <a href="/wiki/Dapoxetine" title="Dapoxetine">Dapoxetine</a>, <a href="/wiki/Escitalopram" title="Escitalopram">Escitalopram</a>, <a href="/wiki/Femoxetine" title="Femoxetine">Femoxetine</a>, <a href="/wiki/Fluoxetine" title="Fluoxetine">Fluoxetine</a>, <a href="/wiki/Fluvoxamine" title="Fluvoxamine">Fluvoxamine</a>, <a href="/wiki/Paroxetine" title="Paroxetine">Paroxetine</a>, <strong class="selflink">Sertraline</strong>, <a href="/wiki/Vilazodone" title="Vilazodone">Vilazodone</a>, <a href="/wiki/Zimelidine" title="Zimelidine">Zimelidine</a>)<br />
<i><a href="/wiki/Tricyclic_antidepressant" title="Tricyclic antidepressant">TCAs</a>/<a href="/wiki/Tetracyclic_antidepressant" title="Tetracyclic antidepressant">Tetras</a></i> (<a href="/wiki/Cianopramine" title="Cianopramine">Cianopramine</a>, <a href="/wiki/Clomipramine" title="Clomipramine">Clomipramine</a>, <a href="/wiki/Nefazodone" title="Nefazodone">Nefazodone</a>, <a href="/wiki/Trazodone" title="Trazodone">Trazodone</a>)</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Norepinephrine_reuptake_inhibitor" title="Norepinephrine reuptake inhibitor">N RI</a> / <a href="/wiki/Adrenergic_uptake_inhibitor" title="Adrenergic uptake inhibitor">A RI</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Atomoxetine" title="Atomoxetine">Atomoxetine</a> • <a href="/wiki/Ciclazindol" title="Ciclazindol">Ciclazindol</a> • <a href="/wiki/Maprotiline" title="Maprotiline">Maprotiline</a> • <a href="/wiki/Nisoxetine" title="Nisoxetine">Nisoxetine</a> • <a href="/wiki/Oxaprotiline" title="Oxaprotiline">Oxaprotiline</a> • <a href="/wiki/Reboxetine" title="Reboxetine">Reboxetine</a> • <a href="/wiki/Talopram" title="Talopram">Talopram</a> • <a href="/wiki/Viloxazine" title="Viloxazine">Viloxazine</a><br />
<i><a href="/wiki/Tricyclic_antidepressant" title="Tricyclic antidepressant">TCAs</a>/<a href="/wiki/Tetracyclic_antidepressant" title="Tetracyclic antidepressant">Tetras</a></i> (<a href="/wiki/Amoxapine" title="Amoxapine">Amoxapine</a>, <a href="/wiki/Butriptyline" title="Butriptyline">Butriptyline</a>, <a href="/wiki/Desipramine" title="Desipramine">Desipramine</a>/<a href="/wiki/Lofepramine" title="Lofepramine">Lofepramine</a>, <a href="/wiki/Dibenzepin" title="Dibenzepin">Dibenzepin</a>, <a href="/wiki/Dosulepin_hydrochloride" title="Dosulepin hydrochloride">Dosulepin</a>, <a href="/wiki/Doxepin" title="Doxepin">Doxepin</a>, <a href="/wiki/Imipramine" title="Imipramine">Imipramine</a>, <a href="/wiki/Iprindole" title="Iprindole">Iprindole</a>, <a href="/wiki/Melitracen" title="Melitracen">Melitracen</a>, <a href="/wiki/Nitroxazepine" title="Nitroxazepine">Nitroxazepine</a>, <a href="/wiki/Nortriptyline" title="Nortriptyline">Nortriptyline</a>, <a href="/wiki/Protriptyline" title="Protriptyline">Protriptyline</a>, <a href="/wiki/Trimipramine" title="Trimipramine">Trimipramine</a>)</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Dopamine_reuptake_inhibitor" title="Dopamine reuptake inhibitor">D RI</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Medifoxamine" title="Medifoxamine">Medifoxamine</a> • <a href="/wiki/Phenmetrazine" title="Phenmetrazine">Phenmetrazine</a> • <a href="/wiki/Vanoxerine" title="Vanoxerine">Vanoxerine</a><br />
<i><a href="/wiki/Tricyclic_antidepressant" title="Tricyclic antidepressant">TCAs</a></i> (<a href="/wiki/Amineptine" title="Amineptine">Amineptine</a>)</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Serotonin-norepinephrine_reuptake_inhibitor" title="Serotonin-norepinephrine reuptake inhibitor">SN RI</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Bicifadine" title="Bicifadine">Bicifadine</a> • <a href="/wiki/Clovoxamine" title="Clovoxamine">Clovoxamine</a> • <a href="/wiki/Desvenlafaxine" title="Desvenlafaxine">Desvenlafaxine</a> • <a href="/wiki/Duloxetine" title="Duloxetine">Duloxetine</a> • <a href="/wiki/Indeloxazine" title="Indeloxazine">Indeloxazine</a> • <a href="/wiki/Milnacipran" title="Milnacipran">Milnacipran</a> • <a href="/wiki/Nefazodone" title="Nefazodone">Nefazodone</a> • <a href="/wiki/Venlafaxine" title="Venlafaxine">Venlafaxine</a><br />
<i><a href="/wiki/Tricyclic_antidepressant" title="Tricyclic antidepressant">TCAs</a></i> (<a href="/wiki/Amitriptyline" title="Amitriptyline">Amitriptyline</a>)</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Norepinephrine-dopamine_reuptake_inhibitor" title="Norepinephrine-dopamine reuptake inhibitor">ND RI</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Bupropion" title="Bupropion">Bupropion</a> • <a href="/wiki/Nomifensine" title="Nomifensine">Nomifensine</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Serotonin-noradrenaline-dopamine_reuptake_inhibitor" title="Serotonin-noradrenaline-dopamine reuptake inhibitor">SND RI</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Brasofensine" title="Brasofensine">Brasofensine</a> • <a href="/wiki/Diclofensine" title="Diclofensine">Diclofensine</a> • <a href="/wiki/Tesofensine" title="Tesofensine">Tesofensine</a></div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background: LightYellow;"><a href="/wiki/Selective_serotonin_reuptake_enhancer" title="Selective serotonin reuptake enhancer">SSREs</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><i><a href="/wiki/Tricyclic_antidepressant" title="Tricyclic antidepressant">TCAs</a></i> (<a href="/wiki/Tianeptine" title="Tianeptine">Tianeptine</a>)</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background: LightYellow;"><a href="/wiki/Adrenergic_antagonist" title="Adrenergic antagonist">AAs</a> at <a href="/wiki/Alpha-2_adrenergic_receptor" title="Alpha-2 adrenergic receptor">A2</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><i><a href="/wiki/Tetracyclic_antidepressant" title="Tetracyclic antidepressant">Tetras</a></i> (<a href="/wiki/Mianserin" title="Mianserin">Mianserin</a>, <a href="/wiki/Mirtazapine" title="Mirtazapine">Mirtazapine</a>)</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background: LightYellow;"><a href="/wiki/Sigma_receptor#Agonists" title="Sigma receptor">SAs</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><i><a href="/wiki/Tricyclic_antidepressant" title="Tricyclic antidepressant">TCAs</a></i> (<a href="/wiki/Opipramol" title="Opipramol">Opipramol</a>)</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background: LightYellow;"><a href="/wiki/Melatonin_receptor" title="Melatonin receptor">MAs</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><i><a href="/wiki/Melatonin_receptor#Agonists" title="Melatonin receptor">Melatonin receptor agonists</a></i> (<a href="/wiki/Agomelatine" title="Agomelatine">Agomelatine</a>)</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
<div style="right:10px; display:none;" class="metadata topicon" id="featured-star">
<div><a href="/wiki/Wikipedia:Featured_articles" title="This is a featured article. Click here for more information."><img alt="Featured article" src="http://upload.wikimedia.org/wikipedia/en/6/60/LinkFA-star.png" width="14" height="14" border="0" /></a></div>
</div>


<!-- 
NewPP limit report
Preprocessor node count: 82784/1000000
Post-expand include size: 777401/2048000 bytes
Template argument size: 311725/2048000 bytes
Expensive parser function count: 0/500
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:149612-0!1!0!default!!en!2 and timestamp 20090403225348 -->
<div class="printfooter">
Retrieved from "<a href="http://en.wikipedia.org/wiki/Sertraline">http://en.wikipedia.org/wiki/Sertraline</a>"</div>
			<div id='catlinks' class='catlinks'><div id="mw-normal-catlinks"><a href="/wiki/Special:Categories" title="Special:Categories">Categories</a>:&#32;<span dir='ltr'><a href="/wiki/Category:Selective_serotonin_reuptake_inhibitors" title="Category:Selective serotonin reuptake inhibitors">Selective serotonin reuptake inhibitors</a></span></div><div id="mw-hidden-catlinks" class="mw-hidden-cats-hidden">Hidden categories:&#32;<span dir='ltr'><a href="/wiki/Category:Featured_articles" title="Category:Featured articles">Featured articles</a></span></div></div>			<!-- end content -->
						<div class="visualClear"></div>
		</div>
	</div>
		</div>
		<div id="column-one">
	<div id="p-cactions" class="portlet">
		<h5>Views</h5>
		<div class="pBody">
			<ul>
	
				 <li id="ca-nstab-main" class="selected"><a href="/wiki/Sertraline" title="View the content page [c]" accesskey="c">Article</a></li>
				 <li id="ca-talk"><a href="/wiki/Talk:Sertraline" title="Discussion about the content page [t]" accesskey="t">Discussion</a></li>
				 <li id="ca-edit"><a href="/w/index.php?title=Sertraline&amp;action=edit" title="You can edit this page. &#10;Please use the preview button before saving. [e]" accesskey="e">Edit this page</a></li>
				 <li id="ca-history"><a href="/w/index.php?title=Sertraline&amp;action=history" title="Past versions of this page [h]" accesskey="h">History</a></li>			</ul>
		</div>
	</div>
	<div class="portlet" id="p-personal">
		<h5>Personal tools</h5>
		<div class="pBody">
			<ul>
				<li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Sertraline" title="You are encouraged to log in; however, it is not mandatory. [o]" accesskey="o">Log in / create account</a></li>
			</ul>
		</div>
	</div>
	<div class="portlet" id="p-logo">
		<a style="background-image: url(http://upload.wikimedia.org/wikipedia/en/b/bc/Wiki.png);" href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z"></a>
	</div>
	<script type="text/javascript"> if (window.isMSIE55) fixalpha(); </script>
	<div class='generated-sidebar portlet' id='p-navigation'>
		<h5>Navigation</h5>
		<div class='pBody'>
			<ul>
				<li id="n-mainpage-description"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z">Main page</a></li>
				<li id="n-contents"><a href="/wiki/Portal:Contents" title="Guides to browsing Wikipedia">Contents</a></li>
				<li id="n-featuredcontent"><a href="/wiki/Portal:Featured_content" title="Featured content — the best of Wikipedia">Featured content</a></li>
				<li id="n-currentevents"><a href="/wiki/Portal:Current_events" title="Find background information on current events">Current events</a></li>
				<li id="n-randompage"><a href="/wiki/Special:Random" title="Load a random article [x]" accesskey="x">Random article</a></li>
			</ul>
		</div>
	</div>
	<div id="p-search" class="portlet">
		<h5><label for="searchInput">Search</label></h5>
		<div id="searchBody" class="pBody">
			<form action="/w/index.php" id="searchform"><div>
				<input type='hidden' name="title" value="Special:Search"/>
				<input id="searchInput" name="search" type="text" title="Search Wikipedia [f]" accesskey="f" value="" />
				<input type='submit' name="go" class="searchButton" id="searchGoButton"	value="Go" title="Go to a page with this exact name if one exists" />&nbsp;
				<input type='submit' name="fulltext" class="searchButton" id="mw-searchButton" value="Search" title="Search Wikipedia for this text" />
			</div></form>
		</div>
	</div>
	<div class='generated-sidebar portlet' id='p-interaction'>
		<h5>Interaction</h5>
		<div class='pBody'>
			<ul>
				<li id="n-aboutsite"><a href="/wiki/Wikipedia:About" title="Find out about Wikipedia">About Wikipedia</a></li>
				<li id="n-portal"><a href="/wiki/Wikipedia:Community_portal" title="About the project, what you can do, where to find things">Community portal</a></li>
				<li id="n-recentchanges"><a href="/wiki/Special:RecentChanges" title="The list of recent changes in the wiki [r]" accesskey="r">Recent changes</a></li>
				<li id="n-contact"><a href="/wiki/Wikipedia:Contact_us" title="How to contact Wikipedia">Contact Wikipedia</a></li>
				<li id="n-sitesupport"><a href="http://wikimediafoundation.org/wiki/Donate" title="Support us">Donate to Wikipedia</a></li>
				<li id="n-help"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia">Help</a></li>
			</ul>
		</div>
	</div>
	<div class="portlet" id="p-tb">
		<h5>Toolbox</h5>
		<div class="pBody">
			<ul>
				<li id="t-whatlinkshere"><a href="/wiki/Special:WhatLinksHere/Sertraline" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j">What links here</a></li>
				<li id="t-recentchangeslinked"><a href="/wiki/Special:RecentChangesLinked/Sertraline" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</a></li>
<li id="t-upload"><a href="/wiki/Wikipedia:Upload" title="Upload files [u]" accesskey="u">Upload file</a></li>
<li id="t-specialpages"><a href="/wiki/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</a></li>
				<li id="t-print"><a href="/w/index.php?title=Sertraline&amp;printable=yes" rel="alternate" title="Printable version of this page [p]" accesskey="p">Printable version</a></li>				<li id="t-permalink"><a href="/w/index.php?title=Sertraline&amp;oldid=280831519" title="Permanent link to this version of the page">Permanent link</a></li><li id="t-cite"><a href="/w/index.php?title=Special:Cite&amp;page=Sertraline&amp;id=280831519">Cite this page</a></li>			</ul>
		</div>
	</div>
	<div id="p-lang" class="portlet">
		<h5>Languages</h5>
		<div class="pBody">
			<ul>
				<li class="interwiki-de"><a href="http://de.wikipedia.org/wiki/Sertralin">Deutsch</a></li>
				<li class="interwiki-es"><a href="http://es.wikipedia.org/wiki/Sertralina">Español</a></li>
				<li class="interwiki-eu"><a href="http://eu.wikipedia.org/wiki/Sertralina">Euskara</a></li>
				<li class="interwiki-fa"><a href="http://fa.wikipedia.org/wiki/%D8%B3%D8%B1%D8%AA%D8%B1%D8%A7%D9%84%DB%8C%D9%86">فارسی</a></li>
				<li class="interwiki-fr"><a href="http://fr.wikipedia.org/wiki/Sertraline">Français</a></li>
				<li class="interwiki-ko"><a href="http://ko.wikipedia.org/wiki/%EC%84%A4%ED%8A%B8%EB%9E%84%EB%A6%B0">한국어</a></li>
				<li class="interwiki-it"><a href="http://it.wikipedia.org/wiki/Sertralina_cloridrato">Italiano</a></li>
				<li class="interwiki-lv"><a href="http://lv.wikipedia.org/wiki/Sertral%C4%ABns">Latviešu</a></li>
				<li class="interwiki-lt"><a href="http://lt.wikipedia.org/wiki/Sertralinas">Lietuvių</a></li>
				<li class="interwiki-hu"><a href="http://hu.wikipedia.org/wiki/Sertralin">Magyar</a></li>
				<li class="interwiki-nl"><a href="http://nl.wikipedia.org/wiki/Sertraline">Nederlands</a></li>
				<li class="interwiki-ja"><a href="http://ja.wikipedia.org/wiki/%E3%82%BB%E3%83%AB%E3%83%88%E3%83%A9%E3%83%AA%E3%83%B3">日本語</a></li>
				<li class="interwiki-no"><a href="http://no.wikipedia.org/wiki/Sertralin">‪Norsk (bokmål)‬</a></li>
				<li class="interwiki-pl"><a href="http://pl.wikipedia.org/wiki/Sertralina">Polski</a></li>
				<li class="interwiki-pt"><a href="http://pt.wikipedia.org/wiki/Sertralina">Português</a></li>
				<li class="interwiki-ru"><a href="http://ru.wikipedia.org/wiki/%D0%A1%D0%B5%D1%80%D1%82%D1%80%D0%B0%D0%BB%D0%B8%D0%BD">Русский</a></li>
				<li class="interwiki-fi"><a href="http://fi.wikipedia.org/wiki/Sertraliini">Suomi</a></li>
				<li class="interwiki-sv"><a href="http://sv.wikipedia.org/wiki/Sertralin">Svenska</a></li>
				<li class="interwiki-zh"><a href="http://zh.wikipedia.org/wiki/%E8%88%8D%E6%9B%B2%E6%9E%97">中文</a></li>
			</ul>
		</div>
	</div>
		</div><!-- end of the left (by default at least) column -->
			<div class="visualClear"></div>
			<div id="footer">
				<div id="f-poweredbyico"><a href="http://www.mediawiki.org/"><img src="/skins-1.5/common/images/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" /></a></div>
				<div id="f-copyrightico"><a href="http://wikimediafoundation.org/"><img src="/images/wikimedia-button.png" border="0" alt="Wikimedia Foundation"/></a></div>
			<ul id="f-list">
					<li id="lastmod"> This page was last modified on 31 March 2009, at 09:43.</li>
					<li id="copyright">All text is available under the terms of the <a class='internal' href="http://en.wikipedia.org/wiki/Wikipedia:Text_of_the_GNU_Free_Documentation_License" title="Wikipedia:Text of the GNU Free Documentation License">GNU Free Documentation License</a>. (See <b><a class='internal' href="http://en.wikipedia.org/wiki/Wikipedia:Copyrights" title="Wikipedia:Copyrights">Copyrights</a></b> for details.) <br /> Wikipedia&reg; is a registered trademark of the <a href="http://www.wikimediafoundation.org">Wikimedia Foundation, Inc.</a>, a U.S. registered <a class='internal' href="http://en.wikipedia.org/wiki/501%28c%29#501.28c.29.283.29" title="501(c)(3)">501(c)(3)</a> <a href="http://wikimediafoundation.org/wiki/Deductibility_of_donations">tax-deductible</a> <a class='internal' href="http://en.wikipedia.org/wiki/Non-profit_organization" title="Non-profit organization">nonprofit</a> <a href="http://en.wikipedia.org/wiki/Charitable_organization" title="Charitable organization">charity</a>.<br /></li>
					<li id="privacy"><a href="http://wikimediafoundation.org/wiki/Privacy_policy" title="wikimedia:Privacy policy">Privacy policy</a></li>
					<li id="about"><a href="/wiki/Wikipedia:About" title="Wikipedia:About">About Wikipedia</a></li>
					<li id="disclaimer"><a href="/wiki/Wikipedia:General_disclaimer" title="Wikipedia:General disclaimer">Disclaimers</a></li>
			</ul>
		</div>
</div>

		<script type="text/javascript">if (window.runOnloadHook) runOnloadHook();</script>
<!-- Served by srv199 in 0.046 secs. --></body></html>
